false 2020 FY 0001385280 --12-31 2.00 2.00 2.00 2025-03-31 2.00 P3Y P1Y 0 0 us-gaap:PropertyPlantAndEquipmentNet us-gaap:PropertyPlantAndEquipmentNet P2Y6M P7Y7M6D P4Y4M24D P9Y2M12D P1Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y 0.0325 May 2023 0.0159 November 2021 0.015 0.0029 0.0558 0.0808 September 2023 November 2023 September 2025 October 2023 0001385280 2020-01-01 2020-12-31 xbrli:shares 0001385280 2021-02-15 iso4217:USD 0001385280 2020-06-30 0001385280 2019-12-31 0001385280 2020-12-31 0001385280 cnk:NcmMember 2019-12-31 0001385280 cnk:NcmMember 2020-12-31 0001385280 srt:AffiliatedEntityMember 2019-12-31 0001385280 srt:AffiliatedEntityMember 2020-12-31 iso4217:USD xbrli:shares 0001385280 cnk:AdmissionsRevenueMember 2018-01-01 2018-12-31 0001385280 cnk:AdmissionsRevenueMember 2019-01-01 2019-12-31 0001385280 cnk:AdmissionsRevenueMember 2020-01-01 2020-12-31 0001385280 us-gaap:ConcessionsMember 2018-01-01 2018-12-31 0001385280 us-gaap:ConcessionsMember 2019-01-01 2019-12-31 0001385280 us-gaap:ConcessionsMember 2020-01-01 2020-12-31 0001385280 cnk:OtherRevenuesMember 2018-01-01 2018-12-31 0001385280 cnk:OtherRevenuesMember 2019-01-01 2019-12-31 0001385280 cnk:OtherRevenuesMember 2020-01-01 2020-12-31 0001385280 2018-01-01 2018-12-31 0001385280 2019-01-01 2019-12-31 0001385280 cnk:NcmMember 2018-01-01 2018-12-31 0001385280 cnk:NcmMember 2019-01-01 2019-12-31 0001385280 cnk:NcmMember 2020-01-01 2020-12-31 0001385280 us-gaap:CommonStockMember 2017-12-31 0001385280 us-gaap:TreasuryStockMember 2017-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001385280 us-gaap:RetainedEarningsMember 2017-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001385280 us-gaap:ParentMember 2017-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2017-12-31 0001385280 2017-12-31 0001385280 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-12-31 0001385280 us-gaap:ParentMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-12-31 0001385280 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-12-31 0001385280 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001385280 us-gaap:TreasuryStockMember 2018-01-01 2018-12-31 0001385280 us-gaap:ParentMember 2018-01-01 2018-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001385280 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001385280 us-gaap:CommonStockMember 2018-12-31 0001385280 us-gaap:TreasuryStockMember 2018-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001385280 us-gaap:RetainedEarningsMember 2018-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001385280 us-gaap:ParentMember 2018-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2018-12-31 0001385280 2018-12-31 0001385280 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201901Member 2019-01-01 2019-12-31 0001385280 us-gaap:ParentMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201901Member 2019-01-01 2019-12-31 0001385280 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201901Member 2019-01-01 2019-12-31 0001385280 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001385280 us-gaap:ParentMember 2019-01-01 2019-12-31 0001385280 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001385280 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001385280 us-gaap:CommonStockMember 2019-12-31 0001385280 us-gaap:TreasuryStockMember 2019-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001385280 us-gaap:RetainedEarningsMember 2019-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001385280 us-gaap:ParentMember 2019-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2019-12-31 0001385280 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001385280 us-gaap:ParentMember 2020-01-01 2020-12-31 0001385280 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001385280 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001385280 us-gaap:CommonStockMember 2020-12-31 0001385280 us-gaap:TreasuryStockMember 2020-12-31 0001385280 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001385280 us-gaap:RetainedEarningsMember 2020-12-31 0001385280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001385280 us-gaap:ParentMember 2020-12-31 0001385280 us-gaap:NoncontrollingInterestMember 2020-12-31 0001385280 us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-12-31 0001385280 cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2020-01-01 2020-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 xbrli:pure 0001385280 srt:MinimumMember 2020-12-31 0001385280 srt:MaximumMember 2020-12-31 0001385280 cnk:BuildingsOnOwnedLandMember 2020-01-01 2020-12-31 0001385280 cnk:BuildingsOnLeasedLandMember 2020-01-01 2020-12-31 0001385280 cnk:LandAndBuildingsUnderFinanceLeasesMember 2020-01-01 2020-12-31 0001385280 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2020-01-01 2020-12-31 0001385280 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 us-gaap:LeaseholdImprovementsMember 2020-01-01 2020-12-31 0001385280 cnk:PropertyUnderFinanceLeaseMember 2019-12-31 0001385280 cnk:PropertyUnderFinanceLeaseMember 2020-12-31 cnk:Segment 0001385280 cnk:UsOperatingSegmentMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember 2020-01-01 2020-12-31 0001385280 us-gaap:OtherIntangibleAssetsMember 2020-01-01 2020-12-31 0001385280 us-gaap:TradeNamesMember 2020-01-01 2020-12-31 0001385280 srt:MinimumMember us-gaap:OtherIntangibleAssetsMember 2020-01-01 2020-12-31 0001385280 us-gaap:OtherIntangibleAssetsMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 srt:MaximumMember 2018-01-01 2018-12-31 cnk:Domestic 0001385280 us-gaap:NaturalDisastersAndOtherCasualtyEventsMember 2020-01-01 2020-12-31 cnk:International 0001385280 us-gaap:NaturalDisastersAndOtherCasualtyEventsMember 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:EmployeeRelatedMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:FacilityClosureCostsMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:EmployeeRelatedMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:FacilityClosureCostsMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:ConsolidatedMember cnk:EmployeeRelatedMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:ConsolidatedMember cnk:FacilityClosureCostsMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:ConsolidatedMember cnk:TwentyTwentyRestructuringPlanMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:EmployeeRelatedMember cnk:TwentyTwentyRestructuringPlanMember 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:FacilityClosureCostsMember cnk:TwentyTwentyRestructuringPlanMember 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:TwentyTwentyRestructuringPlanMember 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:FacilityClosureCostsMember cnk:TwentyTwentyRestructuringPlanMember 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:TwentyTwentyRestructuringPlanMember 2020-12-31 0001385280 cnk:ConsolidatedMember cnk:EmployeeRelatedMember cnk:TwentyTwentyRestructuringPlanMember 2020-12-31 0001385280 cnk:ConsolidatedMember cnk:FacilityClosureCostsMember cnk:TwentyTwentyRestructuringPlanMember 2020-12-31 0001385280 cnk:ConsolidatedMember cnk:TwentyTwentyRestructuringPlanMember 2020-12-31 0001385280 us-gaap:NaturalDisastersAndOtherCasualtyEventsMember 2020-12-31 0001385280 srt:MinimumMember cnk:TheatresMember 2020-01-01 2020-12-31 0001385280 cnk:TheatresMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 srt:MinimumMember us-gaap:EquipmentMember 2020-12-31 0001385280 us-gaap:EquipmentMember srt:MaximumMember 2020-12-31 0001385280 cnk:TheatresMember 2020-12-31 0001385280 cnk:TheatresMember cnk:AccruedOtherCurrentLiabilitiesMember 2020-12-31 0001385280 cnk:TheatresMember us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0001385280 us-gaap:EquipmentMember cnk:UtilitiesAndOtherMember 2019-01-01 2019-12-31 0001385280 us-gaap:EquipmentMember cnk:UtilitiesAndOtherMember 2020-01-01 2020-12-31 0001385280 cnk:RealEstatePropertyMember cnk:FacilityLeasingExpenseMember 2019-01-01 2019-12-31 0001385280 cnk:RealEstatePropertyMember cnk:FacilityLeasingExpenseMember 2020-01-01 2020-12-31 0001385280 cnk:DepreciationAndAmortizationMember 2019-01-01 2019-12-31 0001385280 cnk:DepreciationAndAmortizationMember 2020-01-01 2020-12-31 0001385280 us-gaap:InterestExpenseMember 2019-01-01 2019-12-31 0001385280 us-gaap:InterestExpenseMember 2020-01-01 2020-12-31 0001385280 us-gaap:EquipmentMember 2020-12-31 0001385280 cnk:RealEstatePropertyMember 2020-12-31 0001385280 cnk:RealEstatePropertyMember 2019-01-01 2019-12-31 0001385280 cnk:RealEstatePropertyMember 2020-01-01 2020-12-31 0001385280 us-gaap:EquipmentMember 2019-01-01 2019-12-31 0001385280 us-gaap:EquipmentMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:AdmissionMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:AdmissionMember 2020-01-01 2020-12-31 0001385280 us-gaap:AdmissionMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:ConcessionsMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:ConcessionsMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2020-01-01 2020-12-31 0001385280 cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:OtherRevenueMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:OtherRevenueMember 2020-01-01 2020-12-31 0001385280 cnk:OtherRevenueMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:AdmissionMember 2019-01-01 2019-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:AdmissionMember 2019-01-01 2019-12-31 0001385280 us-gaap:AdmissionMember 2019-01-01 2019-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:ConcessionsMember 2019-01-01 2019-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:ConcessionsMember 2019-01-01 2019-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2019-01-01 2019-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2019-01-01 2019-12-31 0001385280 cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2019-01-01 2019-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:OtherRevenueMember 2019-01-01 2019-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:OtherRevenueMember 2019-01-01 2019-12-31 0001385280 cnk:OtherRevenueMember 2019-01-01 2019-12-31 0001385280 cnk:UsOperatingSegmentMember 2019-01-01 2019-12-31 0001385280 cnk:InternationalOperatingSegmentMember 2019-01-01 2019-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:AdmissionMember 2018-01-01 2018-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:AdmissionMember 2018-01-01 2018-12-31 0001385280 us-gaap:AdmissionMember 2018-01-01 2018-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:ConcessionsMember 2018-01-01 2018-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:ConcessionsMember 2018-01-01 2018-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2018-01-01 2018-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2018-01-01 2018-12-31 0001385280 cnk:ScreenAdvertisingScreenRentalAndPromotionalRevenuesMember 2018-01-01 2018-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:OtherRevenueMember 2018-01-01 2018-12-31 0001385280 cnk:InternationalOperatingSegmentMember cnk:OtherRevenueMember 2018-01-01 2018-12-31 0001385280 cnk:OtherRevenueMember 2018-01-01 2018-12-31 0001385280 cnk:UsOperatingSegmentMember 2018-01-01 2018-12-31 0001385280 cnk:InternationalOperatingSegmentMember 2018-01-01 2018-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:UsOperatingSegmentMember 2020-01-01 2020-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:InternationalOperatingSegmentMember 2020-01-01 2020-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-12-31 0001385280 us-gaap:TransferredOverTimeMember cnk:UsOperatingSegmentMember 2020-01-01 2020-12-31 0001385280 us-gaap:TransferredOverTimeMember cnk:InternationalOperatingSegmentMember 2020-01-01 2020-12-31 0001385280 us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:UsOperatingSegmentMember 2019-01-01 2019-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-12-31 0001385280 us-gaap:TransferredOverTimeMember cnk:UsOperatingSegmentMember 2019-01-01 2019-12-31 0001385280 us-gaap:TransferredOverTimeMember cnk:InternationalOperatingSegmentMember 2019-01-01 2019-12-31 0001385280 us-gaap:TransferredOverTimeMember 2019-01-01 2019-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:UsOperatingSegmentMember 2018-01-01 2018-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember cnk:InternationalOperatingSegmentMember 2018-01-01 2018-12-31 0001385280 us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-12-31 0001385280 us-gaap:TransferredOverTimeMember cnk:UsOperatingSegmentMember 2018-01-01 2018-12-31 0001385280 us-gaap:TransferredOverTimeMember cnk:InternationalOperatingSegmentMember 2018-01-01 2018-12-31 0001385280 us-gaap:TransferredOverTimeMember 2018-01-01 2018-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2019-12-31 0001385280 cnk:OtherDeferredRevenuesMember 2019-12-31 0001385280 cnk:OtherDeferredRevenuesMember 2020-01-01 2020-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember cnk:NcmMember 2020-01-01 2020-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2020-12-31 0001385280 cnk:OtherDeferredRevenuesMember 2020-12-31 0001385280 2020-01-01 2020-12-31 0001385280 2021-01-01 2020-12-31 0001385280 2022-01-01 2020-12-31 0001385280 2023-01-01 2020-12-31 0001385280 2024-01-01 2020-12-31 0001385280 2025-01-01 2020-12-31 0001385280 cnk:OtherDeferredRevenuesMember 2020-01-01 2020-12-31 0001385280 cnk:OtherDeferredRevenuesMember 2021-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001385280 cnk:FirstQuarterDividendMember 2018-01-01 2018-12-31 0001385280 cnk:SecondQuarterDividendMember 2018-01-01 2018-12-31 0001385280 cnk:ThirdQuarterDividendMember 2018-01-01 2018-12-31 0001385280 cnk:FourthQuarterDividendMember 2018-01-01 2018-12-31 0001385280 cnk:FirstQuarterDividendMember 2019-01-01 2019-12-31 0001385280 cnk:SecondQuarterDividendMember 2019-01-01 2019-12-31 0001385280 cnk:ThirdQuarterDividendMember 2019-01-01 2019-12-31 0001385280 cnk:FourthQuarterDividendMember 2019-01-01 2019-12-31 0001385280 cnk:FirstQuarterDividendMember 2020-01-01 2020-12-31 0001385280 cnk:InvestmentInNcmMember 2017-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2017-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-01-01 2018-12-31 0001385280 cnk:InvestmentInNcmMember 2018-01-01 2018-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2018-01-01 2018-12-31 0001385280 cnk:OtherRevenueMember 2018-01-01 2018-12-31 0001385280 cnk:InterestExpenseNcmMember 2018-01-01 2018-12-31 0001385280 cnk:CashReceivedMember 2018-01-01 2018-12-31 0001385280 cnk:DistributionsFromNcmMember 2018-01-01 2018-12-31 0001385280 cnk:EquityInEarningsLossMember cnk:NcmMember 2018-01-01 2018-12-31 0001385280 cnk:OtherRevenueMember cnk:NcmMember 2018-01-01 2018-12-31 0001385280 cnk:InvestmentInNcmMember 2018-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2018-12-31 0001385280 cnk:DistributionsFromNcmMember 2018-12-31 0001385280 cnk:EquityInEarningsLossMember cnk:NcmMember 2018-12-31 0001385280 cnk:OtherRevenueMember 2018-12-31 0001385280 cnk:InterestExpenseNcmMember 2018-12-31 0001385280 cnk:CashReceivedMember 2018-12-31 0001385280 cnk:InvestmentInNcmMember 2019-01-01 2019-12-31 0001385280 cnk:NCMScreenAdvertisingAdvancesMember 2019-01-01 2019-12-31 0001385280 cnk:OtherRevenueMember 2019-01-01 2019-12-31 0001385280 cnk:CashReceivedMember 2019-01-01 2019-12-31 0001385280 cnk:InterestExpenseNcmMember 2019-01-01 2019-12-31 0001385280 cnk:DistributionsFromNcmMember 2019-01-01 2019-12-31 0001385280 cnk:EquityInEarningsLossMember cnk:NcmMember 2019-01-01 2019-12-31 0001385280 cnk:OtherRevenueMember cnk:NcmMember 2019-01-01 2019-12-31 0001385280 cnk:InvestmentInNcmMember 2019-12-31 0001385280 cnk:DistributionsFromNcmMember 2019-12-31 0001385280 cnk:EquityInEarningsLossMember cnk:NcmMember 2019-12-31 0001385280 cnk:OtherRevenueMember 2019-12-31 0001385280 cnk:InterestExpenseNcmMember 2019-12-31 0001385280 cnk:CashReceivedMember 2019-12-31 0001385280 cnk:InvestmentInNcmMember 2020-01-01 2020-12-31 0001385280 cnk:OtherRevenueMember 2020-01-01 2020-12-31 0001385280 cnk:CashReceivedMember 2020-01-01 2020-12-31 0001385280 cnk:InterestExpenseNcmMember 2020-01-01 2020-12-31 0001385280 cnk:DistributionsFromNcmMember 2020-01-01 2020-12-31 0001385280 cnk:EquityInEarningsLossMember cnk:NcmMember 2020-01-01 2020-12-31 0001385280 cnk:OtherRevenueMember cnk:NcmMember 2020-01-01 2020-12-31 0001385280 cnk:InvestmentInNcmMember 2020-12-31 0001385280 cnk:DistributionsFromNcmMember 2020-12-31 0001385280 cnk:EquityInEarningsLossMember cnk:NcmMember 2020-12-31 0001385280 cnk:OtherRevenueMember 2020-12-31 0001385280 cnk:InterestExpenseNcmMember 2020-12-31 0001385280 cnk:CashReceivedMember 2020-12-31 0001385280 cnk:ScreenAdvertisingRentalRevenueMember 2020-01-01 2020-12-31 0001385280 cnk:NcmMember cnk:PropertiesAndEquipmentMember 2018-01-01 2018-12-31 0001385280 cnk:NcmMember cnk:PropertiesAndEquipmentMember 2019-01-01 2019-12-31 0001385280 cnk:NcmMember cnk:PropertiesAndEquipmentMember 2020-01-01 2020-12-31 0001385280 2020-01-01 2020-03-31 0001385280 cnk:InvestmentInNcmMember 2020-03-31 0001385280 cnk:AnnualCommonUnitAdjustmentMember 2017-12-30 2018-03-29 0001385280 cnk:AnnualCommonUnitAdjustmentMember 2019-01-01 2019-03-31 0001385280 cnk:AnnualCommonUnitAdjustmentMember 2020-01-01 2020-03-31 0001385280 cnk:NcmMember 2018-07-05 0001385280 cnk:NcmMember 2018-07-04 2018-07-05 0001385280 cnk:NcmMember 2018-07-04 0001385280 2021-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-12-31 0001385280 2022-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-12-31 0001385280 2023-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-12-31 0001385280 2024-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-12-31 0001385280 2026-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2019-12-31 0001385280 2025-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-12-31 0001385280 2026-01-01 cnk:NCMScreenAdvertisingAdvancesMember 2020-12-31 0001385280 srt:MinimumMember cnk:NcmMember 2020-01-01 2020-12-31 0001385280 srt:MaximumMember cnk:NcmMember 2020-01-01 2020-12-31 0001385280 cnk:NcmMember 2017-12-29 2018-12-27 0001385280 cnk:NcmMember 2018-12-28 2019-12-26 0001385280 cnk:NcmMember 2019-12-26 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2017-12-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2017-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2017-12-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2017-12-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2017-12-31 0001385280 us-gaap:OtherAffiliatesMember 2017-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2018-01-01 2018-12-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2018-01-01 2018-12-31 0001385280 us-gaap:OtherAffiliatesMember 2018-01-01 2018-12-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2018-01-01 2018-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2018-01-01 2018-12-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2018-01-01 2018-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2018-12-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2018-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2018-12-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2018-12-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2018-12-31 0001385280 us-gaap:OtherAffiliatesMember 2018-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2019-01-01 2019-12-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2019-01-01 2019-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2019-01-01 2019-12-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2019-01-01 2019-12-31 0001385280 us-gaap:OtherAffiliatesMember 2019-01-01 2019-12-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2019-01-01 2019-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 us-gaap:OtherAffiliatesMember 2019-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-12-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-12-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-12-31 0001385280 us-gaap:OtherAffiliatesMember 2020-01-01 2020-12-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2020-01-01 2020-12-31 0001385280 cnk:ACJVLLCMember us-gaap:OtherAffiliatesMember 2020-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember us-gaap:OtherAffiliatesMember 2020-12-31 0001385280 cnk:FEConceptsLLCMember us-gaap:OtherAffiliatesMember 2020-12-31 0001385280 cnk:OtherInvestmentMember us-gaap:OtherAffiliatesMember 2020-12-31 0001385280 us-gaap:OtherAffiliatesMember 2020-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember 2020-12-31 0001385280 srt:MaximumMember cnk:DigitalCinemaImplementationPartnersMember 2020-01-01 2020-12-31 cnk:Studio 0001385280 us-gaap:OtherAffiliatesMember cnk:DigitalCinemaImplementationPartnersMember 2020-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember 2018-01-01 2018-12-31 0001385280 cnk:DigitalCinemaImplementationPartnersMember 2019-01-01 2019-12-31 0001385280 cnk:ACJVLLCMember cnk:FilmRentalsAndAdvertisingMember 2018-01-01 2018-12-31 0001385280 cnk:ACJVLLCMember cnk:FilmRentalsAndAdvertisingMember 2018-12-28 2019-12-26 0001385280 cnk:ACJVLLCMember cnk:FilmRentalsAndAdvertisingMember 2020-01-01 2020-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember 2020-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember 2017-12-29 2018-12-27 0001385280 cnk:DigitalCinemaDistributionCoalitionMember 2019-01-01 2019-12-31 0001385280 cnk:DigitalCinemaDistributionCoalitionMember 2020-01-01 2020-12-31 0001385280 cnk:CNMKTexasPropertiesLLCMember 2018-04-29 2018-04-30 0001385280 cnk:AWSRInvestmentsLimitedLiabilityCompanyMember cnk:CNMKTexasPropertiesLLCMember 2018-04-29 2018-04-30 0001385280 cnk:CNMKTexasPropertiesLLCMember 2018-04-30 0001385280 cnk:AWSRInvestmentsLimitedLiabilityCompanyMember cnk:CNMKTexasPropertiesLLCMember 2018-04-30 0001385280 cnk:AWSRInvestmentsLimitedLiabilityCompanyMember cnk:CNMKTexasPropertiesLLCMember 2019-01-01 2019-12-31 0001385280 cnk:AWSRInvestmentsLimitedLiabilityCompanyMember cnk:CNMKTexasPropertiesLLCMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember 2018-12-31 0001385280 cnk:InternationalOperatingSegmentMember 2018-12-31 0001385280 cnk:UsOperatingSegmentMember 2019-12-31 0001385280 cnk:InternationalOperatingSegmentMember 2019-12-31 0001385280 cnk:UsOperatingSegmentMember 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember 2020-12-31 cnk:Theatre 0001385280 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-12-31 0001385280 us-gaap:GoodwillMember us-gaap:MarketApproachValuationTechniqueMember 2020-01-01 2020-03-31 0001385280 cnk:TradenameIntangibleAssetMember us-gaap:IncomeApproachValuationTechniqueMember 2020-01-01 2020-03-31 0001385280 cnk:OtherLongLivedAssetMember us-gaap:MarketApproachValuationTechniqueMember 2020-01-01 2020-03-31 0001385280 us-gaap:GoodwillMember 2020-04-01 2020-06-30 0001385280 cnk:TradenameIntangibleAssetMember 2020-04-01 2020-06-30 0001385280 cnk:OtherLongLivedAssetMember 2020-04-01 2020-06-30 0001385280 us-gaap:GoodwillMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2020-09-30 0001385280 cnk:TradenameIntangibleAssetMember us-gaap:IncomeApproachValuationTechniqueMember 2020-07-01 2020-09-30 0001385280 cnk:OtherLongLivedAssetMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2020-09-30 0001385280 us-gaap:GoodwillMember us-gaap:MarketApproachValuationTechniqueMember 2020-10-01 2020-12-31 0001385280 cnk:TradenameIntangibleAssetMember us-gaap:IncomeApproachValuationTechniqueMember 2020-10-01 2020-12-31 0001385280 cnk:OtherLongLivedAssetMember us-gaap:MarketApproachValuationTechniqueMember 2020-10-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember cnk:InvestmentInNcmMember 2020-01-01 2020-12-31 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteDueTwentyTwentyTwoMember 2019-12-31 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteDueTwentyTwentyTwoMember 2020-12-31 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueTwentyTwentyThreeMember 2019-12-31 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueTwentyTwentyThreeMember 2020-12-31 0001385280 cnk:EightPointSevenFivePercentSeniorSecuredNoteDueTwentyTwentyFiveMember 2020-12-31 0001385280 cnk:FourPointFivePercentConvertibleSeniorNoteDueTwentyTwentyFiveMember 2020-12-31 0001385280 cnk:TermLoanCreditFacilityMember cnk:SeniorSecuredCreditFacilityMember 2020-12-31 0001385280 cnk:RevolvingCreditLineMember cnk:SeniorSecuredCreditFacilityMember 2020-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember 2018-03-29 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember 2020-01-01 2020-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember 2019-01-01 2019-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember 2018-01-01 2018-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember 2017-01-01 2017-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember 2020-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember cnk:TermLoanCreditFacilityMember 2020-01-01 2020-12-31 0001385280 cnk:RevolvingCreditLineMember cnk:AmendedSeniorSecuredCreditFacilityMember 2020-01-01 2020-12-31 0001385280 cnk:TermLoanCreditFacilityMember cnk:AmendedSeniorSecuredCreditFacilityMember cnk:OneMonthEurodollarRateMember 2020-01-01 2020-12-31 0001385280 cnk:RevolvingCreditLineMember cnk:AmendedSeniorSecuredCreditFacilityMember cnk:OneMonthEurodollarRateMember srt:MinimumMember 2020-01-01 2020-12-31 0001385280 cnk:RevolvingCreditLineMember cnk:AmendedSeniorSecuredCreditFacilityMember cnk:OneMonthEurodollarRateMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 cnk:RevolvingCreditLineMember cnk:AmendedSeniorSecuredCreditFacilityMember srt:MinimumMember 2020-01-01 2020-12-31 0001385280 cnk:RevolvingCreditLineMember cnk:AmendedSeniorSecuredCreditFacilityMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember cnk:TermLoanCreditFacilityMember 2019-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember cnk:RevolvingCreditLineMember 2019-12-31 0001385280 cnk:AmendedSeniorSecuredCreditFacilityMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 cnk:FourPointFiveZeroConvertibleSeniorNotesMember 2020-08-21 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueMayTwentyTwentyThreeMember 2013-05-24 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueMayTwentyTwentyThreeMember 2013-05-23 2013-05-24 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueJuneOneTwentyTwentyThreeMember 2016-05-21 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueJuneOneTwentyTwentyThreeMember 2016-05-20 2016-05-21 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueJuneOneTwentyTwentyThreeMember 2016-12-31 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueJuneOneTwentyTwentyThreeMember 2016-01-01 2016-12-31 0001385280 cnk:FourPointEightSevenFivePercentSeniorNotesMember 2020-01-01 2020-12-31 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueMayTwentyTwentyThreeMember 2020-01-01 2020-12-31 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueMayTwentyTwentyThreeMember 2020-12-31 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteDueTwentyTwentyTwoMember 2012-12-18 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteDueTwentyTwentyTwoMember 2012-12-17 2012-12-18 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteDueTwentyTwentyTwoMember 2020-01-01 2020-12-31 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteDueTwentyTwentyTwoMember 2012-01-01 2012-12-31 0001385280 cnk:FivePointOneTwoFivePercentSeniorNoteMember 2020-01-01 2020-12-31 0001385280 cnk:EightPointSevenFivePercentSecuredNotesMember 2020-04-20 0001385280 cnk:EightPointSevenFivePercentSecuredNotesMember 2020-04-20 2020-04-20 0001385280 srt:ScenarioForecastMember cnk:FivePointOneTwoFivePercentSeniorNoteMember 2022-09-13 0001385280 srt:ScenarioForecastMember cnk:FivePointOneTwoFivePercentSeniorNoteMember 2022-09-13 2022-09-13 0001385280 srt:ScenarioForecastMember cnk:FourPointEightSevenFivePercentSeniorNotesMember 2023-02-27 0001385280 srt:ScenarioForecastMember cnk:FourPointEightSevenFivePercentSeniorNotesMember 2023-02-27 2023-02-27 0001385280 cnk:FourPointFiveZeroConvertibleSeniorNotesMember 2020-08-21 2020-08-21 0001385280 cnk:FourPointFiveZeroConvertibleSeniorNotesMember srt:MinimumMember 2020-08-21 2020-08-21 0001385280 cnk:FourPointFiveZeroConvertibleSeniorNotesMember 2020-01-01 2020-12-31 cnk:TradingDay 0001385280 cnk:FourPointFiveZeroConvertibleSeniorNotesMember 2020-12-31 0001385280 2020-08-21 2020-08-21 0001385280 cnk:ColombiaLoansMember 2020-01-01 2020-12-31 0001385280 cnk:PeruLoanMember 2020-01-01 2020-12-31 0001385280 cnk:BrazilLoanMember 2020-01-01 2020-12-31 0001385280 cnk:ChileLoanMember 2020-01-01 2020-12-31 0001385280 cnk:PeruLoanMember 2020-12-31 0001385280 cnk:ChileLoanMember 2020-12-31 0001385280 cnk:ColombiaLoansMember srt:MinimumMember 2020-12-31 0001385280 cnk:BrazilLoanMember srt:MinimumMember 2020-12-31 0001385280 cnk:ColombiaLoansMember srt:MaximumMember 2020-12-31 0001385280 cnk:BrazilLoanMember srt:MaximumMember 2020-12-31 cnk:Agreement 0001385280 us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementOneMember 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementTwoMember 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementThreeMember 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementFourMember 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementOneMember 2020-01-01 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementTwoMember 2020-01-01 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementThreeMember 2020-01-01 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember cnk:InterestRateSwapAgreementFourMember 2020-01-01 2020-12-31 0001385280 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-12-31 0001385280 cnk:AccruedOtherCurrentLiabilitiesMember 2020-12-31 0001385280 us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0001385280 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001385280 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001385280 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001385280 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001385280 country:BR 2018-12-31 0001385280 country:AR 2018-12-31 0001385280 country:CO 2018-12-31 0001385280 country:CL 2018-12-31 0001385280 country:PE 2018-12-31 0001385280 country:BR 2019-12-31 0001385280 country:AR 2019-12-31 0001385280 country:CO 2019-12-31 0001385280 country:CL 2019-12-31 0001385280 country:PE 2019-12-31 0001385280 country:BR 2020-12-31 0001385280 country:AR 2020-12-31 0001385280 country:CO 2020-12-31 0001385280 country:CL 2020-12-31 0001385280 country:PE 2020-12-31 0001385280 country:BR 2018-01-01 2018-12-31 0001385280 country:AR 2018-01-01 2018-12-31 0001385280 country:CO 2018-01-01 2018-12-31 0001385280 country:CL 2018-01-01 2018-12-31 0001385280 country:PE 2018-01-01 2018-12-31 0001385280 cnk:OtherForeignCountriesMember 2018-01-01 2018-12-31 0001385280 cnk:InternationalSubsidiariesMember us-gaap:ParentMember 2018-01-01 2018-12-31 0001385280 country:BR 2019-01-01 2019-12-31 0001385280 country:CO 2019-01-01 2019-12-31 0001385280 country:CL 2019-01-01 2019-12-31 0001385280 country:PE 2019-01-01 2019-12-31 0001385280 cnk:OtherForeignCountriesMember 2019-01-01 2019-12-31 0001385280 cnk:InternationalSubsidiariesMember us-gaap:ParentMember 2019-01-01 2019-12-31 0001385280 country:BR 2020-01-01 2020-12-31 0001385280 country:CO 2020-01-01 2020-12-31 0001385280 country:CL 2020-01-01 2020-12-31 0001385280 country:PE 2020-01-01 2020-12-31 0001385280 cnk:OtherForeignCountriesMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalSubsidiariesMember us-gaap:ParentMember 2020-01-01 2020-12-31 0001385280 country:AR 2019-01-01 2019-12-31 0001385280 country:AR 2020-01-01 2020-12-31 0001385280 cnk:CinemarkPartnersSecondMember 2019-12-31 0001385280 cnk:CinemarkPartnersSecondMember 2020-12-31 0001385280 cnk:LaredoTheatreMember 2019-12-31 0001385280 cnk:LaredoTheatreMember 2020-12-31 0001385280 cnk:GreeleyLtdMember 2019-12-31 0001385280 cnk:GreeleyLtdMember 2020-12-31 0001385280 cnk:OtherNoncontrollingInterestsMember 2019-12-31 0001385280 cnk:OtherNoncontrollingInterestsMember 2020-12-31 0001385280 cnk:CinemarkPartnersSecondMember 2019-12-31 0001385280 cnk:CinemarkPartnersSecondMember 2020-12-31 0001385280 cnk:LaredoTheatreMember 2019-12-31 0001385280 cnk:LaredoTheatreMember 2020-12-31 0001385280 cnk:GreeleyLtdMember 2019-12-31 0001385280 cnk:GreeleyLtdMember 2020-12-31 0001385280 srt:MinimumMember 2018-01-01 2018-12-31 0001385280 srt:MinimumMember 2019-01-01 2019-12-31 0001385280 srt:MinimumMember 2020-01-01 2020-12-31 0001385280 srt:MaximumMember 2019-01-01 2019-12-31 0001385280 srt:MaximumMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockMember 2017-12-31 0001385280 us-gaap:RestrictedStockMember 2018-12-31 0001385280 us-gaap:RestrictedStockMember 2019-12-31 0001385280 us-gaap:RestrictedStockMember 2018-01-01 2018-12-31 0001385280 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0001385280 us-gaap:RestrictedStockMember 2020-12-31 0001385280 us-gaap:RestrictedStockMember srt:MinimumMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockMember srt:DirectorMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockMember cnk:EmployeeMember srt:MinimumMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockMember cnk:EmployeeMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockMember cnk:EmployeeMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AccountingStandardsUpdate201807Member 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AccountingStandardsUpdate201807Member 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockMember us-gaap:AccountingStandardsUpdate201807Member 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember 2019-01-01 2019-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2019-01-01 2019-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember 2018-01-01 2018-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2018-01-01 2018-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember cnk:ThresholdIrrMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember cnk:TargetedIrrMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember cnk:MaximumIrrMember 2020-01-01 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember cnk:StockGrantsTwentySixteenMember 2019-01-01 2019-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember cnk:StockGrantsTwentySeventeenMember 2019-01-01 2019-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001385280 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001385280 cnk:StockGrantsTwentySixteenMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001385280 cnk:StockGrantsTwentyEightteenMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001385280 2017-01-01 2017-12-31 0001385280 cnk:CARESMember 2020-01-01 2020-12-31 0001385280 us-gaap:ForeignCountryMember 2019-12-31 0001385280 us-gaap:ForeignCountryMember 2020-12-31 0001385280 us-gaap:DomesticCountryMember 2019-12-31 0001385280 us-gaap:DomesticCountryMember 2020-12-31 0001385280 us-gaap:ForeignCountryMember 2020-01-01 2020-12-31 0001385280 cnk:MessrsMitchellGambleFernandesAndCavalierMember 2020-01-01 2020-12-31 0001385280 cnk:MrZoradiMember 2020-01-01 2020-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001385280 cnk:UsOperatingSegmentMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001385280 cnk:InternationalOperatingSegmentMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001385280 us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0001385280 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0001385280 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-12-31 0001385280 cnk:OtherInvesteesMember 2018-01-01 2018-12-31 0001385280 cnk:OtherInvesteesMember 2019-01-01 2019-12-31 0001385280 cnk:OtherInvesteesMember 2020-01-01 2020-12-31 0001385280 cnk:OtherEquityInvesteesMember 2020-01-01 2020-12-31 0001385280 country:US srt:ReportableGeographicalComponentsMember 2018-01-01 2018-12-31 0001385280 country:US srt:ReportableGeographicalComponentsMember 2019-01-01 2019-12-31 0001385280 country:US srt:ReportableGeographicalComponentsMember 2020-01-01 2020-12-31 0001385280 country:BR srt:ReportableGeographicalComponentsMember 2018-01-01 2018-12-31 0001385280 country:BR srt:ReportableGeographicalComponentsMember 2019-01-01 2019-12-31 0001385280 country:BR srt:ReportableGeographicalComponentsMember 2020-01-01 2020-12-31 0001385280 cnk:OtherInternationalCountriesMember srt:ReportableGeographicalComponentsMember 2018-01-01 2018-12-31 0001385280 cnk:OtherInternationalCountriesMember srt:ReportableGeographicalComponentsMember 2019-01-01 2019-12-31 0001385280 cnk:OtherInternationalCountriesMember srt:ReportableGeographicalComponentsMember 2020-01-01 2020-12-31 0001385280 srt:GeographyEliminationsMember 2018-01-01 2018-12-31 0001385280 srt:GeographyEliminationsMember 2019-01-01 2019-12-31 0001385280 srt:GeographyEliminationsMember 2020-01-01 2020-12-31 0001385280 country:US srt:ReportableGeographicalComponentsMember 2019-12-31 0001385280 country:US srt:ReportableGeographicalComponentsMember 2020-12-31 0001385280 country:BR srt:ReportableGeographicalComponentsMember 2019-12-31 0001385280 country:BR srt:ReportableGeographicalComponentsMember 2020-12-31 0001385280 cnk:OtherInternationalCountriesMember srt:ReportableGeographicalComponentsMember 2019-12-31 0001385280 cnk:OtherInternationalCountriesMember srt:ReportableGeographicalComponentsMember 2020-12-31 0001385280 cnk:LaredoTheatreLtdMember 2020-01-01 2020-12-31 0001385280 cnk:LaredoTheatreLtdMember 2019-01-01 2019-12-31 0001385280 cnk:LaredoTheatreLtdMember 2018-01-01 2018-12-31 0001385280 cnk:CopperBeechCapitalLLCMember 2018-01-01 2018-12-31 0001385280 cnk:CopperBeechCapitalLLCMember 2019-01-01 2019-12-31 0001385280 cnk:CopperBeechCapitalLLCMember 2020-01-01 2020-12-31 0001385280 cnk:SyufyEnterprisesLpMember 2020-01-01 2020-12-31 cnk:Facility cnk:Lease 0001385280 cnk:SyufyEnterprisesLpMember 2019-01-01 2019-12-31 0001385280 cnk:SyufyEnterprisesLpMember 2018-01-01 2018-12-31 0001385280 cnk:FEConceptsLLCMember 2020-12-31 0001385280 cnk:FEConceptsLLCMember 2020-01-01 2020-12-31 0001385280 cnk:FEConceptsLLCMember 2019-01-01 2019-12-31 0001385280 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-12-31 0001385280 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-01-01 2018-12-31 0001385280 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001385280 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0001385280 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001385280 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0001385280 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0001385280 2019-01-01 2019-03-31 0001385280 2019-04-01 2019-06-30 0001385280 2019-07-01 2019-09-30 0001385280 2019-10-01 2019-12-31 0001385280 2020-04-01 2020-06-30 0001385280 2020-07-01 2020-09-30 0001385280 2020-10-01 2020-12-31 0001385280 srt:ParentCompanyMember 2019-12-31 0001385280 srt:ParentCompanyMember 2020-12-31 0001385280 srt:ParentCompanyMember 2018-01-01 2018-12-31 0001385280 srt:ParentCompanyMember 2019-01-01 2019-12-31 0001385280 srt:ParentCompanyMember 2020-01-01 2020-12-31 0001385280 srt:ParentCompanyMember us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-12-31 0001385280 srt:ParentCompanyMember 2017-12-31 0001385280 srt:ParentCompanyMember 2018-12-31 0001385280 cnk:SeniorNotesFourPointEightSevenFivePercentDueJuneOneTwentyTwentyThreeMember 2013-05-24 0001385280 srt:ParentCompanyMember us-gaap:SeniorSubordinatedNotesMember 2020-12-31 0001385280 srt:ParentCompanyMember cnk:SeniorSecuredCreditFacilityMember 2020-12-31 0001385280 srt:ParentCompanyMember cnk:FirstQuarterDividendMember 2018-01-01 2018-12-31 0001385280 srt:ParentCompanyMember cnk:SecondQuarterDividendMember 2018-01-01 2018-12-31 0001385280 srt:ParentCompanyMember cnk:ThirdQuarterDividendMember 2018-01-01 2018-12-31 0001385280 srt:ParentCompanyMember cnk:FourthQuarterDividendMember 2018-01-01 2018-12-31 0001385280 srt:ParentCompanyMember cnk:FirstQuarterDividendMember 2019-01-01 2019-12-31 0001385280 srt:ParentCompanyMember cnk:SecondQuarterDividendMember 2019-01-01 2019-12-31 0001385280 srt:ParentCompanyMember cnk:ThirdQuarterDividendMember 2019-01-01 2019-12-31 0001385280 srt:ParentCompanyMember cnk:FourthQuarterDividendMember 2019-01-01 2019-12-31 0001385280 srt:ParentCompanyMember cnk:FirstQuarterDividendMember 2020-01-01 2020-12-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM ______ TO ______

Commission File Number 001-33401

CINEMARK HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware | 20-5490327
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)
3900 Dallas Parkway Plano, TX (Address of principal executive offices) | 75093 (Zip Code)

Registrant’s telephone number, including area code: (972) 665-1000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, par value $0.001 per share | CNK | New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ |  | Accelerated filer | ☐
Non-accelerated filer | ☐ |  | Smaller reporting company | ☐
Emerging growth company | ☐ |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of the voting and non-voting common equity owned by non-affiliates of the registrant on June 30, 2020, computed by reference to the closing price for the registrant’s common stock on the New York Stock Exchange on such date was approximately $1.23 billion (106,745,094 shares at a closing price per share of $11.55).

As of February 15, 2021, 118,583,610 shares of common stock were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the registrant’s definitive proxy statement, in connection with its 2021 annual meeting of stockholders, to be filed within 120 days of December 31, 2020, are incorporated by reference into Part III, Items 10-14, of this annual report on Form 10-K.

Table of Contents

| Page
Cautionary Statement Regarding Forward-Looking Statements |  | 1
PART I |  |  |  |
Item 1. |  | Business |  | 2
Item 1A. |  | Risk Factors |  | 14
Item 1B. |  | Unresolved Staff Comments |  | 23
Item 2. |  | Properties |  | 23
Item 3. |  | Legal Proceedings |  | 23
PART II |  |  |  |
Item 5. |  | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |  | 24
Item 6. |  | Selected Financial Data |  | 25
Item 7. |  | Management’s Discussion and Analysis of Financial Condition and Results of Operations |  | 27
Item 7A. |  | Quantitative and Qualitative Disclosures About Market Risk |  | 47
Item 8. |  | Financial Statements and Supplementary Data |  | 48
Item 9. |  | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |  | 48
Item 9A. |  | Controls and Procedures |  | 48
Item 9B. |  | Other Information |  | 49
PART III |  |  |  |
Item 10. |  | Directors, Executive Officers and Corporate Governance |  | 51
Item 11. |  | Executive Compensation |  | 51
Item 12. |  | Security Ownership of Certain Beneficial Owners and Management and Related StockholderMatters |  | 51
Item 13. |  | Certain Relationships and Related Transactions, and Director Independence |  | 51
Item 14. |  | Principal Accounting Fees and Services |  | 51
PART IV |  |  |  |
Item 15. |  | Exhibits, Financial Statement Schedules |  | 51
SIGNATURES |  | 62

Cautionary Statement Regarding Forward-Looking Statements

This annual report on Form 10-K includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. The “forward looking statements” include our current expectations, assumptions, estimates and projections about our business and our industry. They include statements relating to:

| • | future revenues, expenses and profitability;

| • | the future development and expected growth of our business;

| • | projected capital expenditures;

| • | attendance at movies generally or in any of the markets in which we operate;

| • | the number or diversity of popular movies released and our ability to successfully license and exhibit popular films;

| • | national and international growth in our industry;

| • | competition from other exhibitors and alternative forms of entertainment;

| • | determinations in lawsuits in which we are defendants; and

| • | the impact of the COVID-19 pandemic on us, the motion picture exhibition industry, and the economy in general, including our response to the COVID-19 pandemic related to suspension of operations at our theatres, personnel reductions and other cost-cutting measures and measures to maintain necessary liquidity and increases in expenses relating to precautionary measures at our facilities to protect the health and well-being of our customers and employees.

You can identify forward-looking statements by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions which are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. In evaluating forward-looking statements, you should carefully consider the risks and uncertainties described in the “Risk Factors” section in Item 1A of this Form 10-K and elsewhere in this Form 10-K. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements and risk factors contained in this Form 10-K. Forward-looking statements contained in this Form 10-K reflect our view only as of the date of this Form 10-K. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Cinemark Holdings, Inc. is a Delaware corporation incorporated on August 2, 2006. Our principal executive offices are at 3900 Dallas Parkway, Plano, Texas 75093. Our telephone number is (972) 665-1000. General information about us can be found at www.cinemark.com. Our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or15(d) of the Exchange Act are available on our website free of charge under the heading "Investor Relations - Financials - SEC Filings" as soon as reasonably practicable after such reports are filed with, or furnished to, the Securities and Exchange Commission, or the SEC. Additionally, all of our filings with the SEC can be accessed on the SEC's website at www.sec.gov.

Unless the context otherwise requires, all references to “we,” “our,” “us,” “the issuer”, “the Company” or “Cinemark” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries. All references to Latin America are to Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Unless otherwise specified, all operating and other statistical data are as of and for the year ended December 31, 2020.

1

PART I

Item 1. Business

Cinemark Holdings, Inc. and subsidiaries is a leader in the motion picture exhibition industry, with theatres in the United States, or “U.S.,” Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay.

We are a leader and one of the most geographically diverse operators in the motion picture exhibition industry. As of December 31, 2020, we operated 531 theatres and 5,958 screens in the U.S. and Latin America. Our U.S. circuit had 331 theatres and 4,507 screens in 42 states and our international circuit had 200 theatres and 1,451 screens in 15 countries. Our significant and diverse presence in the U.S. and Latin America has made us an important distribution channel for movie studios and other content providers. We believe our portfolio of modern, high-quality theatres with multiple platforms provides a preferred destination for moviegoers and has contributed to our historically consistent financial performance.

As of December 31, 2020, we managed our business under two reportable operating segments: U.S. markets and international markets. See Note 21 to our consolidated financial statements.

Impact of COVID-19 Pandemic

The outbreak of the COVID-19 pandemic has had an unprecedented impact on the world and our industry. As a movie exhibitor that operates spaces where patrons gather in close proximity, we have been, and continue to be, significantly impacted by the COVID-19 pandemic. At the initial outbreak of the COVID-19 pandemic, to comply with government mandates, we temporarily closed all of our theatres in the U.S. and Latin America effective March 17, 2020 and March 18, 2020, respectively. In conjunction with the temporary closure of our theatres in March 2020, we implemented temporary personnel and salary reductions, limited non-essential operating and capital expenditures, and negotiated modified timing and/or abatement of contractual payments with landlords and other major suppliers until our theatres reopened. In addition, we suspended our quarterly dividend.

As of December 31, 2020, we had reopened 217 of our domestic theatres and 129 of our international theatres, showing a limited volume of new releases along with library content during reduced operating hours with limited capacities.

Some of the health and safety protocols that we have implemented in our theatres for the safety of our employees, guests and surrounding communities include:

| • | staggering showtimes and limiting capacities to maximize physical distancing;

| • | instituting seat buffering technology to ensure social distancing within the auditorium;

| • | requiring face masks for all guests within the theater, which may only be removed for eating and drinking in the auditoriums;

| • | implementing stringent disinfecting and sanitizing protocols and providing ample supplies of hand sanitizer and seat wipes for patrons;

| • | delivering an abundant supply of fresh outdoor air, maintaining optimal air circulation and eliminating potential pollutants through filtration;

| • | encouraging contactless transactions; and

| • | requiring that employees receive special training, participate in wellness check-ins and use personal protective wear, including face masks and gloves.

While some staffing has been brought back to support theatre reopenings, we continue operating with reduced staffing and limiting capital expenditures to essential activities and projects. Government restrictions also continue to fluctuate with the status of the virus, impacting our reopening plans. We continue to work with landlords and other vendors on modified contractual payment terms while we continue to navigate through the impact of the COVID-19 pandemic and seek to recover a routine level of operations

2

Our focus on maintaining a strong balance sheet and low leverage allowed us to enter the global COVID-19 pandemic in a solid financial position. Based on our current estimates of recovery, we believe we have and will generate sufficient cash to sustain operations. Nonetheless, the COVID-19 pandemic has had, and continues to have, adverse effects on our business, results of operations, cash flows, financial condition, access to credit markets and ability to service existing and future indebtedness, some of which are significant.

Motion Picture Exhibition Industry Overview

Domestic

North American industry results for 2020 are not yet available, and as a result of the COVID-19 pandemic and resulting temporary theatre closures, are expected to be significantly lower than prior years. Preliminary estimates indicate that box office revenues were approximately $2.2 billion for 2020, down approximately 81% as compared to 2019.

The following table represents the results of a survey by Motion Picture Association of America, or MPAA, published during March 2020, outlining the historical trends in U.S. box office performance for the five-year period from 2015 through 2019.

|  | U.S. Box |  |  |  |  |  |  |  |  |
|  | Office Revenues |  |  | Attendance |  |  | Average Ticket |
Year |  | ($ in billions) |  |  | (in billions) |  |  | Price |
2015 |  | $ | 11.1 |  |  |  | 1.32 |  |  | $ | 8.43 |
2016 |  | $ | 11.4 |  |  |  | 1.32 |  |  | $ | 8.65 |
2017 |  | $ | 11.1 |  |  |  | 1.24 |  |  | $ | 8.97 |
2018 |  | $ | 11.9 |  |  |  | 1.30 |  |  | $ | 9.11 |
2019 |  | $ | 11.4 |  |  |  | 1.24 |  |  | $ | 9.16 |

While the industry experienced drastically reduced results during 2020 as a direct result of the COVID-19 pandemic, industry statistics show slight increases and decreases in attendance over the past five years. Historically, domestic box office revenues remained relatively stable during this period. Even during recessionary periods, industry results demonstrated stability and a continued ability to attract consumers. Box office performance has been primarily dependent on the quality, quantity and timing of film product. Average ticket prices can also be driven by the mix of film product and availability of films in premium formats.

Films released during the year ended December 31, 2020 included Bad Boys for Life, Sonic the Hedgehog, Birds of Prey, Dolittle, The Invisible Man and The Call of the Wild. The carryover of late 2019 releases such as 1917, Jumanji: The Next Level and Star Wars: The Rise of Skywalker also contributed to industry box office during early 2020. Due to the temporary closure of many theatres beginning in March, movie studios delayed the release of many films originally planned for 2020. As we reopened our domestic theatres, we offered patrons primarily library content, bringing back many classics to the big screen. As more theatres reopened and enhanced health and safety protocols were implemented, studios began releasing new content, which included Wonder Woman 1984, Tenet, The Croods: A New Age, The New Mutants, Unhinged, The War with Grandpa and Honest Thief.

Currently, films scheduled for release in 2021 include the sequel to Marvel’s Spider-man Far From Home, Top Gun Maverick, Black Widow, F9, Luca, Eternals, Mission: Impossible 7, No Time to Die, Cruella, and Minions: The Rise of Gru, among others. As the industry navigates the continued impact of the COVID-19 pandemic and the various regulations and restrictions, film release schedules may continue to fluctuate.

International

According to MPAA, international box office revenues were approximately $30.8 billion for the year ended December 31, 2019. More specifically, Latin American box office revenues were $2.7 billion for the year ended December 31, 2019. As noted above, industry performance for 2020 was significantly impacted by the COVID-19 pandemic and results are not yet available. Preliminary estimates for Latin American box office revenues for 2020 is $0.3 billion, down approximately 89% compared to 2019.

3

In addition to the quality, quantity and timing of Hollywood product, performance in Latin American markets is also impacted by social behaviors, growing populations, and continued retail development. In many Latin American countries, including Brazil, Argentina, Colombia, Peru and Chile, successful local film product can also contribute to box office growth. However, local restrictions and regulations implemented as a result of the COVID-19 pandemic impacted movie production and movie-going during 2020 similar to the U.S.

Drivers of Continued Industry Success

Industry dynamics continue to evolve as a result of the COVID-19 pandemic, but we believe the following factors will continue to drive the strength of our industry:

Importance of Theatrical Success in Establishing Movie Brands. Theatrical exhibition has long been the primary distribution channel for new major motion picture releases. In addition to representing a significant share of a film’s overall revenues, a successful theatrical release “brands” a film and is one of the major contributors to a film’s success in “downstream” markets, such as digital downloads, video on-demand, DVDs, pay television, network and syndicated television, and streaming video on demand, as well as theme parks and branded retail merchandise. While some film releases for 2020 did not have, and certain films for 2021 are not expected to have, a normal exclusive theatrical release window due to theatre closures associated with the COVID-19 pandemic, theatrical exhibition is expected to continue to contribute a significant portion of overall revenues generated by a film.

Convenient and Affordable Form of Out-Of-Home Entertainment. Post COVID-19 pandemic, as venues continue to reopen and restrictions are lifted, we expect consumption of media and out-of-home experiential offerings to continue to increase due to pent up demand associated with the COVID-19 pandemic. Movie going remains one of the most convenient and affordable forms of out-of-home entertainment. While the average movie ticket price in the U.S. was $9.16 for 2019, average prices for other forms of out-of-home entertainment in the U.S., including sporting events and theme parks, ranged from approximately $32.99 to $102.35 per ticket according to MPAA. (As of the date of this report, 2020 industry data was not yet available.)

Expansion of Concepts and Product Offerings that Enhance the Movie-Going Experience. Over recent years, the motion picture exhibition industry has invested in the development of new movie theatre platforms and concepts to respond to varying and changing consumer preferences as well as to differentiate the movie-going experience from other in-home and out-of-home entertainment options. Some examples include changing the overall style, and amenities of theatres, as well as expansion of concession product offerings that provide more variety to traditional popcorn, fountain drinks and candy. Enhanced projection and sound equipment and motion seats are offered in some locations to further enhance the movie viewing experience. New and enhanced programming alternatives expand the industry’s entertainment offerings to attract a broader customer base. As a result of the COVID-19 pandemic, we offered new options to our guests, including Private Watch Parties to allow them to see a movie of their choice with a group of their choice as well as seat buffering technology to facilitate social distancing while enjoying out-of-home entertainment. We offered many classic and holiday movies in the absence of new film releases. To encourage contactless transactions in our theatres, while further enhancing the movie-going experience, we developed mobile concession ordering and delivery-to-seat options in some locations.

Contribution of International Markets to Box Office Performance. International markets continue to be an important component of the overall box office revenues generated by Hollywood films, accounting for $30.8 billion, or approximately 73%, of 2019 total worldwide box office revenues according to MPAA. (As of the date of this report, 2020 industry data was not yet available.) Theatres in international markets are continuing to reopen as local restrictions are revised. Film release schedules are expected to follow those of the U.S. consistent with previous years. We believe the contribution of markets outside North America to the global box office revenues will continue to be meaningful.

Our Strategy

Our primary objective for the past few years has been to attract and expand audiences to maximize attendance and box office, and then pursue monetization opportunities to capture ancillary revenue. We focused on providing an extraordinary guest experience, investing in our core circuit and continuing to grow organically to accomplish

4

these goals. While our long-term strategies remain consistent, for the near term we have shifted our focus to cash preservation and liquidity, closely managing costs and restructuring our operations and teams to be more efficient, and keeping our guests and employees safe and healthy. We expect this focus to continue until we fully recover from the impact of the COVID-19 pandemic.

Upon recovery from the impacts of the COVID-19 pandemic and the resurgence of the industry, our long-term strategies will again become front and center. These include:

Provide an Extraordinary Guest Experience. We differentiate our theatres by focusing on various initiatives that continuously enhance the in-theatre guest experience. We have a market-adaptive approach with our theatre amenities, including Luxury Lounger recliner seats, our exhibitor-branded premium large format, XD, and expanded food and beverage offerings. Our investment in these preferred amenities allows us to create and maintain a high-quality theatrical experience throughout our circuit. We believe our ongoing focus on providing an extraordinary in-theatre guest experience is a primary factor of our consistent industry-leading results. While our capital investments may be reduced temporarily, we will continue to ensure that our locations are well maintained.

Enhance Overall Guest Engagement. We offer loyalty and subscription programs that help provide a personalized experience, continued investment in our website and mobile app features and tailored custom interactions. We pursue a wide range of strategic marketing initiatives to communicate and build consumer awareness, better understand the unique preferences of our guests and enrich their movie-going experience.

Pursue Organic and Synergistic Growth Opportunities and Maintain Core Circuit. We have consistently reinvested our cash flows from operations in our circuit with a focus on new and exciting ways to attract guests. Our commitment to investing in our theatre assets is demonstrated by our level of capital expenditures for the years ended December 31, 2017, 2018 and 2019 of approximately $380.9 million, $346.1 million, and $303.6 million, respectively. In addition to our Luxury Lounger recliner seats and premium large format XD auditoriums, we have incorporated other market-adaptive concepts such as full bars and dine-in options. We selectively build or acquire new theatres in markets where we can establish and maintain a strong market position. During the year ended December 31, 2019, we built eleven new theatres with 97 screens and acquired two theatres with 30 screens. During the year ended December 31, 2019, we also grew organically and built eleven new theatres with 97 screens and acquired two theatres with 30 screens. As a result of a significant reduction in our operating cash flows for 2020, we halted nonessential capital expenditures and reduced our capital expenditures to $83.9 million for the year. We built four theatres with 44 screens during 2020, as these projects were underway at the start of the COVID-19 pandemic. For the short term, we will continue to focus our capital investments on essential projects and maintaining the high quality of our assets, while we refortify our balance sheet.

Competitive Strengths

We believe the following strengths have allowed us to compete effectively in the past and continue to help us navigate through the impacts of the COVID-19 pandemic:

Disciplined Operating Philosophy. Our balanced and disciplined investment approach centers on building new theatres, thoughtfully reinvesting in our existing theatres and acquiring theatres that will complement our circuit and offer a meaningful return. Our operating philosophy focuses on creating an extraordinary guest experience, maintaining favorable theatre-level economics, controlling operating costs and effectively reacting to economic and market changes.

We have long believed in the combination of a strong balance sheet and ensuring our capital investments earn a solid return. This philosophy has proved to be successful for us, and helped us enter the COVID-19 pandemic in a strong financial position. We will continue to be disciplined with our cash management and liquidity strategies as we recover from the impacts of the COVID-19 pandemic, ensuring we effectively service our debt and other obligations.

Leading Position in Our U.S. Markets. Based on our performance in recent years, we have a leading market share in most of the U.S. markets we serve, which includes a presence in 42 states. For the year ended December 31, 2019, we ranked either first or second, based on box office revenues, in 20 out of our top 25 U.S. markets, including

5

the San Francisco Bay Area, Dallas, Houston, Salt Lake City, Sacramento, Cleveland, Austin and Las Vegas. During 2020, we continued our leadership position as we were one of the first circuits to start to reopen our theatres and we have remained open as local regulations allow. As of December 31, 2020, we had 217 theatres reopened in the U.S.

Located in Top Latin American Markets. We have successfully established a significant presence in major cities in Latin America, with theatres in 15 of the 20 largest metropolitan areas in South America. We are the largest exhibitor in Brazil and Argentina and have significant market presence in Colombia, Peru and Chile. Our geographic diversity makes us an important global distribution channel for the movie studios. While our performance during 2020 was impacted by the temporary closure of our theatres, we continue to reopen theatres in the region with 129 open as of December 31, 2020.

State-of-the-Art Theatre Circuit. We offer a state-of-the-art movie-going experience, which we believe makes our theatres preferred destinations for moviegoers in our markets. During the year ended December 31, 2019, we built eleven new theatres with 97 screens. Our capital investments were very limited during 2020 due the COVID-19 pandemic, but we built four theatres with 44 new screens. As of December 31, 2020, we had commitments to open 195 new screens over the next three years. We have also started to convert our theatres to laser projectors, further enhancing the movie-going experiences. We expect the conversion to be completed over the next ten years.

We have incorporated Luxury Lounger recliner seats in all of our recent domestic new builds and have also repositioned many of our existing domestic theatres to offer this premium seating feature. We currently feature Luxury Loungers in 2,815 domestic auditoriums, representing almost 63% of our domestic circuit.

We offer our guests a premium large format experience through our 16 IMAX screens and our 278 XD auditoriums, which represents the largest exhibitor-branded premium large format footprint in the industry. Our XD auditoriums offer a premium experience utilizing the latest in digital projection and enhanced custom sound, including a Barco Auro 11.1 or Dolby Atmos sound system in select locations. The XD experience includes wall-to-wall screens, wrap-around sound, plush seating and a maximum comfort entertainment environment for an immersive experience. The benefits of our XD auditoriums include program flexibility, as we can show the content of our choice, and there is no additional revenue share component outside of routine film rental.

We offer enhanced food and beverages such as gourmet pizzas, burgers, and sandwiches, and a selection of beers, wines, and cocktails, all of which can be enjoyed in the comfort of the auditoriums, at approximately 60% of our worldwide theatres. We also offer market-adaptive concepts with full bars or dine-in areas in certain of our theatres and continue to expand to additional locations.

We currently have auditoriums that offer seats with immersive cinematic motion, which we refer to as motion seats, throughout our worldwide circuit. These motion seats are programmed in harmony with the audio and video content of the film and further immerse guests in the on-screen action. We offer motion seats in 121 theatres throughout our worldwide circuit.

Experienced Management. Led by Chairman and founder Lee Roy Mitchell, Chief Executive Officer Mark Zoradi, Chief Operating Officer and Chief Financial Officer Sean Gamble, President-International Valmir Fernandes, and Executive Vice President and General Counsel Michael Cavalier, our global operational management team has extensive industry experience. Additionally, our country general managers are local citizens familiar with cultural, political and economic factors impacting their country, which enables them to more effectively manage the local business. Our global management team has successfully navigated us through many industry and economic cycles over the years and their leadership in steering the Company during the COVID-19 pandemic is a testament to their abilities and effectiveness as stewards of the Company.

6

Theatre Operations

As of December 31, 2020, we operated 531 theatres and 5,958 screens in 42 U.S. states and 15 Latin American countries.

We opened our first theatre in the U.S. during 1984. Our domestic circuit has expanded primarily due to organic growth and two significant acquisitions. We currently have theatres in 105 designated market areas, or DMAs. The following table summarizes the geographic locations of our U.S. theatre circuit as of December 31, 2020.

|  | Total |  | Total |
State |  | Theatres |  | Screens |
Texas |  | 86 |  |  | 1,144 |
California |  | 62 |  |  | 819 |
Ohio |  | 27 |  |  | 349 |
Utah |  | 15 |  |  | 190 |
Nevada |  | 9 |  |  | 140 |
Colorado |  | 9 |  |  | 136 |
Illinois |  | 8 |  |  | 110 |
Kentucky |  | 8 |  |  | 109 |
Pennsylvania |  | 8 |  |  | 107 |
Florida |  | 7 |  |  | 122 |
Arizona |  | 7 |  |  | 104 |
Washington |  | 7 |  |  | 81 |
Louisiana |  | 6 |  |  | 83 |
North Carolina |  | 6 |  |  | 73 |
Oregon |  | 5 |  |  | 84 |
Virginia |  | 5 |  |  | 68 |
Iowa |  | 4 |  |  | 62 |
Connecticut |  | 4 |  |  | 58 |
Oklahoma |  | 4 |  |  | 57 |
New Jersey |  | 4 |  |  | 50 |
Michigan |  | 3 |  |  | 46 |
Arkansas |  | 3 |  |  | 44 |
Mississippi |  | 3 |  |  | 41 |
Indiana |  | 3 |  |  | 34 |
South Carolina |  | 3 |  |  | 34 |
Maryland |  | 2 |  |  | 39 |
New Mexico |  | 2 |  |  | 38 |
Massachusetts |  | 2 |  |  | 30 |
Georgia |  | 2 |  |  | 27 |
South Dakota |  | 2 |  |  | 26 |
Montana |  | 2 |  |  | 25 |
Delaware |  | 2 |  |  | 22 |
West Virginia |  | 2 |  |  | 22 |
Kansas |  | 1 |  |  | 20 |
Idaho |  | 1 |  |  | 18 |
New York |  | 1 |  |  | 17 |
Alaska |  | 1 |  |  | 16 |
Alabama |  | 1 |  |  | 14 |
Tennessee |  | 1 |  |  | 14 |
Wisconsin |  | 1 |  |  | 14 |
New Hampshire |  | 1 |  |  | 12 |
Minnesota |  | 1 |  |  | 8 |
Total |  | 331 |  |  | 4,507 |

7

We first entered Latin America when we opened a theatre in Chile in 1993. Since then, through our focused international growth strategy, we have developed one of the most geographically diverse theatre circuits in the region. We have balanced our risk through a diversified international portfolio, which includes theatres in 15 of the 20 largest metropolitan areas in South America. We have established significant presence in Brazil and Argentina, where we are the largest exhibitor. We also have significant market presence in Colombia, Peru and Chile. The following table summarizes the geographic locations of our international theatre circuit as of December 31, 2020.

Country |  | Total Theatres |  |  | Total Screens |
Brazil |  |  | 86 |  |  |  | 633 |
Colombia |  |  | 31 |  |  |  | 181 |
Argentina |  |  | 22 |  |  |  | 191 |
Chile |  |  | 20 |  |  |  | 141 |
Central America(1) |  |  | 18 |  |  |  | 127 |
Peru |  |  | 12 |  |  |  | 98 |
Ecuador |  |  | 8 |  |  |  | 51 |
Bolivia |  |  | 1 |  |  |  | 13 |
Paraguay |  |  | 1 |  |  |  | 10 |
Curacao |  |  | 1 |  |  |  | 6 |
Total |  |  | 200 |  |  |  | 1,451 |

| (1) | Includes Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala.

Content

We offer a variety of content at our theatres. During the COVID-19 pandemic, as we were reopening theatres, we offered primarily library content to our guests, and we added new releases as they became available. We also offered our guests the ability to select a film for private viewing with our Private Watch Parties in a group of up to 20 family members and friends. In normal operating times, we monitor upcoming films and other content and work diligently with film distributors to license content that we believe will be most successful in our theatres. We play mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. We offer content in both 2-D and 3-D formats in all of our theatres, and in many locations, we offer either our exhibitor-branded premium large format, XD, or IMAX. We also offer a format that features motion seats and added sensory features.

We regularly play art and independent films, under our CineArts banner, at many of our U.S. theatres and offer local film product in our international markets, providing a variety of film choices to our guests. We have also historically offered a classic series at a majority of our U.S. theatres and some of our international theatres, which involves playing digitally re-mastered classic movies from a variety of genres during non-peak times. We also offer multi-cultural foreign language films and e-sports gaming events in our theatres.

Our joint venture, AC JV, LLC, with Regal Entertainment Group, or Regal, and AMC Entertainment, Inc., or AMC, provides marketing and distribution of live and pre-recorded entertainment programming to movie theatres to augment theatres’ feature film schedules, which includes the Metropolitan Opera, sports programs, concert events, and other special presentations, that may be live or pre-recorded. We, along with AC JV, LLC, continue to identify new ways to utilize our theatre platform to provide alternative content to consumers beyond movies.

Film Licensing

In the domestic marketplace, our corporate film department negotiates with film distributors to license films for each of our domestic theatres. In each of our international offices, our local film personnel negotiate with local offices of major film distributors, local film distributors and independent content providers to license films for our international theatres. Film distributors are responsible for determining film release dates and film marketing campaigns and the related expenditures, while we are responsible for booking the films at each of our theatres at the optimal showtimes for our guests.

8

In both our domestic and international locations, we pay film rental fees based on a film’s box office receipts at our theatres. Film rental rates are negotiated based on either a sliding scale formula under which the rate is based on a standard rate matrix that is established prior to a film’s run; a firm terms formula, as determined prior to a film’s run, under which we pay a negotiated rate; or a rate that is negotiated after a film’s run.

Food and Beverage

Concession sales are our second largest revenue source, historically representing approximately 35% of total revenues. We have devoted considerable management effort to expanding concession sales by enhancing our offerings and adapting to our customers’ changing preferences, as discussed below.

Product Mix. Common concession products offered at all of our theatres may include various sizes and types of popcorn, soft drinks, coffees, non-carbonated drinks, candy and quickly-prepared or pre-prepared food, such as hot dogs, pizza, pretzel bites, nachos and ice cream. The food and beverage offerings vary based on consumer preferences in a particular market. We have introduced some healthier snack and beverage options for our guests, which are available at some locations, added alcohol offerings in a growing number of theatres, partnered with Pizza Hut to offer freshly-made Pizza Hut pizzas in select theatres, and also offer diverse ethnic foods based on market demographics.

In select locations, we have expanded concession product offerings to include a broader variety of food and drink options, such as gourmet pizzas, burgers, and sandwiches and a selection of beers, wines, and cocktails, all of which can be enjoyed in the comfort of the auditoriums.

Our proprietary point-of-sale system allows our category managers to monitor product sales and readily make adjustments to product mix on a theatre-by-theatre or market-by-market basis, when necessary. This program flexibility also allows us to efficiently activate and manage both national or regional product launches and promotional initiatives to further grow food and beverage sales.

Pricing. New products and promotions are introduced on a regular basis to increase concession purchase incidence by existing consumers as well as to attract new consumers. In certain international countries and in all of our domestic theatres, we offer a free loyalty program that routinely offers food and beverage discounts. Our paid Movie Club membership program also allows our domestic guests to sign-up for exclusive concessions discounts.

During 2020, when we started reopening our U.S. theatres as government restrictions lifted, we limited our concession product offerings and implemented “Welcome Back” pricing discounts on core concessions (fountain soda, popcorn and candy) as well as select alcohol, hot dog and nacho products.

Staff Training. Employees are continually trained in proper sales techniques, food preparation and handling and maintaining concession product quality. Some of our product promotions include a motivational element that rewards theatre staff for exceptional sales of certain promotional items. During 2020, we implemented enhanced food safety and cleanliness protocols to align with the Center for Disease Control’s, or CDC, COVID-19-specific recommendations relative to concession and restaurant areas.

Theatre Design. Our theatres are designed to optimize the guest purchase experience at the concession stands, which includes multiple concession counters throughout a theatre to facilitate serving guests in an expedited manner. We strategically place large concession stands within theatres to heighten visibility, reduce the length of concession lines, and improve traffic flow around the concession stands. We incorporate self-serve candy cases and bottled drink coolers at our traditional crew-serve theatres to help provide convenience for our guests, drive impulse purchases and increase product availability for these two core categories. We also have self-service cafeteria-style concession areas in many of our domestic theatres, which allow customers to select their own refreshments and proceed to the cash register when they are ready. This design allows for more efficient service, and superior visibility of concession items. We also have lobby bars and VIP lounges in many domestic and international theatres.

9

During the latter part of 2020, we implemented mobile concession ordering at approximately half of our U.S. theatres allowing guests to purchase and pre-pay for select concession products and pick them up at the concession stand upon arrival or have them delivered to their seat.

Cost Control. We negotiate prices for concession supplies directly with concession vendors and manufacturers to obtain volume discounts and also negotiate volume-based and promotional-based rebates. Concession supplies are generally managed through a distribution network in which inventory is delivered to the theatres after receiving orders directly from the theatres. We conduct frequent inventory counts of concession products at every theatre to ensure proper stock levels are maintained to appropriately serve our guests.

As previously mentioned, to focus on operational efficiency and cost reduction since the start of the COVID-19 pandemic, we streamlined our menu offerings within each product category with a renewed focus on core brands and products. While we still offer a broad assortment of food and beverage items, product streamlining has allowed us to closely manage inventory levels and reduce labor costs associated with more complex food offerings.

Screen Advertising

In our domestic markets, our theatres are part of the in-theatre digital network operated by National CineMedia, LLC, or NCM. NCM provides advertising to our theatres through its branded “Noovie” pre-show entertainment program and also handles lobby promotions and displays for our theatres. We believe that the reach, scope and digital delivery capability of NCM’s network provides an effective platform for national, regional and local advertisers to reach our audience. We receive a monthly theatre access fee for participation in the NCM network and also earn screen rental revenue on a per patron basis or revenue share basis depending on the placement of the advertisement. As of December 31, 2020, we had an approximate 25% ownership interest in NCM. See Note 8 to our consolidated financial statements for further discussion of our investment in NCM.

Throughout our international markets, we have established our Flix Media brand that handles screen advertising functions in Brazil, Argentina, Chile, Central America, Colombia, Paraguay, Bolivia, Ecuador and Curacao. Our Flix Media marketing personnel work with local agencies and advertisers to coordinate screen advertising in our theatres as well as other theatres in our markets. In addition to screen advertising in our theatres, we continue to expand Flix Media’s services to include, among other things, alternative content, digital media and other synergistic media opportunities. In a few of our other international markets, we outsource our screen advertising to local companies who have established relationships with local advertisers that provide similar programming benefits. The terms of our international screen advertising contracts vary by country; however, we generally earn a percentage of the screen advertising revenues for access to our screens.

Upon reopening our theatres, we utilized our pre-show programming to remind guests about The Cinemark Standard, which encompasses our enhanced comprehensive cleaning and safety protocols.

Marketing and Promotions

Our investment in digital marketing over the past several years enables us to expand our reach to our guests and communicate with them on a consistent basis regarding our promotions and offerings. The growth in our digital communication ability has been particularly effective over the past year to keep our guests engaged, informed and excited about our theatre reopenings and “Welcome Back” offers. We adapted our marketing strategy with an emphasis on consistent organic communication to keep our millions of guests informed through email, social media, and website and mobile app updates. We also implemented strategic public relations campaigns, both nationally and locally. We supplemented our organic communication with targeted advertising to communicate our enhanced cleaning and safety protocols, generate theatre reopening awareness and alert guests as to advance ticket sale dates.

While awaiting a steady stream of new film content, marketing and promotions played a pivotal role in encouraging moviegoers to visit their local Cinemark theatres. We branded our library content “Comeback Classics” and had enticing “Welcome Back” pricing on those films, as well as for our limited concessions offerings. We continually initiated unique, interactive marketing campaigns, such as our Halloween giveaway and 12 Days of Merry. These campaigns drove loyal and prospective customers to visit our website and our theatres to earn discounts, bonus coupons and prizes.

10

In recognition that there was a segment of the audience who would prefer to visit our theatres and stay within their trusted group, we introduced Private Watch Parties. Our Private Watch Party program allows guests to rent an entire auditorium to watch a film that they choose from our current library and bring up to 20 guests for a price range of $99-$149.

We automatically paused Movie Club subscriptions upon the initial closure of our theatres, alleviating the impact of recurring monthly payments on members while allowing them to maintain their benefits. Additionally, we extended the expiration date of all loyalty points into 2021.

In traditional times, we generally market our theatres and special events, including new theatre grand openings, remodel openings and VIP events, using email, organic and paid digital advertising, and radio and television advertising spots. We exhibit previews of coming attractions and current films as part of our on-screen pre-feature program. We offer guests access to movie times, the ability to buy their tickets and reserve their seats in advance and purchase gift cards at our website www.cinemark.com and via our smart phone and tablet applications. Customers can subscribe to our emails and push notifications to receive information about current and upcoming films at their preferred Cinemark theatre(s), including details about upcoming XD movies, advanced ticket sales, screenings, special events, concerts, live broadcasts, contests, promotions, and our latest concessions and merchandise offerings. We partner with film distributors on a regular basis to promote upcoming films through local, regional and national programs that are exclusive to our theatres.

We interact with guests every day on social media platforms, such as Instagram, Facebook, and Twitter. Through social media, we provide relevant information, quick access to advanced ticketing information and upcoming movies and events, as well as to respond to guest feedback. Guests can also utilize social media to ask questions regarding their local Cinemark theatre offerings, movie-related information or to provide suggestions.

We launched a subscription membership program for our domestic circuit in December 2017 named Movie Club. Movie Club offers guests a standard ticket credit, member-pricing for a companion ticket and concession and other transaction discounts for a monthly fixed price. Movie Club is a unique option to reward our loyal guests and allows us to stay informed of our frequent guests’ preferences.

We offer a free domestic loyalty program to our guests, named Movie Fan. Movie Fan allows our guests to earn one point for every dollar they spend. Points can then be redeemed for tickets, concession items and discounts, as well as unique and limited-edition rewards that relate to films currently playing in our theatres.

We also have loyalty programs in some of our international markets that either allow customers to pay a nominal fee for an annual membership card that provides them with certain admissions and concession discounts or that allows guests to earn loyalty points for each purchase. Similar to the Movie Fan program, our points-based international programs offer discounts on movie tickets and concessions. Our global loyalty programs put us in direct contact with our guests and provide additional opportunities for us to partner with the studios and our vendors through targeted promotions.

Competition

We are one of the leaders in the motion picture exhibition industry. We compete against local, regional, national and international exhibitors with respect to attracting guests, licensing films and developing new theatre sites. Our primary U.S. competitors include Regal and AMC and our primary international competitors, which vary by country, include Cinépolis, Cine Colombia, CinePlanet, Kinoplex (GSR), Village Cines, Hoyts Chile, SuperCines and Araujo.

We are generally able to book films without regard to the film bookings of other exhibitors at many of our theatres. In certain limited situations, distributors allocate movies to only one theatre in a market generally based on demographics, the conditions, capacity and grossing potential of each theatre, and the terms of exhibition. In all theatres, our success in attracting guests can depend on customer service quality, location, theatre capacity, quality of projection and sound equipment, film showtime availability and ticket prices.

11

We compete for new theatre sites with other movie theatre exhibitors as well as other entertainment venues. Securing a potential site depends upon factors such as commercial terms, committed investment and resources, theatre design and capacity, revenue potential, and financial stability.

We face competition from other forms of out-of-home entertainment competing for the public’s leisure time and disposable income, such as family entertainment centers, concerts, theme parks and sporting events. We also face competition for patrons from a number of alternative film distribution channels, such as streaming services, digital downloads, video on-demand, DVDs, pay television, network and syndicated television, and streaming video on demand.

Seasonality

Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. The most successful motion pictures have historically been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a hit film during other periods can impact this seasonality trend. The timing, quantity and quality of film releases can have a significant impact on our results of operations, and the results of one period are not necessarily indicative of results for the following period or for the same period in the following year.

Corporate Operations

Our worldwide headquarters, referred to as the Cinemark Service Centre, or CSC, is located in Plano, Texas. Personnel at the CSC provide oversight and support for our domestic and international theatres, and includes our executive team and department heads in charge of film licensing, food and beverage, theatre operations, theatre construction and maintenance, real estate, human resources, marketing, legal, finance, accounting, tax and information technology. Our U.S. operations are comprised of twenty regions, each of which is headed by a regional vice president. We have nine regional offices in Latin America responsible for the local management of theatres in fifteen countries (Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala and Curacao are managed out of one Central American regional office). Each regional office is headed by a general manager or a member of our international management team with additional personnel responsible for film licensing, marketing, human resources, information technology, operations and finance. We have divisional chief financial officers in Brazil and Argentina and a regional chief financial officer located in Chile that oversees Chile, Bolivia and Paraguay.

Human Capital

Our business is seasonal and therefore, our headcount can vary throughout the year depending on the timing and success of movie releases. While we do not have unionized employees within our domestic employee base, some of our international locations are subject to union regulations.

At the time we temporarily closed our theatres in March 2020 due to the COVID-19 pandemic, we had approximately 18,000 employees in the U.S and approximately 10,500 employees in our international markets. In response to the swift and significant impacts of the COVID-19 pandemic on our business, we undertook a number of operational measures, which included temporary and permanent reductions of personnel. Our focus upon the reopening of our theatres was to re-hire our hourly team members who were impacted upon closure of our theatres. We currently have approximately 8,300 employees in the U.S., approximately 30% of whom are full-time employees and 70% of whom are part-time employees. We have approximately 6,300 employees in our international markets, approximately 80% of whom are full-time employees and approximately 20% of whom are part-time employees.

The COVID-19 pandemic continues to impact the lives of our employees and we have taken steps to help protect their health and safety and maintain business continuity. A vast majority of our CSC employees continue to work remotely, which we expect will continue over the near term. The health and safety of our employees, guests and communities is a top priority. As such, we established stringent, enhanced cleaning and safety protocols at our corporate offices and theatres, including mandatory face covering, physical distance requirements, enhanced

12

cleaning and mandatory temperature screening. We also implemented a COVID-19 hotline to report positive COVID-19 tests. As part of that reporting process, we developed a robust contact tracing program to quickly identify team members who may have been in close contact with the infected individual.

In our Mission, Vision and Values Statement, our employees form the core of our Cinemark Values, or our Values. We strive to (i) act with honesty and integrity, respect and care for each other, our guests, communities and partners, (ii) provide a safe environment for our employees and guests, (ii) be the best in what we do and (iv) empower our people to make decisions and take responsibility. Guided by our Values, we are committed to creating a company where everyone is included and respected, and where we support each other in reaching our full potential. We take pride in the fact that many of our employees, including executive management, international general managers and field employees, have significant tenure with the Company. A vast majority of our field employees who were hired as we started reopening our theatres were employed by us prior to the pandemic.

We seek to be an equitable, diverse and inclusive company. We are committed to diverse representation across all levels of our workforce to reflect the vibrant and thriving diversity of the communities in which we live and work. As part of our ongoing commitment to a diverse and inclusive workforce, we support employee-driven support groups or Employee Resource Groups, or ERGs. The ERGs are open to all employees in the CSC and the Technology Operations Presentation, or TOP, Center and are based on employee interests such as work life balance, PRIDE, environmental, faith-based and cross-cultural. These groups help foster inclusion among all teammates, build awareness, recruit and retain a diverse workforce necessary for the Company to successfully operate in a global, multicultural, and evolving business environment.

To attract and retain the most qualified talent, we offer competitive benefits, including market-competitive compensation, healthcare, paid time off, parental leave and a 401(k) retirement savings and investment plan with generous Company matching. We support the continuous development of professional, technical and leadership skills of our employees by offering tuition assistance, skills development courses through partnerships with leading educational institutions, and leadership development and training both generally and as part of our diversity and inclusion initiatives. Employees are encouraged to provide feedback about their experience through periodic employee engagement surveys. These voluntary surveys provide overall and department-specific reports and enables us to improve employee experience and culture. We aspire to provide a safe, open and accountable work environment for our employees. We provide a hotline for all employees to report workplace concerns and violations. We address such concerns and take appropriate actions that uphold our Values.

Regulations

The distribution of motion pictures is largely regulated by antitrust laws and has been the subject of numerous antitrust cases. The manner in which we can license films from certain major film distributors has been influenced by consent decrees resulting from these cases. Consent decrees bind certain major film distributors and require the films of such distributors to be offered and licensed to exhibitors, including Cinemark, on a theatre-by-theatre and film-by-film basis. Consequently, exhibitors cannot enter into long-term arrangements with major distributors, but must negotiate for licenses on a theatre-by-theatre and film-by-film basis.

We are subject to various general regulations applicable to our operations including the Americans with Disabilities Act of 1990, or the ADA, and regulations recently issued by the U.S. Food and Drug Administration that require nutrition labels for certain menu items. Our domestic and international theatre operations are also subject to federal, state and local laws governing such matters as wages, working conditions, citizenship, health and sanitation requirements and various business licensing and permitting.

As a result of the COVID-19 pandemic, we are subject to various cleaning, health and safety protocols, capacity restrictions and curfews, which can vary at the city, county and state level.

Financial Information About Geographic Areas

We currently have operations in the U.S., Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao, and Paraguay, which are reflected in the consolidated financial statements. See Note 21 to our consolidated financial statements for segment information and financial information by geographic area.

13

Item 1A. Ri sk Factors

An investment in our common stock or debt securities involves risks and uncertainties and our actual results and future trends may differ materially from our past or projected future performance. We urge investors to consider carefully the risk factors described below in evaluating the information contained in this report.

Risks Related to the COVID-19 Pandemic

The COVID-19 pandemic has disrupted and is expected to continue to disrupt our industry and our business and could continue to materially affect our financial condition, liquidity, cash flows, results of operations and ability to service our existing and future indebtedness, for an extended period of time.

The outbreak of the COVID-19 pandemic has disrupted, and we expect it will continue to disrupt, our industry and our business for an extended period of time. While we have reopened 217 of our domestic theatres and 129 of our international theatres as of December 31, 2020, our business, results of operations, liquidity, cash flows and financial condition continue to be severely impacted by the COVID-19 pandemic. One of the key factors that has materially affected our business is the availability of new films for exhibition at our theatres. Due to the COVID-19 pandemic, production of films has been temporarily halted or delayed and new film releases have been postponed, resulting in a drastic reduction in the volume of new films available for theatrical exhibition. Even when new films are available, studios have reduced the window for video and digital releases or have released directly to alternative film distribution channels such as streaming services and bypassed a theatrical release.

In addition to the impact on film product availability for theatrical exhibition, governmental restrictions such as limitations on capacity and food and beverage sales continue to impact our results of operations, liquidity and cash flows. As the COVID-19 pandemic continues to develop, there could be additional federal, state or local responses that further restrict in-person gathering and/or movement of guests or otherwise impact our business. Even as restrictions are lifted, consumers may not be comfortable gathering in a large group or within a closed space for a few hours at a time.

We cannot predict when the effects of the COVID-19 pandemic will subside, whether the response to contain or mitigate the COVID-19 pandemic through the development and availability of effective treatments and vaccines, including the vaccines recently approved by the FDA for emergency use in the U.S., will be successful or if business will return to normal levels of operation. The longer and more severe the pandemic, including repeat or cyclical outbreaks, the more severe the adverse effects will be on our business, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness.

The outbreak of COVID-19 has also significantly increased economic and demand uncertainty. It is likely that the current outbreak or continued spread of COVID-19 will cause an economic slowdown, and it is possible that it could cause a global recession. For additional information on risks related to a slowdown or recession, see “—Other General Risks—General political, social, health and economic conditions can adversely affect our attendance.”

To the extent the COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described in this “Risk Factors” section, including but not limited to those relating to our high level of indebtedness, our need to generate sufficient cash flows to service our indebtedness and our ability to comply with the covenants contained in the agreements that govern our indebtedness.

Risks Related to Our Business and Operations

Our business depends on film production and performance.

Our business depends on both the availability of suitable films for exhibition in our theatres and the success of those films in our markets. Reduced volume of film releases, poor performance of films, the disruption in the production of films due to events such as a strike by directors, writers or actors, a reduction in financing options for the film distributors, or a reduction in the production and marketing efforts of the film distributors to make and promote their films could have an adverse effect on our business by resulting in fewer patrons and reduced revenues. During 2020, we saw a significant reduction in the quantity of films available to exhibit in our theatres. We expect the quantity of new film releases available for theatrical exhibition to continue to be lower than historical levels

14

during 2021, due to production delays, theatre closures, government restrictions and consumer sentiment, all directly correlating to the status of the COVID-19 pandemic.

Our results of operations fluctuate on a seasonal basis.

Our results of operations vary from period to period based upon the quantity and quality of the motion pictures that we show in our theatres. The major film distributors generally release the films they anticipate will be most successful during the summer and holiday seasons. Consequently, we typically generate higher revenues during these periods. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a successful film during other periods or the failure of an expected success at a key time could alter this seasonality trend. Due to the dependency on the success of films released from one period to the next, results of operations for one period may not be indicative of the results for the following period or the same period in the following year.

A deterioration in relationships with film distributors could adversely affect our ability to obtain commercially successful films.

We rely on the film distributors to supply the films shown in our theatres. The film distribution business is highly concentrated, with five major film distributors accounting for approximately 80% of U.S. box office revenues and 40 of the top 50 grossing films during 2019. Film distributors license films to exhibitors on a theatre-by-theatre and film-by-film basis. Consequently, we cannot guarantee a supply of films by entering into long-term arrangements with major distributors. We are therefore required to negotiate licenses for each film and for each theatre. A deterioration in our relationship with any of the major film distributors could adversely affect our ability to obtain commercially successful films and to negotiate favorable licensing terms for such films, both of which could adversely affect our business and operating results.

We face intense competition for patrons and films which may adversely affect our business.

The motion picture exhibition industry is highly competitive. We compete against local, regional, national and international exhibitors in many of our markets. We compete for both patrons and licensing of films. In markets where we do not face nearby competitive theatres, there is a risk of new theatres being built. The degree of competition for patrons is dependent upon such factors as location, theatre capacity, presentation quality, film showtime availability, customer service quality, products and amenities offered, and ticket prices. The principal competitive factors with respect to film licensing include the theatre’s location and its demographics, the condition, capacity and grossing potential of each theatre, and licensing terms. We also face competition from new concept theatres such as dine-in theatres and tavern style theatres that open in close proximity to our conventional theatres. If we are unable to attract patrons or to license successful films, our business may be adversely affected.

An increase in competing forms of entertainment or the use of alternative film distribution channels may reduce movie theatre attendance and limit revenue growth.

We compete with other forms of out-of-home entertainment, such as family entertainment centers, concerts, theme parks, gaming and sporting events, for our patrons’ leisure time and disposable income. We also face competition for patrons from a number of alternative film distribution channels, such as digital downloads, video on-demand, DVDs, pay television, network and syndicated television, and streaming video on demand. Some of these distribution channels have seen growth in production in recent years. A significant increase in popularity of these alternative film distribution channels, competing forms of entertainment or improvements in technologies available at home could have an adverse effect on our business and results of operations.

Our results of operations may be impacted by the shrinking, or elimination of, video and digital release windows.

The average video and digital release window, which represents the time that elapses from the date of a film’s theatrical release to the date a film is available for DVD, has been approximately 90 days and digital purchase for ownership (also known as electronic sell-through) has been approximately 74 days for the past several years. During the COVID-19 pandemic, certain studios have adopted strategies that reduced, or in some cases eliminated, the

15

release windows. Warner Brothers announced that its entire film slate for 2021 will move to simultaneous release in theatres and on HBO Max. Disney has released movie titles to Disney+ and bypassed theatrical releases altogether and has indicated that some titles will be released simultaneously to theatres and on Disney+. Other studious may adopt similar strategies due to the COVID-19 pandemic and may lead to permanent changes that shorten or eliminate exclusive theatrical windows. These practices have significantly impacted our revenues. If studios continue to reduce or eliminate the windows for certain films even after the industry recovers or, if our patrons continue to choose to wait for an in-home release rather than attend a theatre to view the film, it may continue to adversely impact our business and results of operations, financial condition and cash flows.

Our foreign operations are subject to adverse regulations, economic instability and currency exchange risk.

We have 200 theatres with 1,451 screens in fifteen countries in Latin America. Brazil represented approximately 8.6% of our consolidated 2020 revenues. Governmental regulation of the motion picture industry in foreign markets differs from that in the U.S. Changes in regulations affecting prices and quota systems requiring the exhibition of locally-produced films may adversely affect our international operations. Our international operations are subject to certain political, economic and other uncertainties not encountered by our domestic operations, including risks of severe economic downturns and high inflation. We also face risks of currency fluctuations, hard currency shortages and controls of foreign currency exchange and cash transfers to the U.S., all of which could have an adverse effect on the results of our operations.

We are subject to impairment losses due to potential declines in the fair value of our assets.

We have a significant amount of long-lived assets. We evaluate long-lived assets for impairment at the theatre level. Therefore, if a theatre is directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or condition of the areas surrounding the theatre, we may record impairment charges to reflect the decline in estimated fair value of that theatre.

We also have a significant amount of goodwill and tradename intangible assets. Declines in our stock price or market capitalization, declines in our attendance due to increased competition in certain regions and/or countries or economic factors that lead to a decline in attendance in any given region or country could result in impairments of goodwill and our intangible assets.

We are subject to uncertainties relating to future expansion plans, including our ability to identify suitable acquisition candidates or new theatre site locations, and to obtain financing for such activities on favorable terms or at all.

We have greatly expanded our operations over the last decade through targeted worldwide theatre development and acquisitions. We continue to pursue a strategy of expansion that will involve the development of new theatres and may involve acquisitions of existing theatres and theatre circuits both in the U.S. and internationally. There is significant competition for new site locations and for existing theatre and theatre circuit acquisition opportunities. As a result of such competition, we may not be able to acquire attractive site locations, existing theatres or theatre circuits on terms we consider acceptable. The pace of our growth may also be impacted by delays in site development caused by other parties. Acquisitions and expansion opportunities may divert a significant amount of management’s time away from the operation of our business. Growth by acquisition also involves risks relating to difficulties in integrating the operations and personnel of acquired companies and the potential loss of key employees of acquired companies. Our expansion strategy may not result in improvements to our business, financial condition, profitability, or cash flows. Further, our expansion programs may require financing above our existing borrowing capacity and operating cash flows. We may not be able to obtain such financing or ensure that such financing will be available to us on acceptable terms or at all.

16

Risks Related to Financing and Liquidity

We have substantial long-term lease and debt obligations, which may restrict our ability to fund current and future operations and that restrict our ability to enter into certain transactions.

We have, and will continue to have, significant long-term debt service obligations and long-term lease obligations. As of December 31, 2020, we had $2,527.9 million in long-term debt obligations, $141.0 million in finance lease obligations and $1,346.7 million in long-term operating lease obligations. Our substantial lease and debt obligations pose risk by:

| • | requiring us to dedicate a substantial portion of our cash flows to payments on our lease and debt obligations, thereby reducing the availability of our cash flows from operations to fund working capital, capital expenditures, acquisitions and other corporate requirements and to pay dividends;

| • | impeding our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions and other purposes;

| • | subjecting us to the risk of increased sensitivity to interest rate increases on our variable rate debt, including our borrowings under our senior secured credit facility;

| • | limiting our ability to invest in innovations in technology and implement new platforms or concepts in our theatres; and

| • | making us more vulnerable to adverse economic, market and industry conditions (including the impact of the COVID-19 pandemic), limit our flexibility in planning for, or reacting to, changes in our business operations or to our industry overall, and place us at a disadvantage in relation to our competitors that have lower debt levels.

Our ability to make scheduled payments of principal and interest with respect to our indebtedness will depend on our ability to generate positive cash flows and on our future financial results. Our ability to generate positive cash flows is subject to general economic, financial, competitive, regulatory and other factors that are beyond our control. Once we recover from the COVID-19 pandemic, we may not be able to generate cash flows at historical levels, or guarantee that future borrowings will be available under our senior secured credit facility, in an amount sufficient to enable us to pay our indebtedness. If our cash flows and capital resources are insufficient to fund our lease and debt service obligations, we may be forced to reduce or delay capital expenditures, sell assets or operations, seek additional capital or restructure or refinance our indebtedness. We may not be able to take any of these actions, and these actions may not be successful or permit us to meet our scheduled debt service obligations and these actions may be restricted under the terms of our existing or future debt agreements, including our senior secured credit facility.

If we fail to make any required payment under the agreements governing our leases and indebtedness or fail to comply with the financial and operating covenants contained in them, we would be in default, and as a result, our debt holders would have the ability to require that we immediately repay our outstanding indebtedness and the lenders under our senior secured credit facility could terminate their commitments to lend us money and foreclose against the assets securing their borrowings. We could be forced into bankruptcy or liquidation. The acceleration of our indebtedness under one agreement may permit acceleration of indebtedness under other agreements that contain cross-default and cross-acceleration provisions. If our indebtedness is accelerated, we may not be able to repay our indebtedness or borrow sufficient funds to refinance it. Even if we are able to obtain new financing, it may not be on commercially reasonable terms or on terms that are acceptable to us. If our debt holders require immediate payment, we may not have sufficient assets to satisfy our obligations under our indebtedness.

A lowering or withdrawal of the ratings assigned or a change in outlook to our outstanding debt securities by

rating agencies may increase our future borrowing costs and reduce our access to capital.

17

We are rated by nationally recognized rating agencies. The rating scales and methodologies used to derive individual ratings may vary from agency to agency. Credit ratings are issued by credit rating agencies based on evaluations of our ability to pay back our outstanding debt and the likelihood that we would default on that debt prior to its maturity. The credit ratings issued by the rating agencies represent the rating agency's evaluation of both qualitative and quantitative information for our company. The credit ratings that are issued are based on the rating agency’s judgment and experience in determining what information should be considered in giving a rating to a particular company. Ratings are always subject to change and there can be no assurance that our current ratings will continue for any given period of time.

Our debt currently has a non-investment grade rating, and any rating assigned could be lowered (or outlook thereof could be changed) or withdrawn entirely by a rating agency if, in that rating agency’s judgment, future circumstances relating to the basis of the rating, such as adverse changes in our business or industry, including as a result of the COVID-19 pandemic, so warrant. Any future lowering of our ratings likely would make it more difficult or more expensive for us to obtain additional debt financing. In particular, our access to the capital markets may be impacted, our other funding sources may decrease, the cost of debt may increase as a result of increased interest rates or fees, and we may be required to provide additional credit assurances, including collateral, under certain contracts or arrangements.

Our inability to raise funds necessary to settle conversions of, or to repurchase, the 4.50% Convertible Senior Notes (as defined below), upon a fundamental change as described in the indenture governing the 4.50% Convertible Senior Notes, may lead to defaults under such indenture and under agreements governing our existing or future indebtedness.

If we settle the 4.50% Convertible Senior Notes by cash, or by a combination of cash and shares of our common stock, upon a fundamental change as described in the indenture governing the 4.50% Convertible Senior Notes, we will be required to make cash payments with respect to the 4.50% Convertible Senior Notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to make purchases of the 4.50% Convertible Senior Notes being surrendered or converted. In addition, our ability to repurchase the 4.50% Convertible Senior Notes or to pay cash upon conversion of the 4.50% Convertible Senior Notes is limited by the agreements governing our existing indebtedness (including the senior secured credit facility) and may also be limited by law, by regulatory authority or by agreements that will govern our future indebtedness. Our failure to repurchase 4.50% Convertible Senior Notes at a time when the repurchase is required by the indenture governing the 4.50% Convertible Senior Notes or to pay cash payable on future conversions of the 4.50% Convertible Senior Notes as required by such indenture would constitute a default under such indenture. A default under the indenture governing the 4.50% Convertible Senior Notes or the fundamental change itself could also lead to a default under agreements governing our existing or future indebtedness (including the senior secured credit facility and the indentures governing Cinemark USA, Inc.’s senior notes).

The conditional conversion feature of the 4.50% Convertible Senior Notes, if triggered, may adversely affect our financial condition and operating results.

In the event the conditional conversion feature of the 4.50% Convertible Senior Notes is triggered, holders of the 4.50% Convertible Senior Notes will be entitled to convert the 4.50% Convertible Senior Notes at any time during specified periods at their option. If one or more holders elect to convert their 4.50% Convertible Senior Notes, initially we elect to satisfy our conversion obligations by combination settlement. In addition, in the future, we may elect to settle all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their 4.50% Convertible Senior Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the 4.50% Convertible Senior Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.

Conversion of the 4.50% Convertible Senior Notes will dilute the ownership interest of existing stockholders, or may otherwise depress the price of our common stock.

The conversion of some or all of the 4.50% Convertible Senior Notes will dilute the ownership interests of existing stockholders to the extent we deliver shares of our common stock upon conversion of any of the 4.50%

18

Convertible Senior Notes. The 4.50% Convertible Senior Notes may from time to time in the future be convertible at the option of their holders prior to their scheduled terms under certain circumstances. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the 4.50% Convertible Senior Notes may encourage short selling by market participants because the conversion of the 4.50% Convertible Senior Notes could be used to satisfy short positions, or anticipated conversion of the 4.50% Convertible Senior Notes into shares of our common stock could depress the price of our common stock.

The 4.50% Convertible Senior Notes Hedge Transactions and Warrant Transactions (each as defined below) may affect the value of our common stock.

In connection with the pricing of the 4.50% Convertible Senior Notes, we entered into Hedge Transactions with, and sold Warrants (as defined below) to, Option Counterparties (as defined below). The Hedge Transactions are expected generally to reduce the potential dilution to our common stock upon any conversion of the 4.50% Convertible Senior Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 4.50% Convertible Senior Notes, as the case may be. The Warrants would separately have a dilutive effect to the extent that the market price per share of our common stock exceeds the strike price of any Warrants on the applicable expiration dates unless, subject to the terms of the Warrants, we elect to cash settle the Warrants. In addition, the Option Counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions prior to the maturity of the 4.50% Convertible Senior Notes (and are likely to do so during any observation period related to a conversion of the 4.50% Convertible Senior Notes or following any repurchase of the 4.50% Convertible Senior Notes by us in connection with any fundamental change repurchase date or otherwise). This activity could also cause or avoid an increase or decrease in the market price of our common stock.

In addition, if any such Hedge Transactions and Warrants fail to become effective, the Option Counterparties or their respective affiliates may unwind their hedge positions with respect to our common stock, which could adversely affect the market price of our common stock. The potential effect, if any, of these transactions and activities on the market price of our common stock will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of our common stock.

We are subject to counterparty risk with respect to the 4.50% Convertible Senior Notes Hedge Transactions.

The Option Counterparties are financial institutions or affiliates of financial institutions, and we will be subject to the risk that one or more of such Option Counterparties may default under the Hedge Transactions. Our exposure to the credit risk of the Option Counterparties will not be secured by any collateral. If any Option Counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at that time under our transactions with that counterparty. Our exposure will depend on many factors but, generally, the increase in our exposure will be correlated to the increase in our common stock market price and in the volatility of the market price of our common stock. In addition, upon a default by the Option Counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurance as to the financial stability or viability of any Option Counterparty.

A credit market crisis may adversely affect our ability to raise capital and may materially impact our operations.

Severe dislocations and liquidity disruptions in the credit markets could materially impact our ability to obtain debt financing on reasonable terms or at all. The inability to access debt financing on reasonable terms could materially impact our ability to make acquisitions, invest in technology innovations or significantly expand our business in the future.

Our ability to pay dividends may be limited or otherwise restricted.

Our ability to pay dividends is limited by our status as a holding company and the terms of our senior notes indentures and our senior secured credit facility, which restrict our ability to pay dividends and the ability of certain

19

of our subsidiaries to pay dividends, directly or indirectly, to us. Under our debt instruments, we may pay a cash dividend up to a specified amount, provided we have satisfied certain financial covenants in, and are not in default under, our debt instruments. The declaration of future dividends on our common stock, par value $0.001 per share, or Common Stock, will be at the discretion of our board of directors and will depend upon many factors, including our results of operations, financial condition, earnings, capital requirements, limitations in our debt agreements and legal requirements. We suspended our dividend in March 2020 due to the impact of the COVID-19 pandemic and it is uncertain when we will again declare dividends.

Future sales of our common stock may adversely affect the prevailing market price.

Future sales of substantial amounts of our common stock in the open market and the issuance of the shares reserved for future issuance under our incentive plan, in exchange for outstanding warrants, conversion of outstanding 4.500% Convertible Senior Notes, or in connection with acquisitions or other corporate events, will be dilutive to our existing stockholders and could result in a decrease in our stock price. We cannot predict whether substantial amounts of our common stock will be sold in the open market in anticipation of, or following, any divestiture by any of our large stockholders, our directors or executive officers of their shares of common stock. We can also issue shares of our common stock which are authorized but unissued and not reserved for any specific purpose without any action or approval by our stockholders.

We may not be able to generate additional revenues or continue to realize value from our investment in NCM.

As of December 31, 2020, we owned 40,850,068 common units of NCM, which represented an ownership interest in NCM of approximately 25%. We receive monthly theatre access and advertising fees under our Exhibitor Services Agreement with NCM and we are entitled to receive mandatory quarterly distributions of excess cash from NCM. During the years ended December 31, 2018, 2019 and 2020, the Company received approximately $12.1 million, $13.8 million and $4.7 million in other revenues from NCM, respectively, $22.2 million, $25.9 million and $14.2 million in cash distributions recorded as a reduction of our investment in NCM, respectively, and $15.4 million $12.9 million and $7.0 million in cash distributions in excess of our investment in NCM, respectively. Cinema advertising is a small component of the U.S. advertising market and therefore, NCM competes with larger, more established and well known media platforms such as broadcast radio and television, cable and satellite television, outdoor advertising and Internet portals. In-theatre advertising may not continue to attract advertisers or NCM’s in-theatre advertising format may not continue to be received favorably by theatre patrons. If NCM is unable to continue to generate consistent advertising revenues, its results of operations may be adversely affected and our investment in and distributions and revenues from NCM may be adversely impacted. NCM revenues and excess cash distributions have been significantly impacted by the COVID-19 pandemic and resulting temporary theatre closures. Future NCM revenues and excess cash distributions from NCM to the Company will depend on the reopening of theatres and the recovery of the motion picture exhibition industry.

Regulatory Risks

If we do not comply with the ADA and the safe harbor framework included in the consent order we entered into with the Department of Justice, or the DOJ, we could be subject to further litigation. In addition, if we do not comply with local and government restrictions related to the COVID-19 pandemic, we could be subject to fines or forced to close theatres.

Our theatres must comply with Title III of the ADA and analogous state and local laws. Compliance with the ADA requires among other things that public facilities “reasonably accommodate” individuals with disabilities and that new construction or alterations made to “commercial facilities” conform to accessibility guidelines unless “structurally impracticable” for new construction or technically infeasible for alterations. On November 15, 2004, Cinemark and the DOJ entered into a consent order, which was filed with the U.S. District Court for the Northern District of Ohio, Eastern Division. Under the consent order, the DOJ approved a safe harbor framework for us to construct all of our future stadium-style movie theatres. The DOJ has stipulated that all theatres built in compliance with the consent order will comply with the wheelchair seating requirements of the ADA. If we fail to comply with the ADA, remedies could include imposition of injunctive relief, fines, awards for damages to private litigants and additional capital expenditures to remedy non-compliance. Imposition of significant fines, damage awards or capital expenditures to cure non-compliance could adversely affect our business and operating results.

20

We may be subject to increased labor and benefits costs.

In the U.S., we are subject to United States federal and state laws governing such matters as minimum wages, working conditions and overtime. We are also subject to union regulations in certain of our international markets, which can specify wage rates as well as minimum hours to be paid to certain employees. As federal and state minimum wage rates increase, we may need to increase not only the wages of our minimum wage employees, but also the wages paid to employees at wage rates that are above minimum wage. Labor shortages, increased employee turnover and health care mandates could also increase our labor costs. This in turn could lead us to increase prices, which could impact our sales. Conversely, if competitive pressures or other factors prevent us from offsetting increased labor costs by increases in prices, our results of operations may be adversely impacted.

Provisions in our corporate documents and certain agreements, as well as Delaware law, may hinder a change of control.

Provisions in our amended and restated certificate of incorporation and bylaws, as well as provisions of the Delaware General Corporation Law, could discourage unsolicited proposals to acquire us. These provisions include:

| • | authorization of our board of directors to issue shares of preferred stock without stockholder approval;

| • | a board of directors classified into three classes of directors with the directors of each class having staggered, three-year terms;

| • | provisions regulating the ability of our stockholders to nominate directors for election or to bring matters for action at annual meetings of our stockholders; and

| • | provisions of Delaware law that restrict many business combinations and provide that directors serving on classified boards of directors, such as ours, may be removed only for cause.

Certain provisions of our 8.750% secured notes indenture, 4.875% senior notes indenture, our 5.125% senior notes indenture and our senior secured credit facility may have the effect of delaying or preventing future transactions involving a “change of control.” A “change of control” would require us to make an offer to the holders of each of our 8.750% Secured Notes, 4.875% Senior Notes and our 5.125% Senior Notes (each as defined below) to repurchase all of the outstanding notes at a purchase price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest to the date of purchase. A “change of control” would also be an event of default under our senior secured credit facility.

Risks Related to Cybersecurity and Business Disruptions

Cyber security threats and our failure to protect our electronically stored data could adversely affect our business.

We collect, use, store and maintain electronic information and data necessary to conduct our business, including confidential and proprietary information of the company, our customers, and our employees. We also rely on the availability of information technology systems to operate our business, including for communications, receiving and displaying movies, ticketing, guest services, payments, and other general operations. We rely on some of our vendors to store and process certain data and to manage, host, and/or provide some of our information technology systems. Because of the scope and complexity of our information technology systems, our reliance on vendors to provide, support and protect our systems and data, and the constantly evolving cyber-threat landscape, our information technology systems are subject to the risk of disruption, failure, unauthorized access, cyber-terrorism, human error, misuse, tampering, theft, and other cyber-attacks. These or similar events, whether accidental or intentional, could result in theft, unauthorized access or disclosure, loss, fraudulent or unlawful use of customer, employee or company data, which could harm our reputation or result in a loss of business, as well as remedial and other costs, fines, investigations, enforcement actions or lawsuits. These or similar events could also lead to an interruption in the operation of our systems resulting in business impact, including loss of business. Those same scope, complexity, reliance, and changing cyber-threat landscape factors could also affect our ability to adapt to and comply with changing regulations and contractual obligations applicable to data security and privacy, which are increasingly demanding, both in the United States and in other jurisdictions where we operate. In order to address these risks, we have adopted security measures and technology, operate a security program, and work continuously to evaluate and improve our security posture. However, the development and maintenance of these

21

systems and programs are costly and require ongoing monitoring and updating as technologies change and efforts to overcome security measures become more sophisticated. As such, there can be no assurance that these or similar events will not occur in the future or will not have an adverse effect on our business and results of operation.

In addition to Company-specific cyber threats or events, our business and results of operations could also be impacted by cyber-related events affecting our peers and partners within the entertainment industry, as well as other retail companies. We maintain insurance designed to provide coverage for cyber risks related to what we believe to be adequate and collectible insurance in the event of the theft, loss, fraudulent or unlawful use of customer, employee or company data, but the foregoing events or future events could result in costs and business impacts which may not be covered or may be in excess of any available insurance that we may have procured. As a result, future events could have a material impact on our business and adversely affect our financial condition and results of operations.

Other General Risks

General political, social, health and economic conditions can adversely affect our attendance.

Our results of operations are dependent on general political, social, health and economic conditions, and the impact of such conditions on our theatre operating costs and on the willingness of consumers to spend money at movie theatres. If consumers’ discretionary income declines during a period of an economic downturn or political uncertainty, our operations could be adversely affected. If theatre operating costs, such as utility costs, increase due to political or economic changes, our results of operations could be adversely affected. Political events, such as terrorist attacks, and health-related pandemics or epidemics, such as flu or other virus outbreaks, could cause people to avoid our theatres or other public places where large crowds are in attendance, which could adversely affect our results of operations. In addition, a natural disaster, such as a hurricane or an earthquake, could impact our ability to operate certain of our theatres, which could adversely affect our results of operations.

A failure to adapt to future technological innovations could impact our ability to compete effectively and could adversely affect our results of operations.

While we continue to invest in technological innovations, such as motion seats and satellite distribution technologies, new technological innovations continue to impact our industry. If we are unable to respond to or invest in changes in technology and the technological preferences of our customers, we may not be able to compete with other exhibitors or other entertainment venues, which could adversely affect our results of operations.

Legislative or regulatory initiatives related to global warming/climate change concerns may negatively impact our business.

Recently, there has been an increasing focus and continuous debate on global climate change including increased attention from regulatory agencies and legislative bodies. This increased focus may lead to new initiatives directed at regulating an as yet unspecified array of environmental matters. Legislative, regulatory or other efforts in the U.S. to combat climate change could result in future increases in the cost of raw materials, taxes, transportation and utilities for our vendors and for us which would result in higher operating costs for the Company. Also, compliance of our theatres and accompanying real estate with new and revised environmental, zoning, land-use or building codes, laws, rules or regulations, could have a material and adverse effect on our business. However, we are unable to predict at this time, the potential effects, if any, that any future environmental initiatives may have on our business.

We may be subject to liability under environmental laws and regulations.

We own and operate a large number of theatres and other properties within the U.S. and internationally, which may be subject to various foreign, federal, state and local laws and regulations relating to the protection of the environment or human health. Such environmental laws and regulations include those that impose liability for the investigation and remediation of spills or releases of hazardous materials. We may incur such liability, including for any currently or formerly owned, leased or operated property, or for any site, to which we may have disposed, or arranged for the disposal of, hazardous materials or wastes. Certain of these laws and regulations may impose

22

liability, including joint and several liability, which can result in a liable party being obliged to pay for greater than its share, regardless of fault or the legality of the original disposal. Environmental conditions relating to our properties or operations could have an adverse effect on our business and results of operations and cash flows.

Product recalls and associated costs could adversely affect our reputation and financial condition.

We may be found liable if the consumption of any of the products we sell causes illness or injury. We are also subject to recall by product manufacturers or if the food products become contaminated. Recalls could result in losses due to the cost of the recall, the destruction of the product and lost sales due to the unavailability of the product for a period of time.

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

The following table sets forth a summary of our theatres in U.S. and international markets as of December 31, 2020:

|  | Leased |  |  | Owned |
Segment |  | Theatres |  |  | Theatres |
U.S. |  |  | 288 |  |  |  | 43 |
International |  |  | 200 |  |  |  | — |
Total |  |  | 488 |  |  |  | 43 |

See Item 1, Business – Theatre Operations, for a summary of the geographic locations for our U.S. and international theatre circuit as of December 31, 2020.

The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with base terms generally ranging from 10 to 25 years. In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance and other costs applicable to the property. Variable lease payments include payments based on a percentage of retail sales over defined thresholds or payments adjusted periodically for inflation or changes in attendance. The Company can renew, at its option, a substantial portion of the leases at defined or then market rental rates for various periods. Some leases also provide for escalating rent payments throughout the lease term. See Note 4 to our consolidated financial statements for further discussion of our property leases.

In addition to our theatre properties, we currently own an office building in Plano, Texas, which is our worldwide headquarters. We lease office space in Frisco, Texas for our theatre technology support team and a warehouse in McKinney, TX. We also lease office space in seven regions in Latin America for our local management teams .

Item 3. Legal Proceedings

For a discussion of contingencies related to legal proceedings, see Note 20 to our consolidated financial statements, which is hereby incorporated by reference.

23

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common equity consists of common stock, which has traded on the New York Stock Exchange since April 24, 2007 under the symbol “CNK."

Holders of Common Stock

As of December 31, 2020, there were 227 holders of record of the Company’s common stock and there were no other classes of stock issued and outstanding.

Dividend Policy

We, at the discretion of the board of directors and subject to applicable law, may pay regular quarterly dividends on our common stock. The amount, if any, of the dividends to be paid in the future will depend upon our then available cash, anticipated cash needs, overall financial condition, loan agreement restrictions, future prospects for earnings and cash flows, as well as other relevant factors. In March 2020, our board of directors suspended our dividend policy. See Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operation – Liquidity and Capital Resources – Financing Activities for a discussion of dividend restrictions under our debt agreements.

See Note 7 to our consolidated financial statements for a detail of dividends paid during the years ended December 31, 2018, 2019 and 2020.

Performance Graph

The performance graph is incorporated by reference to the Company’s proxy statement for its annual stockholders meeting to be held on May 20, 2021 and to be filed with the SEC within 120 days after December 31, 2020.

24

Item 6. Selected Financial Data

The following table provides our selected consolidated financial and operating data for the periods and at the dates indicated for each of the five most recent years ended December 31, 2020. You should read the selected consolidated financial and operating data set forth below in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our audited consolidated financial statements and related notes appearing elsewhere in this report. We adopted ASC Topic 606, Revenue Recognition, effective January 1, 2018 (see Note 5 to our consolidated financial statements for related disclosures). We adopted ASC Topic 842, Leases, effective January 1, 2019 (see Note 4 to our consolidated financial statements for related disclosures).

|  | Year Ended December 31, |
|  | 2016 |  |  | 2017 |  |  | 2018 |  |  | 2019 |  |  | 2020 |
Statement of Income Data: |  | (Dollars in thousands, except per share data) |
Revenues: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Admissions |  | $ | 1,789,137 |  |  | $ | 1,794,982 |  |  | $ | 1,834,173 |  |  | $ | 1,805,321 |  |  | $ | 356,508 |
Concession |  |  | 990,103 |  |  |  | 1,038,788 |  |  |  | 1,108,793 |  |  |  | 1,161,083 |  |  |  | 231,046 |
Other |  |  | 139,525 |  |  |  | 157,777 |  |  |  | 278,769 |  |  |  | 316,695 |  |  |  | 98,756 |
Total revenues |  |  | 2,918,765 |  |  |  | 2,991,547 |  |  |  | 3,221,735 |  |  |  | 3,283,099 |  |  |  | 686,310 |
Film rentals and advertising |  |  | 962,655 |  |  |  | 966,510 |  |  |  | 999,755 |  |  |  | 1,003,832 |  |  |  | 186,810 |
Concession supplies |  |  | 154,469 |  |  |  | 166,320 |  |  |  | 180,974 |  |  |  | 206,441 |  |  |  | 48,647 |
Salaries and wages |  |  | 325,765 |  |  |  | 354,510 |  |  |  | 383,860 |  |  |  | 410,086 |  |  |  | 145,031 |
Facility lease expense |  |  | 321,294 |  |  |  | 328,197 |  |  |  | 323,316 |  |  |  | 346,094 |  |  |  | 279,764 |
Utilities and other |  |  | 355,926 |  |  |  | 355,041 |  |  |  | 448,070 |  |  |  | 474,711 |  |  |  | 229,505 |
General and administrative expenses |  |  | 143,355 |  |  |  | 153,278 |  |  |  | 165,173 |  |  |  | 173,384 |  |  |  | 127,599 |
Depreciation and amortization |  |  | 209,071 |  |  |  | 237,513 |  |  |  | 261,162 |  |  |  | 261,155 |  |  |  | 259,776 |
Impairment of long-lived assets |  |  | 2,836 |  |  |  | 15,084 |  |  |  | 32,372 |  |  |  | 57,001 |  |  |  | 152,706 |
Restructuring charges |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 20,369 |
(Gain) loss on disposal of assets and other |  |  | 20,459 |  |  |  | 22,812 |  |  |  | 38,702 |  |  |  | 12,008 |  |  |  | (8,923 | )
Total cost of operations |  | $ | 2,495,830 |  |  | $ | 2,599,265 |  |  | $ | 2,833,384 |  |  | $ | 2,944,712 |  |  | $ | 1,441,284 |
Operating income (loss) |  | $ | 422,935 |  |  | $ | 392,282 |  |  | $ | 388,351 |  |  | $ | 338,387 |  |  | $ | (754,974 | )
Interest expense |  | $ | 108,313 |  |  | $ | 105,918 |  |  | $ | 109,994 |  |  | $ | 99,941 |  |  | $ | 129,871 |
Net income (loss) |  | $ | 256,827 |  |  | $ | 266,019 |  |  | $ | 215,305 |  |  | $ | 193,848 |  |  | $ | (617,948 | )
Net income (loss) attributable to Cinemark Holdings, Inc. |  | $ | 255,091 |  |  | $ | 264,180 |  |  | $ | 213,827 |  |  | $ | 191,386 |  |  | $ | (616,828 | )
Net income (loss) attributable to Cinemark Holdings, Inc. per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 2.19 |  |  | $ | 2.26 |  |  | $ | 1.83 |  |  | $ | 1.63 |  |  | $ | (5.25 | )
Diluted |  | $ | 2.19 |  |  | $ | 2.26 |  |  | $ | 1.83 |  |  | $ | 1.63 |  |  | $ | (5.25 | )
Cash dividends declared per common share |  | $ | 1.08 |  |  | $ | 1.16 |  |  | $ | 1.28 |  |  | $ | 1.36 |  |  | $ | 0.36 |

|  | Year Ended December 31, |
|  | 2016 |  |  | 2017 |  |  | 2018 |  |  | 2019 |  |  | 2020 |
|  | (Dollars in thousands) |
Other Financial Data: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash flow provided by (used for): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating activities |  | $ | 462,910 |  |  | $ | 528,998 |  |  | $ | 556,915 |  |  | $ | 561,995 |  |  | $ | (330,098 | )
Investing activities |  |  | (327,769 | ) |  |  | (410,476 | ) |  |  | (451,370 | ) |  |  | (310,642 | ) |  |  | (83,366 | )
Financing activities |  |  | (163,711 | ) |  |  | (158,008 | ) |  |  | (192,648 | ) |  |  | (186,506 | ) |  |  | 584,408 |
Capital expenditures |  |  | (326,908 | ) |  |  | (380,862 | ) |  |  | (346,073 | ) |  |  | (303,627 | ) |  |  | (83,930 | )

25

|  | As of December 31, |
|  | 2016 |  |  | 2017 |  |  | 2018 |  |  | 2019 |  |  | 2020 |
|  | (Dollars in thousands) |
Balance Sheet Data: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 561,235 |  |  | $ | 522,547 |  |  | $ | 426,222 |  |  | $ | 488,313 |  |  | $ | 655,338 |
Theatre properties and equipment, net |  |  | 1,704,536 |  |  |  | 1,828,054 |  |  |  | 1,833,133 |  |  |  | 1,735,247 |  |  |  | 1,615,062 |
Total assets |  |  | 4,306,633 |  |  |  | 4,470,893 |  |  |  | 4,481,838 |  |  |  | 5,828,017 |  |  |  | 5,562,922 |
Total long-term debt, including current portion, net of unamortized debt discounts and debt issue costs |  |  | 1,788,112 |  |  |  | 1,787,480 |  |  |  | 1,780,611 |  |  |  | 1,777,937 |  |  |  | 2,395,218 |
Equity |  |  | 1,272,960 |  |  |  | 1,405,688 |  |  |  | 1,408,570 |  |  |  | 1,448,322 |  |  |  | 798,969 |

|  | Year Ended December 31, |
Operating Data: |  | 2016 |  |  | 2017 |  |  | 2018 |  |  | 2019 |  |  | 2020 |
United States |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Theatres operated (at period end) |  |  | 339 |  |  |  | 339 |  |  |  | 341 |  |  |  | 345 |  |  |  | 331 |
Screens operated (at period end) |  |  | 4,559 |  |  |  | 4,561 |  |  |  | 4,586 |  |  |  | 4,645 |  |  |  | 4,507 |
Total attendance (in 000s) |  |  | 182,660 |  |  |  | 174,432 |  |  |  | 185,268 |  |  |  | 176,162 |  |  |  | 34,938 |
International |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Theatres operated (at period end) |  |  | 187 |  |  |  | 194 |  |  |  | 205 |  |  |  | 209 |  |  |  | 200 |
Screens operated (at period end) |  |  | 1,344 |  |  |  | 1,398 |  |  |  | 1,462 |  |  |  | 1,487 |  |  |  | 1,451 |
Total attendance (in 000s) |  |  | 104,581 |  |  |  | 102,584 |  |  |  | 96,847 |  |  |  | 103,409 |  |  |  | 19,368 |
Worldwide |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Theatres operated (at period end) |  |  | 526 |  |  |  | 533 |  |  |  | 546 |  |  |  | 554 |  |  |  | 531 |
Screens operated (at period end) |  |  | 5,903 |  |  |  | 5,959 |  |  |  | 6,048 |  |  |  | 6,132 |  |  |  | 5,958 |
Total attendance (in 000s) |  | 287,241 |  |  |  | 277,016 |  |  |  | 282,115 |  |  |  | 279,571 |  |  |  | 54,306 |

26

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the financial statements and accompanying notes included in this report. This discussion may contain forward-looking statements. See “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” for a discussion of the uncertainties and risk associated with these statements. Discussion regarding our financial condition and results of operations for 2019 compared to 2018 is included in Item 7 of our 2019 Annual Report on Form 10-K filed February 21, 2020.

Overview

We are a leader in the motion picture exhibition industry, with theatres in the U.S., Brazil, Argentina, Chile, Colombia, Ecuador, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. As of December 31, 2020, we managed our business under two reportable operating segments – U.S. markets and international markets. See Note 21 to our consolidated financial statements.

Recent Developments

The outbreak of the COVID-19 pandemic has had an unprecedented impact on the world and our industry. As a movie exhibitor that operates spaces where patrons gather in close proximity, we have been, and continue to be, significantly impacted by COVID-19. At the initial outbreak of the COVID-19 pandemic, to comply with government mandates, we temporarily closed all of our theatres in the U.S. and Latin America effective March 17, 2020 and March 18, 2020, respectively. In conjunction with the temporary closure of our theatres in March 2020, we implemented temporary personnel and salary reductions, limited non-essential operating and capital expenditures, and negotiated modified timing and/or abatement of contractual payments with landlords and other major suppliers until our theatres reopened. In addition, we suspended our quarterly dividend.

As of December 31, 2020, we had reopened 217 of our domestic theatres and 129 of our international theatres showing a limited volume of new releases along with library content during reduced operating hours with limited capacities. While some staffing has been brought back to support theatre reopenings, we continue operating with reduced staffing and limiting capital expenditures to essential activities and projects. Government restrictions also continue to fluctuate with the status of the virus, impacting our reopening plans. We continue to work with landlords and other vendors on modified contractual payment terms while we continue to navigate through the impact of the COVID-19 pandemic and seek to recover a routine level of operations.

Our focus on maintaining a strong balance sheet and low leverage allowed us to enter the global COVID-19 pandemic in a solid financial position. Based on our current estimates of recovery, we believe we have and will generate sufficient cash to sustain operations. Nonetheless, the COVID-19 pandemic has had, and continues to have, adverse effects on our business, results of operations, cash flows, financial condition, access to credit markets and ability to service existing and future indebtedness, some of which are significant.

We have elected to take advantage of certain tax-related benefits available under the Coronavirus Aid, Relief, and Economic Security Act of 2020, or the CARES Act signed into U.S. federal law on March 27, 2020. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer social security payments, net operating loss, or NOL, utilization and carryback periods, modifications to the net interest deduction limitations and a technical correction to the 2017 Tax Cuts and Jobs Act, which makes certain qualified improvement property eligible for bonus depreciation. In accordance with the provisions of the CARES Act, we have deferred payment of certain employer payroll taxes for 2020 and have recorded payroll tax credits for expenses related to paying wages and health benefits to employees who were not working as a result of closures and reduced receipts associated with the COVID-19 pandemic. See additional discussion at Note 3 and Note 19 to our consolidated financial statements.

If we receive certain government disaster relief assistance, it may be subject to certain requirements imposed by the government on the recipients of the aid including restrictions on executive officer compensation, share buybacks, dividends, prepayment of debt, incurrence of additional indebtedness and other similar restrictions until the aid is repaid or redeemed in full. However, we cannot predict the manner in which such benefits will be allocated or administered and cannot predict whether we will be able to access such benefits in a timely manner or at all.

27

Revenues and Expenses

We generate revenues primarily from filmed entertainment box office receipts and concession sales with additional revenues from screen advertising and screen rental revenue and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals and electronic video games located in some of our theatres. We also offer alternative entertainment, such as the Metropolitan Opera, concert events, in-theatre gaming, live and pre-recorded sports programs and other special events in our theatres through Fathom Entertainment (operated by AC JV, LLC). NCM provides our domestic theatres with various forms of in-theatre advertising. Our Flix Media subsidiaries provide screen advertising and alternative content for our international circuit and to other international exhibitors.

Films released during the year ended December 31, 2020 included Bad Boys for Life, Sonic the Hedgehog, Birds of Prey, Dolittle, The Invisible Man and The Call of the Wild. The carryover of late 2019 releases such as 1917, Jumanji: The Next Level and Star Wars: The Rise of Skywalker also contributed to industry box office during early 2020. Due to the temporary closure of many theatres since March, movie studios delayed the release of many films originally planned for 2020 or released them directly on streaming platforms or, in some instances, simultaneously with theatrical release. Upon reopening its domestic theatres, the Company offered patrons primarily library content, bringing back many classics to the big screen. As more theatres reopened and safety protocols were implemented, studios began releasing new content, which included Wonder Woman 1984, Tenet, The Croods: A New Age, The New Mutants, Unhinged, The War with Grandpa and Honest Thief.

Currently, films scheduled for release in 2021 include the sequel to Marvel’s Spider-man Far From Home, Top Gun Maverick, Black Widow, F9, Luca, Eternals, Mission: Impossible 7, No Time to Die, Cruella, and Minions: The Rise of Gru, among others. As the industry navigates the continued impact of the COVID-19 pandemic and resulting various regulations and restrictions, film release schedules may continue to change.

Film rental costs are variable in nature and fluctuate with our admissions revenues. Film rental costs as a percentage of revenues are generally higher for periods in which more blockbuster films are released. The Company also receives virtual print fees from studios for certain of its international locations, which are included as a contra-expense in film rentals and advertising costs; however, these costs are expected to be fully recovered during 2021. Advertising costs, which are expensed as incurred, are primarily related to campaigns for new and remodeled theatres, loyalty and membership programs and brand advertising that vary depending on the timing of such campaigns.

Concession supplies expense is variable in nature and fluctuates with our concession revenues and product mix. We negotiate prices for concession supplies directly with concession vendors and manufacturers to obtain volume rates.

Although salaries and wages include a fixed cost component (i.e. the minimum staffing costs to operate a theatre facility during non-peak periods), salaries and wages tend to move in relation to revenues as theatre staffing is adjusted to respond to changes in attendance. Staffing levels may vary based on the amenities offered at a location, such as full service restaurants, bars or expanded food and beverage options. In certain locations, staffing levels are also subject to local regulations.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain leases are subject to percentage rent only, while others are subject to percentage rent in addition to their fixed monthly rent if a target annual performance level is achieved. Facility lease expense as a percentage of revenues is also affected by the number of theatres under operating leases, the number of theatres under finance leases and the number of owned theatres.

Utilities and other costs include both fixed and variable costs and primarily consist of utilities, property taxes, janitorial costs, credit card fees, third party ticket sales commissions, repairs and maintenance expenses, security services and expenses for the maintenance and monitoring of projection and sound equipment.

General and administrative expenses are primarily fixed in nature and consist of the costs to support the overall management of the Company. Fixed expenses include salaries and wages and benefit costs for our corporate

28

office personnel, facility expenses for our corporate and other offices, software maintenance costs and audit fees. Some variable expenses may include incentive compensation, consulting and legal fees, supplies and other costs that are not specifically associated with the operations of our theatres.

Critical Accounting Policies

We prepare our consolidated financial statements in conformity with generally accepted accounting principles in the U.S., or U.S. GAAP. As such, we are required to make certain estimates and assumptions that we believe are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The significant accounting policies, which we believe are the most critical to aid in fully understanding and evaluating our reported consolidated financial results, include the following:

Revenue and Expense Recognition

Our patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on when tickets are put on sale and seat availability. We recognize such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when products are sold to the consumer, or if pre-ordered, after the associated pick-up date has passed. Other revenues primarily consist of screen advertising and screen rental revenues, promotional income, studio trailer placements and transactional fees. We sell gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenues. Deferred revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for movie tickets or concession items. We offer a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. We record the monthly subscription program fees as deferred revenues and record admissions revenues when the showtime for a movie ticket purchased with a credit has passed. We have loyalty programs in the U.S. and many of our international locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, we recognize the fee collected as other revenues on a straight-line basis over the term of the membership. For those loyalty programs that award points to customers based on their purchases, we record a portion of the original transaction proceeds as deferred revenues based on the number of reward points issued to customers and we recognize the deferred revenues when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. We record breakage revenue on gift cards and discount ticket vouchers based on redemption activity and historical experience with unused balances. We generally record breakage revenue upon the expiration of loyalty points and subscription credits. Advances collected on concession and other contracts are deferred and recognized during the period in which we satisfy the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as we meet our performance obligations in accordance with the terms of the contracts.

Film rental costs are subject to the film licensing arrangement and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established prior to the opening of the film, 2) firm terms or 3) estimates of the final settlement rate, which occurs at the conclusion of the film run. Under a sliding scale formula, we pay a percentage of box office revenues using a pre-determined matrix that is based upon box office performance of the film for its full run. Under a firm terms formula, we pay the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can generally be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental costs are adjusted at that time.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain of our leases are subject to monthly percentage rent only, which is accrued each month based on actual revenues. Certain of our other theatres require payment of percentage rent in addition to fixed monthly rent if an annual target revenue level is achieved. Percentage rent expense is estimated and recorded for these theatres on a monthly basis if the theatre’s historical performance or forecasted performance indicates that

29

the annual target revenue level will be reached. Once annual revenues are known, the timing of which is based on the lease agreement, percentage rent expense is adjusted at that time.

Theatre properties and equipment are depreciated using the straight-line method over their estimated useful lives. In estimating the useful lives of our theatre properties and equipment, we have relied upon our experience with such assets and our historical replacement period. We periodically evaluate these estimates and assumptions and adjust them as necessary. Leasehold improvements for which we pay, and to which we have title, are amortized over the lesser of their useful life or the remaining lease term.

Impairment of Long-Lived Assets

We review long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. We also perform a full quantitative impairment evaluation on an annual basis. We assess many factors including the following to determine whether to impair individual theatre assets:

| • | actual theatre level cash flows;

| • | budgeted or forecast theatre level cash flows;

| • | theatre property and equipment carrying values;

| • | operating lease right-of-use asset carrying values;

| • | amortizing intangible asset carrying values;

| • | the age of a recently built theatre;

| • | competitive theatres in the marketplace;

| • | the impact of recent ticket price changes;

| • | the impact of recent theatre remodels or other substantial improvements;

| • | available lease renewal options; and

| • | other factors considered relevant in our assessment of impairment of individual theatre assets.

Long-lived assets are evaluated for impairment on a theatre basis, which we believe is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, we then compare the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Fair value is determined based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples.

See further discussion of our impairment evaluation policy at Note 1 of our consolidated financial statements. See a summary of the impairment evaluations performed during the year ended December 31, 2020 and impairments recorded during the years ended December 31, 2018, 2019 and 2020 at Note 11 to our consolidated financial statements.

Impairment of Goodwill and Intangible Assets

We evaluate goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. We evaluate goodwill for

30

impairment at the reporting unit level and we have allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other, or ASC Topic 350, we may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill.

Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, we can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets. A quantitative tradename impairment assessment includes comparing the carrying values of tradename assets to an estimated fair value. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. A qualitative assessment considers our historical and forecasted revenues and changes in estimated royalty rates, and a comparison of current carrying values to estimated fair values from our most recent quantitative assessment.

See further discussion of our impairment evaluation policy at Note 1 of our consolidated financial statements. See a summary of the impairment evaluations performed during the year ended December 31, 2020 and impairments recorded during the years ended December 31, 2018, 2019 and 2020 at Note 11 to our consolidated financial statements.

Income Taxes

We use an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: We determine whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, we presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). We accrue interest and penalties on uncertain tax positions. See Note 19 to our consolidated financial statements for further discussion of income taxes.

Accounting for Investment in National CineMedia, LLC and Related Agreements

We have an investment in NCM. NCM operates a digital in-theatre network in the U.S. for providing cinema advertising and non-film events. Upon joining NCM, we entered into an Exhibitor Services Agreement, or ESA, with NCM pursuant to which NCM provides advertising, promotion and event services to our theatres. On February 13, 2007, National CineMedia, Inc., or NCM Inc., a newly formed entity that serves as a member and the sole manager of NCM, completed an initial public offering of its common stock. In connection with the NCM Inc. initial public offering, we amended our operating agreement and the Exhibitor Services Agreement, or ESA, with NCM and received proceeds related to the modification of the ESA and our sale of certain of shares in NCM. The ESA modification reflected a shift from circuit share expense under the prior Exhibitor Services Agreement, which obligated NCM to pay us a percentage of revenue, to a monthly theatre access fee, which significantly reduced the

31

contractual amounts paid to the Company by NCM. The Company recorded the proceeds related to the ESA modification as deferred revenue. As a result of the proceeds received as part of the NCM, Inc. initial public offering, the Company had a negative basis in its original membership units in NCM (referred to herein as its Tranche 1 Investment). The Company does not recognize undistributed equity in the earnings on its Tranche 1 Investment until NCM's future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company believes that the accounting model provided by ASC 323-10-35-22 for recognition of equity investee losses in excess of an investor's basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution.

Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCM, Inc. and Cinemark, AMC and Regal, collectively referred to as its Founding Members, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. To account for the receipt of additional common units under the Common Unit Adjustment Agreement, the Company follows the guidance in ASC 323-10-35-29 (formerly EITF 02-18, Accounting for Subsequent Investments in an Investee after Suspension of Equity Loss Recognition) by analogy, which also refers to AICPA Technical Practice Aid 2220.14, which indicates that if a subsequent investment is made in an equity method investee that has experienced significant losses, the investor must determine if the subsequent investment constitutes funding of prior losses. The Company concluded that the construction or acquisition of new theatres that has led to the common unit adjustments equates to making additional investments in NCM. The Company evaluated the receipt of the additional common units in NCM and the assets exchanged for these additional units and has determined that the right to use its incremental new screens would not be considered funding of prior losses. The Company accounts for these additional common units (referred to herein as its Tranche 2 Investment) as a separate investment than its Tranche 1 Investment. The common units received are recorded at fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue. The deferred revenue is amortized over the remaining term of the ESA. The Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of its investment basis.

See Note 8 to our consolidated financial statements for further discussion of our investment in NCM.

32

Results of Operations

The following table sets forth, for the periods indicated, the amounts for certain items reflected in our consolidated statements of income along with each of those items as a percentage of revenues.

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Operating data (in millions): |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |
Admissions |  | $ | 1,834.2 |  |  | $ | 1,805.3 |  |  | $ | 356.5 |
Concession |  |  | 1,108.8 |  |  |  | 1,161.1 |  |  |  | 231.1 |
Other |  |  | 278.8 |  |  |  | 316.7 |  |  |  | 98.7 |
Total revenues |  | $ | 3,221.8 |  |  | $ | 3,283.1 |  |  | $ | 686.3 |
Cost of operations |  |  |  |  |  |  |  |  |  |  |  |
Film rentals and advertising |  |  | 999.8 |  |  |  | 1,003.8 |  |  |  | 186.8 |
Concession supplies |  |  | 181.0 |  |  |  | 206.5 |  |  |  | 48.6 |
Salaries and wages |  |  | 383.9 |  |  |  | 410.1 |  |  |  | 145.0 |
Facility lease expense |  |  | 323.3 |  |  |  | 346.1 |  |  |  | 279.8 |
Utilities and other |  |  | 448.0 |  |  |  | 474.7 |  |  |  | 229.5 |
General and administrative expenses |  |  | 165.2 |  |  |  | 173.4 |  |  |  | 127.6 |
Depreciation and amortization |  |  | 261.2 |  |  |  | 261.2 |  |  |  | 259.8 |
Impairment of long-lived assets |  |  | 32.4 |  |  |  | 57.0 |  |  |  | 152.7 |
Restructuring costs |  |  | — |  |  |  | — |  |  |  | 20.4 |
(Gain) loss on disposal of assets and other |  |  | 38.7 |  |  |  | 12.0 |  |  |  | (8.9 | )
Total cost of operations |  |  | 2,833.5 |  |  |  | 2,944.8 |  |  |  | 1,441.3 |
Operating income (loss) |  | $ | 388.3 |  |  | $ | 338.3 |  |  | $ | (755.0 | )
Operating data as a percentage of total revenues: |
Revenues |  |  |  |  |  |  |  |  |  |  |  |
Admissions |  |  | 56.9 | % |  |  | 55.0 | % |  |  | 51.9 | %
Concession |  |  | 34.4 | % |  |  | 35.4 | % |  |  | 33.7 | %
Other |  |  | 8.7 | % |  |  | 9.6 | % |  |  | 14.4 | %
Total revenues |  |  | 100.0 | % |  |  | 100.0 | % |  |  | 100.0 | %
Cost of operations (1) |  |  |  |  |  |  |  |  |  |  |  |
Film rentals and advertising |  |  | 54.5 | % |  |  | 55.6 | % |  |  | 52.4 | %
Concession supplies |  |  | 16.3 | % |  |  | 17.8 | % |  |  | 21.1 | %
Salaries and wages |  |  | 11.9 | % |  |  | 12.5 | % |  | NM |
Facility lease expense |  |  | 10.0 | % |  |  | 10.5 | % |  | NM |
Utilities and other |  |  | 13.9 | % |  |  | 14.5 | % |  | NM |
General and administrative expenses |  |  | 5.1 | % |  |  | 5.3 | % |  | NM |
Depreciation and amortization |  |  | 8.1 | % |  |  | 8.0 | % |  | NM |
Impairment of long-lived assets |  |  | 1.0 | % |  |  | 1.7 | % |  | NM |
Restructuring costs |  |  | — | % |  |  | — | % |  | NM |
(Gain) loss on disposal of assets and other |  |  | 1.2 | % |  |  | 0.4 | % |  | NM |
Total cost of operations |  |  | 87.9 | % |  |  | 89.7 | % |  | NM |
Operating income (loss) |  |  | 12.1 | % |  |  | 10.3 | % |  | NM |
Average screen count (month end average) |  |  | 5,997 |  |  |  | 6,072 |  |  | NM |
Revenues per average screen (dollars) |  | $ | 537,224 |  |  | $ | 540,695 |  |  | NM |

| (1) | All costs are expressed as a percentage of total revenues, except film rentals and advertising, which are expressed as a percentage of admissions revenues and concession supplies, which are expressed as a percentage of concession revenues. Certain values are considered not meaningful (“NM”) as they are not comparable due to the temporary theatre closures effective March 18, 2020.

33

Comparison of Years Ended December 31, 2020 and December 31, 2019

All of our domestic and international theatres were temporarily closed effective March 17, 2020 and March 18, 2020, respectively, due to the COVID-19 pandemic. We began reopening our domestic theatres in June 2020 and operated under a test-and-learn strategy to define training, communication, implementation and execution of enhanced health and safety protocols. These theatres opened to reduced operating hours with library content and “Welcome Back” pricing for tickets and concession products to encourage patrons to return to the movies. We began opening our international theatres in August 2020. As of December 31, 2020, we had 217 domestic theatres and 129 international theatres reopened. We continue to monitor the status of the COVID-19 pandemic and local government regulations to plan the reopening of our remaining theatres.

Revenues. Total revenues were $686.3 million for 2020 compared to $3,283.1 million for 2019. The table below, presented by reportable operating segment, summarizes our year-over-year revenue performance and certain key performance indicators that impact our revenues.

|  | U.S. Operating Segment |  |  | International Operating Segment |  |  | Consolidated |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Constant Currency (3) |  |  |  |  |  |  |  |  |  |  |  |  |
|  | 2020 |  |  | 2019 |  |  | % Change |  |  | 2020 |  |  | 2019 |  |  | % Change |  |  | 2020 |  |  | % Change |  |  | 2020 |  |  | 2019 |  |  | % Change |
Admissions revenues (1) |  | $ | 291.6 |  |  | $ | 1,431.8 |  |  |  | (79.6 | )% |  | $ | 64.9 |  |  | $ | 373.5 |  |  |  | (82.6 | )% |  | $ | 76.5 |  |  |  | (79.5 | )% |  | $ | 356.5 |  |  | $ | 1,805.3 |  |  |  | (80.3 | )%
Concession revenues (1) |  | $ | 189.6 |  |  | $ | 936.2 |  |  |  | (79.7 | )% |  | $ | 41.5 |  |  | $ | 224.9 |  |  |  | (81.5 | )% |  | $ | 48.1 |  |  |  | (78.6 | )% |  | $ | 231.1 |  |  | $ | 1,161.1 |  |  |  | (80.1 | )%
Other revenues (1)(2) |  | $ | 75.7 |  |  | $ | 212.9 |  |  |  | (64.4 | )% |  | $ | 23.0 |  |  | $ | 103.8 |  |  |  | (77.8 | )% |  | $ | 28.4 |  |  |  | (72.6 | )% |  | $ | 98.7 |  |  | $ | 316.7 |  |  |  | (68.8 | )%
Total revenues (1)(2) |  | $ | 556.9 |  |  | $ | 2,580.9 |  |  |  | (78.4 | )% |  | $ | 129.4 |  |  | $ | 702.2 |  |  |  | (81.6 | )% |  | $ | 153.0 |  |  |  | (78.2 | )% |  | $ | 686.3 |  |  | $ | 3,283.1 |  |  |  | (79.1 | )%
Attendance (1) |  |  | 34.9 |  |  |  | 176.2 |  |  |  | (80.2 | )% |  |  | 19.4 |  |  |  | 103.4 |  |  |  | (81.2 | )% |  |  |  |  |  |  |  |  |  |  | 54.3 |  |  |  | 279.6 |  |  |  | (80.6 | )%
Average ticket price (1) |  | $ | 8.36 |  |  | $ | 8.13 |  |  |  | 2.8 | % |  | $ | 3.35 |  |  | $ | 3.61 |  |  |  | (7.2 | )% |  | $ | 3.94 |  |  |  | 9.1 | % |  | $ | 6.57 |  |  | $ | 6.46 |  |  |  | 1.7 | %
Concession revenues per patron (1) |  | $ | 5.43 |  |  | $ | 5.31 |  |  |  | 2.3 | % |  | $ | 2.14 |  |  | $ | 2.18 |  |  |  | (1.8 | )% |  | $ | 2.48 |  |  |  | 13.8 | % |  | $ | 4.26 |  |  | $ | 4.15 |  |  |  | 2.7 | %

(1) | Revenue and attendance amounts in millions. Average ticket price is calculated as admissions revenues divided by attendance. Concession revenues per patron is calculated as concession revenues divided by attendance.

(2) | U.S. operating segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 21 to our consolidated financial statements.

(3) | Constant currency revenue amounts, which are non-GAAP measurements, were calculated using the average exchange rates for the corresponding months for 2019. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance without the impact of foreign currency fluctuations.

• | U.S. Admissions, concession and other revenues decreased as a result of the 80.2% decrease in attendance due to our theatres being temporarily closed for an extended period of time beginning March 2020. We began reopening theatres in the U.S. in late June 2020, showing library content and limited new releases with limited capacities and reduced operating hours. We offered library content at promotional prices, and also offered Private Watch Parties to our patrons at many of our theatres. We continue to offer a limited menu of concession items in essentially all locations, and at promotional prices for much of the reopening phase. Average ticket price increased due to price increases and the impact of the deferral of admissions revenues for loyalty points issued, partially offset by the impact of promotional pricing during our reopening period. Concession revenues per patron grew primarily due to incremental sales of traditional concession products, the impact of the deferral of concessions revenues for loyalty points issued and price increases prior to the temporary closure of our theatres, partially offset by the impact of promotional pricing during our reopening period. Other revenues in 2020 primarily included the amortization of NCM screen advertising advances and promotional revenues.

• | International. Admissions, concession and other revenues decreased as a result of the 81.2% decrease in attendance due to our theatres being temporarily closed for an extended period of time beginning March 2020. We began reopening international theatres in late August 2020, showing library content and limited new releases

34

| with limited capacities and reduced operating hours. We offered core concession items at our theatres and also offered take out concession items in certain locations. Average ticket price and concession revenues per patron decreased, as reported, primarily due to the impact of changes in foreign currency exchange rates in certain countries in which we operate, partially offset by price increases. Other revenues in 2020 included primarily screen advertising, media and loyalty program revenues.

Cost of Operations. The table below summarizes certain of our theatre operating costs by reportable operating segment (in millions) for the years ended December 31, 2019 and 2020.

|  | U.S. Operating Segment |  |  | International Operating Segment |  |  | Consolidated |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |  |  | Constant Currency 2020 (1) |  |  | 2020 |  |  | 2019 |
Film rentals and advertising |  | $ | 155.3 |  |  | $ | 819.6 |  |  | $ | 31.5 |  |  | $ | 184.2 |  |  | $ | 37.4 |  |  | $ | 186.8 |  |  | $ | 1,003.8 |
Concession supplies |  |  | 36.9 |  |  |  | 156.9 |  |  |  | 11.7 |  |  |  | 49.6 |  |  |  | 14.0 |  |  |  | 48.6 |  |  |  | 206.5 |
Salaries and wages |  |  | 113.8 |  |  |  | 331.2 |  |  |  | 31.2 |  |  |  | 78.9 |  |  |  | 38.0 |  |  |  | 145.0 |  |  |  | 410.1 |
Facility lease expense |  |  | 247.0 |  |  |  | 259.8 |  |  |  | 32.8 |  |  |  | 86.3 |  |  |  | 38.9 |  |  |  | 279.8 |  |  |  | 346.1 |
Utilities and other |  |  | 180.3 |  |  |  | 348.2 |  |  |  | 49.2 |  |  |  | 126.5 |  |  |  | 59.4 |  |  |  | 229.5 |  |  |  | 474.7 |

(1) | Constant currency expense amounts, which are non-GAAP measurements, were calculated using the average exchange rates for the corresponding months for 2019. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance without the impact of foreign currency fluctuations.

• | U.S. Film rentals and advertising costs were 53.3% of admissions revenues for 2020, reflecting both new releases and library content as well as advertising and promotional expenses related to the reopening of our theatres. Film rentals and advertising costs were 57.2% of admissions revenues for 2019, which reflected a higher concentration of blockbuster films. Concession supplies expense was 19.5% of concession revenues for 2020 compared to 16.8% of concession revenues for 2019. The increase in the concession supplies rate was primarily due to the impact of the disposal of perishable food and expired product as a result of the temporary closure of our theatres, as well as promotional pricing implemented during our reopening period

Salaries and wages decreased to $113.8 million for 2020 from $331.2 million for 2019 primarily due to the temporary closure of all of our U.S. theatres for a portion of the 2020 period, limited operating hours for the reopened theatres and our efforts to streamline our operational processes upon reopening. Facility lease expense decreased to $247.0 million for 2020 from $259.8 million for 2019 primarily due to a decline in percentage rent expense and the impact of theatres that were permanently closed. Utilities and other costs decreased to $180.3 million for 2020 from $348.2 million for 2019 as many of these costs, such as credit card fees, security, janitorial costs and repairs and maintenance, are variable in nature and were impacted by the temporary closures of our theatres and reduced operating hours of the theatres that were reopened.

• | International. Film rentals and advertising costs were 48.5% of admissions revenues for 2020 compared to 49.3% of admissions revenues, for 2019. The decrease is due to limited new releases and library content shown in 2020 compared to 2019. Concession supplies expense was 28.4% of concession revenues for 2020 compared to 22.1% of concession revenues for 2019. The increase in the concession supplies rate was primarily due to the impact of the disposal of perishable food and expired product as a result of the temporary closure of our theatres.

Salaries and wages decreased to $31.2 million ($38.0 million in constant currency) for 2020 from $78.9 million for 2019. The decrease was due the temporary closure of all of our international theatres on March 18, 2020, some of which began reopening in August, and our efforts to streamline our operational processes upon reopening. Facility lease expense decreased to $32.8 million (decreased to $38.9 million in constant currency) for 2020 from $86.3 million for 2019. The decrease was due to lower percentage rent and rent-free periods allowed in certain international locations due to temporary mall closures. Utilities and other costs decreased to $49.2 million ($59.4 million in constant currency) for 2020 from $126.5 million for 2019 as many of these costs, such as credit card fees, security, janitorial costs and repairs and maintenance, are variable in nature and

35

were impacted by the temporary closure of our theatres and reduced operating hours of the theatres that were reopened.

General and Administrative Expenses. General and administrative expenses decreased to $127.6 million for 2020 from $173.4 million for 2019. The decrease was primarily due to temporary salary reductions and the furlough of a portion of our corporate office personnel for part of 2020, the impact of the 2020 Restructuring Plan (as defined in Note 3 to our consolidated financial statements), which permanently reduced headcount, reduced incentive compensation expense and the impact of changes in foreign currency exchange rates in certain countries in which we operate.

Depreciation and Amortization. Depreciation and amortization expense decreased to $259.8 million for 2020 from $261.2 million for 2019. The decrease was primarily due to the impact of theatre assets impaired during late 2019 and 2020. See Note 11 to our consolidated financial statements for discussion of impairment.

Impairment of Long-Lived Assets. We recorded asset impairment charges on assets held and used of $152.7 million for 2020 compared to $57.0 million for 2019. Approximately $60.0 million of the impairment charges recorded in 2020 were primarily a result of the prolonged impact of the COVID pandemic on our operations, as some theatres remained closed and film content shifted into future periods, both of which impact estimated future cash flows for theatres. In addition, we recorded an impairment of $92.6 million for our investment in NCM due to the NCM, Inc.’s stock price being below our book value per common unit for a prolonged period of time. Impairment charges for 2019 were specific to theatres that were directly and individually impacted by industry conditions, temporary closures, recovery expectations, increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatres. See Note 11 to our consolidated financial statements for a summary of impairment recorded.

Restructuring costs. We recorded restructuring costs of $20.4 million during 2020 related to the 2020 Restructuring Plan implemented during 2020 as a result of the COVID-19 pandemic. See Note 3 to our consolidated financial statements for further discussion.

(Gain) Loss on Disposal of Assets and Other. We recorded a gain on disposal of assets and other of $(8.9) million during 2020 compared to a loss of $12.0 million during 2019. Activity for 2020 was primarily related to a favorable litigation outcome for a case that was previously accrued and the write-off of previously recorded lease assets and liabilities for terminated and amended lease contracts, partially offset by the retirement of assets related to asset replacements. Activity for 2019 was primarily due to the retirement of assets related to theatre remodels.

Interest Expense. Interest expense, which includes amortization of debt issue costs, amortization of accumulated losses in swap amendments and accretion of interest on the 4.500% Convertible Senior Notes, was $129.9 million for 2020 compared to $100.0 million for 2019. The increase was primarily due to the issuance of 8.750% Secured Notes on April 20, 2020 and the issuance of 4.500% Convertible Senior Notes on August 21, 2020. See also Note 13 to our consolidated financial statements for discussion of our long-term debt and our interest rate swap agreements.

Foreign Currency Exchange Loss. We recorded a foreign currency exchange loss of $4.9 million during 2020 and $3.4 million during 2019 primarily related to intercompany transactions and changes in exchange rates from original transaction dates until cash settlement. See Notes 1 and 15 to our consolidated financial statements for discussion of foreign currency translation.

Distributions from NCM. We recorded distributions received from NCM of $7.0 million during 2020 and $12.9 million during 2019, which were in excess of the carrying value of our Tranche 1 Investment. The decrease in distributions from NCM is primarily due to the impact of theatres being temporarily closed as a result of the COVID-19 pandemic as discussed at Note 3 to our consolidated financial statements. See Note 8 to our consolidated financial statements for discussion of our investment in NCM.

36

Non-cash Distribution from Other Equity Investee. We recorded a non-cash distribution of $12.9 million related to digital projectors distributed to us from DCIP during 2020. See further discussion at Note 9 to our consolidated financial statements.

Interest expense – NCM. We recorded non-cash interest expense of $23.6 million during 2020 compared to $28.6 million during 2019 related to the significant financing component associated with revenues collected in advance under certain of our agreements with NCM. See Note 8 to our consolidated financial statements for a summary of all activity with NCM.

Equity in Income (Loss) of Affiliates. We recorded equity in loss of affiliates of $(38.7) million during 2020 and equity in income of affiliates of $41.9 million during 2019. The decrease in equity income (loss) of affiliates is primarily due to the impact of theatres being temporarily closed as a result of the COVID-19 pandemic as discussed at Note 3 to our consolidated financial statements. See Notes 8 and 9 to our consolidated financial statements for information about our equity investments.

Income Taxes. An income tax benefit of $(309.4) million was recorded for 2020 compared to income tax expense of $79.9 million recorded for 2019. The effective tax rate for 2020 was 33.4% compared to 29.2% for 2019. On March 27, 2020, the CARES Act was enacted in response to the COVID-19 pandemic. The CARES Act contains several business tax provisions aimed at stimulating a failing economy. One of these provisions allows corporate taxpayers to take net operating losses earned in 2018, 2019 and 2020 and carry back those losses five years. We generated significant net operating losses as a result of the COVID-19 pandemic. We carried back these losses under the five-year NOL carryback provision which enabled us to benefit from the losses and re-measure certain deferred tax assets and liabilities at the former federal tax rate of 35%. In 2020, we recorded tax benefits of $187.5 million related to the NOL carryback provision. We have recorded an income tax receivable of $155.7 million at December 31, 2020 and have received cash tax refunds of $124.2 million during the year ended December 31, 2020.

37

Liquidity and Capital Resources

Operating Activities

We primarily collect our revenues in cash, mainly through box office receipts and the sale of concessions. Our revenues are generally received in cash prior to the payment of related expenses; therefore, we have an operating “float” and historically have not required traditional working capital financing. However, we temporarily closed all of our theatres during March 2020. As we continue to reopen our theatres to reduced operating hours and limited capacities, we will fund operating expenses with cash on hand and recent additional financing discussed below under Financing Activities. As discussed in Recent Developments above, based on our current estimates for recovery, we believe that we have and will generate sufficient cash to sustain operations.

Cash provided by (used for) operating activities amounted to $562.0 million and $(330.1) million for the years ended December 31, 2019 and 2020, respectively. The decrease in cash provided by operating activities was primarily a result of the temporary closure of all of our theatres during March 2020.

As discussed in Note 4 to our consolidated financial statements, we negotiated the deferral of rent and other lease-related payments for the second, third and fourth quarters of 2020 with many of our landlords, resulting in approximately $66.2 million in deferred lease payments as of December 31, 2020. We began to repay previously deferred amounts during 2020, while a majority of the repayments will be made throughout 2021 and 2022.

Investing Activities

Our investing activities have been principally related to the development, remodel and acquisition of theatres. New theatre openings, remodels and acquisitions historically have been financed with internally generated cash and by debt financing, including borrowings under our senior secured credit facility. Cash used for investing activities amounted to $310.6 million and $83.4 million for the years ended December 31, 2019 and 2020, respectively. The decrease in cash used for investing activities was primarily due to the suspension of non-essential capital expenditures in response to the temporary closure of our theatres.

Capital expenditures for the years ended December 31, 2019 and 2020 were as follows (in millions):

Period |  | New Theatres |  |  | Existing Theatres |  |  | Total |
Year Ended December 31, 2019 |  | $ | 87.6 |  |  | $ | 216.0 |  |  | $ | 303.6 |
Year Ended December 31, 2020 |  | $ | 25.9 |  |  | $ | 58.0 |  |  | $ | 83.9 |

We operated 531 theatres with 5,958 screens worldwide as of December 31, 2020. Theatres and screens acquired, built and closed during the year ended December 31, 2020 were as follows:

|  | January 1, 2020 |  |  | Built |  |  | Closed |  |  | December 31, 2020 |
U.S. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Theatres |  |  | 345 |  |  |  | 3 |  |  |  | (17) |  |  |  | 331 |
Screens |  |  | 4,645 |  |  |  | 28 |  |  |  | (166) |  |  |  | 4,507 |
International |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Theatres |  |  | 209 |  |  |  | 1 |  |  |  | (10) |  |  |  | 200 |
Screens |  |  | 1,487 |  |  |  | 16 |  |  |  | (52) |  |  |  | 1,451 |
Worldwide |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Theatres |  |  | 554 |  |  |  | 4 |  |  |  | (27) |  |  |  | 531 |
Screens |  |  | 6,132 |  |  |  | 44 |  |  |  | (218) |  |  |  | 5,958 |

As of December 31, 2020, we had the following signed commitments (costs in millions):

38

|  | Theatres |  |  | Screens |  |  | Estimated Cost |
Expected to open during 2021 |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 3 |  |  |  | 42 |  |  | $ | 31.8 |
International |  |  | 3 |  |  |  | 30 |  |  |  | 15.3 |
Total during 2021 |  |  | 6 |  |  |  | 72 |  |  |  | 47.1 |
Expected to open subsequent to 2021 |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 6 |  |  |  | 74 |  |  |  | 50.5 |
International |  |  | 7 |  |  |  | 49 |  |  |  | 19.0 |
Total subsequent to 2021 |  |  | 13 |  |  |  | 123 |  |  |  | 69.5 |
Total commitments at December 31, 2020 |  |  | 19 |  |  |  | 195 |  |  | $ | 116.6 |

Actual expenditures for continued theatre development, remodels and acquisitions are subject to change based upon the availability of attractive opportunities. We plan to fund capital expenditures for our continued development with cash flow from operations, borrowings under our senior secured credit facility, proceeds from debt issuances, sale leaseback transactions and/or sales of excess real estate.

Financing Activities

Cash (used for) provided by financing activities was $(186.5) million and $584.4 million during the years ended December 31, 2019 and 2020, respectively. The increase in cash provided by financing activities was primarily due to the issuance of $250.0 million 8.750% Secured Notes on April 20, 2020, the issuance of $460.0 million 4.500% Convertible Senior Notes on August 21, 2020 and borrowings by certain of our international subsidiaries. In addition, we suspended our dividend in March 2020 due to the temporary closure of our theatres.

We, at the discretion of the board of directors and subject to applicable law, may pay dividends on our common stock. The amount, if any, of the dividends to be paid in the future will depend upon our then available cash, anticipated cash needs, overall financial condition, loan agreement restrictions as discussed below, future prospects for earnings and cash flows, as well as other relevant factors. We suspended our quarterly dividend due to the impact of the COVID-19 pandemic.

We may from time to time, subject to compliance with our debt instruments, purchase our debt securities on the open market depending upon the availability and prices of such securities.

Long-term debt consisted of the following as of December 31, 2019 and 2020 (in millions):

|  | As of December 31, |
|  | 2019 |  |  | 2020 |
Cinemark USA, Inc. term loan due 2025 |  | $ | 646.3 |  |  |  | 639.7 |
Cinemark USA, Inc. 5.125% senior notes due 2022 |  |  | 400.0 |  |  |  | 400.0 |
Cinemark USA, Inc. 4.875% senior notes due 2023 |  |  | 755.0 |  |  |  | 755.0 |
Cinemark USA, Inc. 8.750% senior secured notes due 2025 |  |  | — |  |  |  | 250.0 |
Cinemark Holdings, Inc. 4.500% convertible senior notes due 2025 |  |  | — |  |  |  | 460.0 |
Other |  |  | — |  |  |  | 23.2 |
Total long-term debt |  | $ | 1,801.3 |  |  | $ | 2,527.9 |
Less current portion |  |  | 6.6 |  |  |  | 18.1 |
Subtotal long-term debt, less current portion |  | $ | 1,794.7 |  |  | $ | 2,509.8 |
Less: Debt discounts and debt issuance costs, net of accumulated amortization |  |  | 23.4 |  |  |  | 133.0 |
Long-term debt, less current portion, net of debt issuance costs |  | $ | 1,771.3 |  |  | $ | 2,376.8 |

As of December 31, 2020, we had $100 million in available borrowing capacity on our revolving credit line.

39

As of December 31, 2020, our long-term debt obligations, scheduled interest payments on long-term debt, future minimum lease obligations under non-cancelable operating and finance leases, deferred rent payments due as a result of amended lease terms, scheduled interest payments under finance leases and other obligations for each period indicated are summarized as follows:

|  | Payments Due by Period |
|  | (in millions) |
|  |  |  |  |  | Less Than |  |  |  |  |  |  |  |  |  |  | After |
Contractual Obligations |  | Total |  |  | One Year |  |  | 1 - 3 Years |  |  | 3 - 5 Years |  |  | 5 Years |
Long-term debt (1) |  | $ | 2,527.9 |  |  | $ | 18.1 |  |  | $ | 1,179.4 |  |  | $ | 1,330.4 |  |  | $ | — |
Scheduled interest payments on long-term debt (2) |  | $ | 414.3 |  |  |  | 122.2 |  |  |  | 200.4 |  |  |  | 91.7 |  |  |  | — |
Operating lease obligations (3) |  | $ | 1,613.6 |  |  |  | 268.4 |  |  |  | 476.8 |  |  |  | 360.3 |  |  |  | 508.1 |
Finance lease obligations (3) |  | $ | 174.9 |  |  |  | 22.7 |  |  |  | 43.2 |  |  |  | 38.5 |  |  |  | 70.5 |
Deferred rent due under amended terms (4) |  | $ | 66.2 |  |  |  | 48.4 |  |  |  | 17.8 |  |  |  | — |  |  |  | — |
Purchase and other commitments (5) |  | $ | 137.8 |  |  |  | 69.7 |  |  |  | 66.2 |  |  |  | 1.0 |  |  |  | 0.9 |
Liability for uncertain tax positions (6) |  | $ | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total obligations |  | $ | 4,934.7 |  |  | $ | 549.5 |  |  | $ | 1,983.8 |  |  | $ | 1,821.9 |  |  | $ | 579.5 |

(1) | Amounts are presented before adjusting for debt issuance costs.

(2) | Amounts include scheduled interest payments on fixed rate and variable rate debt agreements. Estimates for the variable rate interest payments were based on interest rates in effect on December 31, 2020. The average interest rates on our fixed rate and variable rate debt were 4.9% and 2.2%, respectively, as of December 31, 2020.

(3) | Amounts include both scheduled principal and interest payments on leases commenced prior to December 31, 2020. See Note 4 to our consolidated financial statements for discussion of lease obligations.

(4) | Amounts due under amended lease terms with landlords where payments due during the year ended December 31, 2020 will be paid in future periods. See further discussion at Lease Deferrals and Abatements at Note 4 to our consolidated financial statements.

(5) | Includes estimated capital expenditures associated with the construction of new theatres to which we were committed as of December 31, 2020, obligations under employment agreements and contractual purchase commitments.

(6) | The contractual obligations table excludes the long-term portion of our liability for uncertain tax positions of $19.2 million because we cannot make a reliable estimate of the timing of the related cash payments. As of December 31, 2020, there was no amount recorded for short-term uncertain tax provisions on the consolidated balance sheet.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Senior Secured Credit Facility

Cinemark USA, Inc. has a senior secured credit facility that includes a $700.0 million term loan and a $100.0 million revolving credit line, or the Credit Agreement. Under the amended Credit Agreement, quarterly principal payments of $1.6 million are due on the term loan through December 31, 2024, with a final principal payment of $613.4 million due on March 29, 2025. Cinemark USA, Inc. had $100.0 million available borrowing capacity on the revolving credit line as of December 31, 2020.

Interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement.

Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries.

40

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as defined in the Credit Agreement, not to exceed 4.25 to 1. See below for discussion of recent covenant waivers.

The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts, or collectively, the Applicable Amount. As of December 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $2.7 billion to its parent company and sole stockholder, Cinemark Holdings, Inc.

On April 17, 2020, in conjunction with the issuance of the 8.750% Secured Notes discussed below, we obtained a waiver of the leverage covenant from the majority of revolving lenders under the Credit Agreement for the fiscal quarters ending September 30, 2020 and December 31, 2020. The waiver is subject to certain liquidity thresholds, restrictions on investments and the use of the Applicable Amount.

On August 21, 2020, in conjunction with the issuance of the 4.500% Convertible Senior Notes discussed below, we further amended the waiver of the leverage covenant through the fiscal quarter ending September 30, 2021. The amendment also i) modifies the leverage covenant calculation beginning with the calculation for the trailing twelve-month period ended December 31, 2021, ii) for purposes of testing the consolidated net senior secured leverage ratio for the fiscal quarters ending on December 31, 2021, March 31, 2022 and June 30, 2022, permits us to substitute Consolidated EBITDA for the first three fiscal quarters of 2019 in lieu of Consolidated EBITDA for the corresponding fiscal quarters of 2021, (iii) modifies the restrictions imposed by the covenant waiver and (iv) makes such other changes to permit the issuance of the 4.500% Convertible Senior Notes discussed below.

We have four interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the term loan outstanding under the Credit Agreement. See Note 13 to our consolidated financial statements for discussion of the interest rate swaps.

At December 31, 2020, there was $639.7 million outstanding under the term loan and no borrowings were outstanding under the $100.0 million revolving line of credit. The average interest rate on outstanding term loan borrowings under the Credit Agreement at December 31, 2020 was approximately 3.4% per annum, after giving effect to the interest rate swap agreements.

4.875% Senior Notes

On May 24, 2013, Cinemark USA, Inc. issued $530.0 million aggregate principal amount of 4.875% senior notes due 2023, at par value, or the 4.875% Senior Notes. Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023.

On March 21, 2016, Cinemark USA, Inc. issued an additional $225.0 million aggregate principal amount of the 4.875% Senior Notes, at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as Cinemark USA, Inc.’s existing 4.875% Senior Notes. The aggregate principal amount of $755.0 million of 4.875% Senior Notes mature on June 1, 2023.

The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and

41

future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes.

The indenture governing the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $2.8 billion to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture governing the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 4.875% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 4.875% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 4.875% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and the actual ratio as of December 31, 2020 was below zero.

Cinemark USA, Inc. may redeem the 4.875% Senior Notes in whole or in part at redemption prices specified in the indenture.

5.125% Senior Notes

On December 18, 2012, Cinemark USA, Inc. issued $400.0 million aggregate principal amount of 5.125% senior notes due 2022, at par value, or the 5.125% Senior Notes. Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022.

The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes.

The indenture governing the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $2.8 billion to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture governing the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 5.125% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.125% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.125% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and the actual ratio as of December 31, 2020 was below zero.

42

Cinemark USA, Inc. may redeem the 5.125% Senior Notes in whole or in part at redemption prices specified in the indenture.

8.750% Secured Notes

On April 20, 2020, Cinemark USA, Inc. issued $250.0 million aggregate principal amount of 8.750% senior secured notes due 2025, or the 8.750% Secured Notes. The 8.750% Secured Notes will mature on May 1, 2025; provided, however, that if (i) on September 13, 2022, the aggregate outstanding principal amount of the 5.125% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50.0 million, the 8.750% Secured Notes will mature on September 14, 2022 and (ii) on February 27, 2023, the aggregate outstanding principal amount of the 4.875% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50.0 million, the 8.750% Secured Notes will mature on February 28, 2023. Interest on the 8.750% Secured Notes is payable on May 1 and November 1 of each year, beginning on November 1, 2020.

The 8.750% Secured Notes are fully and unconditionally guaranteed on a joint and several senior basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or in any other manner become liable with respect to any of Cinemark USA, Inc.’s or its guarantors’ other debt. If Cinemark USA, Inc. cannot make payments on the 8.750% Secured Notes when they are due, Cinemark USA, Inc.’s guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.750% Secured Notes.

The 8.750% Secured Notes and the guarantees are Cinemark USA, Inc.’s and its guarantors’ senior obligations and are:

| • | rank effectively senior in right of payment to Cinemark USA, Inc.’s and its guarantors’ existing and future debt that is not secured by the collateral as described within the indenture governing the 8.750% Secured Notes, or the Collateral, including all obligations under the Credit Agreement, and unsecured obligations, including the existing senior notes, in each case to the extent of the value of the Collateral;

| • | rank effectively junior to Cinemark USA, Inc.’s and its guarantors’ existing and future debt secured by assets that are not part of the Collateral to the extent of the value of the collateral securing such debt, including all obligations under the Credit Agreement;

| • | otherwise rank equally in right of payment to Cinemark USA, Inc.’s and its guarantors’ existing and future senior debt, including debt under the Credit Agreement and the existing senior notes;

| • | rank senior in right of payment to Cinemark USA, Inc.’s and its guarantors’ future subordinated debt; and

| • | be structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s non-guarantor subsidiaries.

The indenture governing the 8.750% Secured Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $3.1 billion to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture governing the 8.750% Secured Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 8.750% Secured Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 8.750% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.750% Secured Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and the actual ratio as of December 31, 2020 was below zero.

4.500% Convertible Senior Notes

On August 21, 2020, Cinemark Holdings, Inc. issued $460.0 million 4.500% convertible senior notes, or the 4.500% Convertible Senior Notes. The 4.500% Convertible Senior Notes will mature on August 15, 2025, unless

43

earlier repurchased or converted. Interest on the notes is payable on February 15 and August 15 of each year, beginning on February 15, 2021.

Holders of the 4.500% Convertible Senior Notes may convert their 4.500% Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2025 only under the following circumstances: (1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (2) if we distribute to all or substantially all stockholders (i) rights options or warrants entitling them to purchase shares at a discount to the recent average trading price of our common stock (including due to a stockholder rights plan) or (ii) our assets or securities or rights, options or warrants to purchase the same with a per share value exceeding 10% of the trading price of our common stock, (3) upon the occurrence of specified corporate events as described further in the indenture. Beginning May 15, 2025, holders may convert their 4.500% Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, or (4) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price (initially $14.35 per share), on each applicable trading day. Upon conversion of the 4.500% Convertible Senior Notes, we will pay or deliver cash, shares of our common stock or a combination of cash and shares of our common stock, at our election.

The initial conversion rate is 69.6767 shares of our common stock per one thousand dollars principal amount of the 4.500% Convertible Senior Notes. The conversion rate will be subject to adjustment upon the occurrence of certain events. If a make-whole fundamental change as defined in the indenture occurs prior to the maturity date, we will, in certain circumstances, increase the conversion rate for a holder who elects to convert its 4.500% Convertible Senior Notes in connection with such make-whole fundamental change.

The 4.500% Convertible Notes are effectively subordinated to any of our, or our subsidiaries’, existing and future secured debt to the extent of the value of the assets securing such indebtedness, including obligations under the Credit Agreement. The 4.500% Convertible Notes are structurally subordinated to all existing and future debt and other liabilities of our subsidiaries, including trade payables and including Cinemark USA’s 5.125% Senior Notes, 4.875% Senior Notes and the 8.750% Secured Notes, or, collectively, Cinemark USA’s senior notes (but excluding all obligations under the Credit Agreement which are guaranteed by Cinemark Holdings, Inc.). The 4.500% Convertible Notes rank equally in right of payment with all of our existing and future unsubordinated debt, including all obligations under the Credit Agreement, which such Credit Agreement is guaranteed by Cinemark Holdings, Inc., and senior in right of payment to any future debt that is expressly subordinated in right of payment to the 4.500% Convertible Senior Notes. The 4.500% Convertible Notes are not guaranteed by any of Cinemark Holdings, Inc.’s subsidiaries.

In accordance with accounting guidance on debt and equity financing, we bifurcated the gross proceeds from the issuance of 4.500% Convertible Senior Notes and recorded a portion as long-term debt and a portion in equity. The long-term debt value was based on the fair value of the debt, determined as the present value of principal and interest payments assuming a market interest rate for similar debt that excluded a conversion feature. The difference between the face value of the 4.500% Convertible Senior Notes and the fair value is referred to as the debt discount, and represents the amount allocated to equity. The debt discount is being amortized to interest expense at an effective interest rate of 10.0% over the contractual terms of the notes.

Concurrently with the issuance of the 4.500% Convertible Senior Notes, we entered into privately negotiated convertible note hedge transactions, or the Hedge Transactions, with one or more of the initial purchasers of the 4.500% Convertible Senior Notes or their respective affiliates, or the Option Counterparties. The Hedge Transactions cover the number of shares of our common stock that will initially underlie the aggregate amount of the 4.500% Convertible Senior Notes, subject to anti-dilution adjustments substantially similar to those applicable to the 4.500% Convertible Senior Notes. The Hedge Transactions are generally expected to reduce potential dilution to our common stock upon any conversion of the 4.500% Convertible Senior Notes and/or offset any cash payments we may be required to make in excess of the principal amount of converted 4.500% Convertible Senior Notes, as the case may be. Concurrently with entering into the Hedge Transactions, we also entered into separate privately negotiated warrant transactions with Option Counterparties, or the Warrant Transactions, whereby we sold to Option

44

Counterparties warrants to purchase (subject to the net share settlement provisions set forth therein) up to the same number of shares of our common stock, subject to customary anti-dilution adjustments, or the Warrants. The Warrants could separately have a dilutive effect to the extent that the market value per share of our common stock exceeds the strike price of the warrants on the applicable expiration dates unless, subject to the terms of the Warrants, we elect to cash settle the Warrants. The exercise price of the Warrants is initially $22.08 and is subject to certain adjustments under the terms of the warrants. The Company received $89.4 million in cash proceeds from the sale of Warrants, which were used along with proceeds from the 4.500% Convertible Senior Notes, to pay approximately $142.1 million to enter into the Hedge Transactions. The tax impact of the conversion option and Warrants amounted to $11.0 million and was recorded in additional paid-in-capital.

Together, the Hedge Transactions and the Warrants are intended to reduce the potential dilution from the conversion of the 4.500% Convertible Senior Notes. The Hedge Transactions and Warrants are recorded in equity and are not accounted for as derivatives, in accordance with applicable accounting guidance.

Additional Borrowings of International Subsidiaries

During the year ended December 31, 2020, certain of our international subsidiaries borrowed an aggregate of $22.3 million under various local bank loans. Below is a summary of these loans:

|  | Loan Amounts |  |  |  |  |  |  |  |  |
Loan Descriptions |  | (in USD millions) |  |  | Interest Rates |  |  | Covenants |  | Maturity
Colombia (3 loans) |  | $ | 4.4 |  |  | 3.25% to 5.85% plus variable |  |  | Negative and ratio covenants |  | May 2023 September 2025
Peru loan |  | $ | 2.9 |  |  | 1.5% |  |  | Negative covenants |  | September 2023
Brazil (3 loans) |  | $ | 9.0 |  |  | 1.59% to 8.08% |  |  | Negative covenants |  | October 2023 November 2021
Chile loan |  | $ | 6.0 |  |  | 0.29% |  |  | Negative covenants |  | November 2023

Additionally, we deposited cash into a collateral account to support the issuance of letters of credit to the lenders for certain of the international loans noted above. The total amount deposited was $13.8 million and is considered restricted cash as of December 31, 2020.

Covenant Compliance

As of December 31, 2020, we believe we were in full compliance with all agreements, including all related covenants, governing our outstanding debt.

Ratings

We are rated by nationally recognized rating agencies. The rating scales and methodologies used to derive individual ratings may vary from agency to agency. Credit ratings are issued by credit rating agencies based on evaluations of our ability to pay back our outstanding debt and the likelihood that we would default on that debt prior to its maturity. The credit ratings issued by the credit rating agencies represent the credit rating agency's evaluation of both qualitative and quantitative information for our company. The credit ratings that are issued are based on the credit rating agency’s judgment and experience in determining what information should be considered in giving a rating to a particular company. Ratings are always subject to change and there can be no assurance that our current ratings will continue for any given period of time. A downgrade of our debt ratings, depending on the extent, could increase the cost to borrow funds.

New Accounting Pronouncements

See Note 2 to our consolidated financial statements for a discussion of recently issued accounting pronouncements and their impact on our financial statements.

45

Seasonality

Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. The most successful motion pictures have historically been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a hit film during other periods can alter this seasonality trend. The timing, quantity and quality of such film releases can have a significant effect on our results of operations, and the results of one quarter are not necessarily indicative of results for the next quarter or for the same period in the following year.

46

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

We have exposure to financial market risks, including changes in interest rates and foreign currency exchange rates.

Interest Rate Risk

We are currently party to variable rate debt facilities. An increase or decrease in interest rates would affect our interest expense relating to our variable rate debt facilities. At December 31, 2020, there was an aggregate of approximately $62.9 million of variable rate debt outstanding under these facilities, after giving effect to the interest rate swap agreements discussed below. Based on the interest rates in effect on the variable rate debt outstanding at December 31, 2020, a 100 basis point increase in market interest rates would increase our annual interest expense by approximately $0.6 million.

The table below provides information about our fixed rate and variable rate long-term debt agreements as of December 31, 2020:

|  | Expected Maturity for the Twelve-Month Periods Ending December 31, |  |  | Average |
|  | (in millions) |  |  | Interest |
|  | 2021 |  |  | 2022 |  |  | 2023 |  |  | 2024 |  |  | 2025 |  |  | Thereafter |  |  | Total |  |  | Fair Value |  |  | Rate |
Fixed rate |  | $ | — |  |  | $ | 400.0 |  |  | $ | 755.0 |  |  | $ | — |  |  | $ | 1,310.0 |  |  | $ | — |  |  | $ | 2,465.0 |  |  | $ | 2,593.0 |  |  |  | 4.9 | %
Variable rate |  |  | 18.1 |  |  |  | 13.1 |  |  |  | 11.3 |  |  |  | 6.9 |  |  |  | 13.5 |  |  |  | — |  |  |  | 62.9 |  |  |  | 59.6 |  |  |  | 2.2 | %
Total debt (1) |  | $ | 18.1 |  |  | $ | 413.1 |  |  | $ | 766.3 |  |  | $ | 6.9 |  |  | $ | 1,323.5 |  |  | $ | — |  |  | $ | 2,527.9 |  |  | $ | 2,652.6 |  |  |  |  |

(1) | Amounts are presented before adjusting for debt issuance costs and debt discounts.

Interest Rate Swap Agreements

All of our interest rate swap agreements qualify for cash flow hedge accounting. The fair values of the interest rate swaps are recorded on our consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. See Note 13 to our consolidated financial statements for further discussion of the interest rate swap agreements.

Below is a summary of our interest rate swap agreements as of December 31, 2020:

Notional |  |  |  |  |  |  |  |  |  |
Amount |  | Effective Date |  | Pay Rate |  |  | Receive Rate |  | Expiration Date
$ 137.5 million |  | December 31, 2018 |  | 2.122% |  |  | 1-Month LIBOR |  | December 31, 2024
$ 175.0 million |  | December 31, 2018 |  | 2.124% |  |  | 1-Month LIBOR |  | December 31, 2024
$ 137.5 million |  | December 31, 2018 |  | 2.193% |  |  | 1-Month LIBOR |  | December 31, 2024
$ 150.0 million |  | March 31, 2020 |  | 0.570% |  |  | 1-Month LIBOR |  | March 31, 2022
$ 600.0 million |  |  |  |  |  |  |  |  |  |

Foreign Currency Exchange Rate Risk

We are also exposed to market risk arising from changes in foreign currency exchange rates as a result of our international operations. Generally, we export from the U.S. certain of the equipment and interior finish items and other operating supplies used by our international subsidiaries. A majority of the revenues and operating expenses of our international subsidiaries are transacted in the country’s local currency. U.S. GAAP requires that our subsidiaries use the currency of the primary economic environment in which they operate as their functional currency. If our subsidiaries operate in a highly inflationary economy, U.S. GAAP requires that the U.S. dollar be used as the functional currency for the subsidiary, which could impact future results of operations as reported. Currency fluctuations in the countries in which we operate result in us reporting exchange gains (losses) or foreign currency translation adjustments. Based upon our equity ownership in our international subsidiaries as of December 31, 2020, holding everything else constant, a 10% immediate, simultaneous, unfavorable change in all of the foreign currency exchange rates to which we are exposed, would decrease the aggregate net book value of our

47

investments in our international subsidiaries by approximately $63.6 million and would decrease the aggregate net income of our international subsidiaries for the year ended December 31, 2020 by $14.8 million, respectively.

We deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018.

Item 8. Financial Statements and Supplementary Data

The financial statements and supplementary data are listed on the Index on page F-1 of this Form 10-K. Such financial statements and supplementary data are included herein beginning on page F-3.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of the Effectiveness of Disclosure Controls and Procedures

As of December 31, 2020, under the supervision and with the participation of our principal executive officer and principal financial officer, we carried out an evaluation required by the Exchange Act of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of December 31, 2020, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 that occurred during the quarter ended December 31, 2020 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) of the Exchange Act. The Company’s internal control framework and processes are designed to provide reasonable assurance to management and the board of directors regarding the reliability of financial reporting and the preparation of the Company’s consolidated financial statements in accordance with the accounting principles generally accepted in the U.S. Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2020 based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO, in Internal Control—Integrated Framework (2013). As a result of this assessment, management concluded that, as of December 31, 2020, our internal control over financial reporting was effective.

Certifications of our Chief Executive Officer and our Chief Financial Officer, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Annual Report. This "Controls and Procedures" section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

48

The Company’s independent registered public accounting firm, Deloitte & Touche LLP, which has direct access to the Company’s board of directors through its Audit Committee, have audited the consolidated financial statements prepared by the Company. Their report on the consolidated financial statements is included in Part II, Item 8, Financial Statements and Supplementary Data. Deloitte & Touche LLP has issued an attestation report on the Company’s internal control over financial reporting.

Limitations on Controls

Management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors or fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.

Item 9B. Other Information

None.

49

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of Cinemark Holdings, Inc.

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Cinemark Holdings, Inc. and subsidiaries (the “Company”) as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated financial statements and financial statement schedule as of and for the year ended December 31, 2020, of the Company and our report dated February 26, 2021, expressed an unqualified opinion on those financial statements and financial statement schedule.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Deloitte & Touche LLP
Dallas, Texas
February 26, 2021

50

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting to be held on May 20, 2021 and to be filed with the SEC within 120 days after December 31, 2020.

Item 11. Executive Compensation

Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting to be held on May 20, 2021 and to be filed with the SEC within 120 days after December 31, 2020.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting to be held on May 20, 2021 and to be filed with the SEC within 120 days after December 31, 2020.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting to be held on May 20, 2021 and to be filed with the SEC within 120 days after December 31, 2020.

Item 14. Principal Accounting Fees and Services

Incorporated by reference to the Company’s proxy statement for its annual stockholders meeting to be held on May 20, 2021 and to be filed with the SEC within 120 days after December 31, 2020.

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a) Documents Filed as Part of this Report

| 1. | The financial statement schedules and related data listed in the accompanying Index beginning on page F-1 are filed as a part of this report.

| 2. | The exhibits listed in the accompanying Index beginning on page 46 are filed as a part of this report.

(b) Exhibits

See the accompanying Index beginning on page 52.

(c) Financial Statement Schedules

Schedule I – Condensed Financial Information of Registrant beginning on page S-1.

All Schedules not identified above have been omitted because they are not required, are not applicable or the information is included in the consolidated financial statements or notes contained in this report.

51

EXHIBIT INDEX

Number |  | Exhibit Title
3.1 |  | Second Amended and Restated Certificate of Incorporation of Cinemark Holdings, Inc. filed with the Delaware Secretary of State on April 9, 2007 (incorporated by reference to Exhibit 3.1 to Amendment No. 2 to our Registration Statement on Form S-1, File No. 333-140390, filed April 9, 2007).
3.2(a) |  | Amended and Restated Bylaws of Cinemark Holdings, Inc. dated April 9, 2007 (incorporated by reference to Exhibit 3.2 to Amendment No. 2 to our Registration Statement on Form S-1, File No. 333-140390, filed April 9, 2007).
3.2(b) |  | First Amendment to the Amended and Restated Bylaws of Cinemark Holdings, Inc. dated April 16, 2007 (incorporated by reference to Exhibit 3.2(b) to Amendment No. 4 to our Registration Statement on Form S-1, File No. 333-140390, filed April 19, 2007).
3.2(c) |  | Second Amendment to the Amended and Restated Bylaws of Cinemark Holdings, Inc. dated August 20, 2015 (incorporated by reference to Exhibit 3.1 to Current Report on Form 8K, File No. 001-33401, filed August 21, 2015).
4.1 |  | Description of common stock (incorporated by reference to Exhibit 4.1 to the Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 21, 2020).
4.2 |  | Specimen stock certificate of Cinemark Holdings, Inc. (incorporated by reference to Exhibit 4.1 to Amendment No. 2 to our Registration Statement on Form S-1, File No. 333-140390, filed April 9, 2007).
4.3(a) |  | Indenture, dated as of December 18, 2012, between Cinemark USA, Inc. and Wells Fargo Bank, N.A. governing the 5.125% senior notes issued thereunder (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401, filed December 20,2012).
4.3(b) |  | Form of 5.125% senior notes of Cinemark USA, Inc. (contained in the Indenture listed as Exhibit 4.4(a) above) (incorporated by reference to Exhibit 4.1 to the Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed December 20, 2012).
4.4(a) |  | Indenture, dated as of May 24, 2013, between Cinemark USA, Inc. and Well Fargo Bank, N.A. governing the 4.875% Senior Notes issued thereunder (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401 filed May 28, 2013).
4.4(b) |  | Form of 4.875% Senior Notes of Cinemark USA, Inc. (contained in the Indenture listed as Exhibit 4.5(a) above (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401, filed May 28, 2013).
4.5 |  | First Supplemental Indenture, dated as of March 21, 2016, among Cinemark USA, Inc., the Guarantors named therein and Wells Fargo Bank, N.A., as trustee (incorporated by reference to Exhibit 4.3 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed March 21, 2016).
4.6(a) |  | Indenture, dated as of April 20, 2020, among Cinemark USA, Inc., the Guarantors named therein and Wells Fargo Bank, N.A., as trustee and collateral agent (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401 filed April 20, 2020).
4.6(b) |  | Form of 8.750% senior secured notes of Cinemark USA, Inc. (contained in the Indenture listed as Exhibit 4.6(a) above) (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed on April 20, 2020).
4.7(a) |  | Indenture, dated as of August 21, 2020, between Cinemark Holdings, Inc. and Wells Fargo Bank, N.A., as trustee (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed August 24, 2020).
4.7(b) |  | Form of 4.50% convertible senior notes of Cinemark Holdings, Inc. (contained in the Indenture listed as Exhibit 4.7(a) above) (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed on August 24, 2020).
10.1(a) |  | Management Agreement, dated December 10, 1993, between Laredo Theatre, Ltd. and Cinemark USA, Inc. (incorporated by reference to Exhibit 10.14(b) to Cinemark USA, Inc.’s Annual Report on Form 10-K, File No. 033-47040, filed March 31, 1994). (P)
10.1(b) |  | First Amendment to Management Agreement of Laredo Theatre, Ltd., effective as of December 10, 2003, between CNMK Texas Properties, Ltd. (successor in interest to Cinemark USA, Inc.) and Laredo Theatre Ltd. (incorporated by reference to Exhibit 10.1(d) to Cinemark, Inc.’s Registration Statement on Form S-4, File No. 333-116292, filed June 8, 2004).
10.1(c) |  | Second Amendment to Management Agreement of Laredo Theatres, Ltd., effective as of December 10, 2008, between CNMK Texas Properties, L.L.C. (Successor in interest to Cinemark USA, Inc.) and Laredo Theatre Ltd. (incorporated by reference to Exhibit 10.1(c) to the Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed March 13, 2009).
10.1(d) |  | Third Amendment to Management Agreement of Laredo Theatres, Ltd., effective as of December 10, 2013, between CNMK Texas Properties, L.L.C. (Successor in interest to Cinemark USA, Inc.) and Laredo Theatre Ltd. (incorporated by reference to Exhibit 10.1(d) to the Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 24, 2016).
10.2 |  | License Agreement, dated December 10, 1993, between Laredo Joint Venture and Cinemark USA, Inc. (incorporated by reference to Exhibit 10.14(c) to Cinemark USA, Inc.’s Annual Report on Form 10-K, File No. 033-47040, filed March 31, 1994). (P)

52

Number |  | Exhibit Title
10.3(a) |  | Amended and Restated Credit Agreement, dated as of December 18, 2012, among Cinemark USA, Inc., Cinemark Holdings, Inc., the several banks and other financial institutions and entities from time to time parties thereto, Barclays Bank PLC, Deutsche Bank Securities Inc., Morgan Stanley Senior Funding, Inc. and Wells Fargo Securities, LLC, as joint bookrunners, Morgan Stanley Senior Funding, Inc., as syndication agent, Deutsche Bank Securities Inc., Wells Fargo Securities, Inc. and Webster Bank, N.A., as co-documentation agents, and Barclays Bank PLC, as administrative agent. (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed December 20, 2012).
10.3(b) |  | Second Amendment to the Amended and Restated Credit Agreement, dated as of May 8, 2015, among Cinemark USA, Inc., Cinemark Holdings, Inc., the several banks and other financial institutions and entities from time to time parties thereto, Barclays Bank PLC as administrative agent, Barclays Bank PLC as lead arranger, Barclays, Morgan Stanley Senior Funding, Inc., Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC, as joint bookrunners, J.P.Morgan Securities LLC, Webster Bank, N.A., as co-arrangers (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed May 14, 2015).
10.3 (c) |  | Third Amendment to the Amended and Restated Credit Agreement, dated as of June 13, 2016, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed June 17, 2016).
10.3 (d) |  | Fourth Amendment to the Amended and Restated Credit Agreement, dated as of December 15, 2016, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed December 20, 2016).
10.3 (e) |  | Fifth Amendment to the Amended and Restated Credit Agreement, dated as of June 16, 2017, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed June 20, 2017).
10.3 (f) |  | Sixth Amendment to the Amended and Restated Credit Agreement, dated as of November 28, 2017, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed December 4, 2017).
10.3 (g) |  | Seventh Amendment to the Amended and Restated Credit Agreement, dated as of March 29, 2018, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed April 4, 2018).
10.3(h) |  | Eighth Amendment and Waiver to the Amended and Restated Credit Agreement, dated as of April 17, 2020, by and among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401 filed April 20, 2020).
10.3(i) |  | Amendment to Eighth Amendment and Waiver, dated as of August 21, 2020, by and among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, and Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed August 24, 2020).
10.3(j) |  | Guarantee and Collateral Agreement, dated as of October 5, 2006, among Cinemark Holdings, Inc., Cinemark, Inc., CNMK Holding, Inc., Cinemark USA, Inc. and each subsidiary guarantor party thereto (incorporated by reference to Exhibit 10.6 to Current Report on Form 8-K, File No. 033-47040, filed by Cinemark USA, Inc. October 12, 2006).
10.3(k) |  | Reaffirmation agreement, dated as of December 18, 2012, between Cinemark Holdings, Inc., Cinemark USA, Inc. and each subsidiary guarantor party thereto (incorporated by reference to Exhibit 10.4(c) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 28, 2013).
+10.4(a) |  | Employment Agreement, dated as of December 15, 2008, between Cinemark Holdings, Inc. and Lee Roy Mitchell (incorporated by reference to Exhibit 10.5 (q) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed March 13, 2009).
+10.4(b) |  | Amendment to Employment Agreement dated as of November 12, 2014 between Cinemark Holdings, Inc. and Lee Roy Mitchell (incorporated by reference to Exhibit 10.6(h) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 27, 2015).
+10.4(c) |  | Employment Agreement dated as of June 23, 2014, by and between Cinemark Holdings, Inc. and Sean Gamble (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed June 23, 2014).
+10.4(d) |  | Employment agreement, dated as of June 16, 2008, between Cinemark Holdings, Inc. and Michael Cavalier (incorporated by reference to Exhibit 10.4 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2008).
+10.4(e) |  | Employment Agreement, dated as of February 15, 2010, between Cinemark Holdings, Inc. and Valmir Fernandes (incorporated by reference to Exhibit 10.5(u) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed March 10, 2010).

53

Number |  | Exhibit Title
+10.4(f) |  | Amended and Restated Employment Agreement, dated as of February 19, 2016, between Cinemark Holdings, Inc. and Mark Zoradi (incorporated by reference to Exhibit 10.6(l) to the Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 24, 2016).
+10.4(g) |  | First Amendment to the Amended and Restated Employment Agreement, dated as of February 20, 2018, between Cinemark Holdings, Inc. and Mark Zoradi (incorporated by reference to Exhibit 10.l to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed February 23, 2018).
+10.4(h) |  | Second Amended and Restated Employment Agreement, dated as of November 18, 2020, between Cinemark Holdings, Inc. and Mark Zoradi (incorporated by reference to Exhibit 10.l to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed November 20, 2020).
+10.5(a) |  | Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan, dated November 19, 2020 (incorporated by reference to Exhibit 10.l to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed November 20, 2020).
+10.5(b) |  | Form of Stock Option Award Agreement pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.5(c) |  | Form of Performance Stock Award Agreement pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.4 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.5(d) |  | Form of Restricted Stock Award Agreement pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.5(e) |  | Form of Performance Stock Unit Award Certificate pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.6 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.5(f) |  | Form of Restricted Stock Unit Award Certificate pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.7 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.6(a) |  | Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan, dated as of November 19, 2020 (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed November 20, 2020).
*+10.6(b) |  | Form of Restricted Stock Award Agreement pursuant to the Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan.
*+10.6(c) |  | Form of Restricted Stock Award Agreement pursuant to the Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (officer).
*+10.6(d) |  | Form of Restricted Stock Unit Award Certificate pursuant to the Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan.
*+10.6(e) |  | Form of Restricted Stock Unit Award Certificate pursuant to the Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (officer).
*+10.6(f) |  | Form of Performance Stock Award Agreement pursuant to the Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan.
*+10.6(g) |  | Form of Performance Stock Award Agreement pursuant to the Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (officer).
*+10.6(h) |  | Form of Performance Stock Unit Award Certificate pursuant to Amended and Rested the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan.
*+10.6(i) |  | Form of Performance Stock Unit Award Certificate pursuant to the Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (officer).
10.7(a) |  | Amended and Restated Exhibitor Services Agreement between National CineMedia, LLC and Cinemark USA, Inc., dated as of December 26, 2013(incorporated by reference to Exhibit 10.45 to Cinemark Holdings, Inc.’s Annual Report on Form 10-K , File No. 001-33401, filed February 28, 2014).
10.7(b) |  | First Amendment to Amended and Restated Exhibitor Services Agreement between National CineMedia, LLC and Cinemark USA, Inc. dated as of September 17, 2019 (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 5, 2019).
10.8 |  | Third Amended and Restated Limited Liability Company Operating Agreement, dated as of February 12, 2007, by and between Cinemark Media, Inc., American Multi-Cinema, Inc., Regal CineMedia, LLC and National CineMedia, Inc. (incorporated by reference to Exhibit 10.9 to Amendment No. 1 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed March 16, 2007).
10.9(a) |  | Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 14, Sacramento, CA (incorporated by reference to Exhibit 10.10(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.9(b) |  | First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 14, Sacramento, CA (incorporated by reference to Exhibit 10.10(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).

54

Number |  | Exhibit Title
10.9(c) |  | Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 14, Sacramento, CA (incorporated by reference to Exhibit 10.10(c) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.9(d) |  | Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 14, Sacramento, CA (incorporated by reference to Exhibit 10.10(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.9(e) |  | Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc.(succeeded by Century Theatres, Inc.), as tenant, for Century Stadium 14, Sacramento, CA. (incorporated by reference to Exhibit 10.10(a) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.10(a) |  | Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.11(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.10(b) |  | First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.11(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.10(c) |  | Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.11(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.10(d) |  | Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.11(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.10(e) |  | Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Laguna 16, Elk Grove, CA. (incorporated by reference to Exhibit 10.10(b) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.10(f) |  | Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Laguna 16, Elk Grove, CA. (incorporated by reference to Exhibit 10.5 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.10(g) |  | Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Laguna 16, Elk Grove, CA(incorporated by reference to Exhibit 10.3 of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed June 3, 2020).
10.11(a) |  | Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.14(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.11(b) |  | First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.14(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.11(c) |  | Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.14(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.11(d) |  | Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.14(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.11(e) |  | Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA. (incorporated by reference to Exhibit 10.10(c) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).

55

Number |  | Exhibit Title
10.11(f) |  | Fifth Amendment, dated as of January 29, 2018 to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA. (incorporated by reference to Exhibit 10.4 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.11(g) |  | Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.2 of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed June 3, 2020).
10.12(a) |  | Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.12(b) |  | First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.12(c) |  | Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.12(d) |  | Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.12(e) |  | Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(e) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.12(f) |  | Fifth Amendment to Indenture of Lease, dated as of October 5, 2012 by and between Syufy Enterprises, L.P. as landlord and Century Theatres, Inc., as tenant, for Cinedome 12, Henderson, NV. (incorporated by reference to Exhibit 10.13(f) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 27, 2015).
10.12(g) |  | Sixth Amendment to Indenture of Lease, dated as of January 29, 2018 by and between Syufy Enterprises, L.P. as landlord and Century Theatres, Inc., as tenant, for Cinedome 12, Henderson, NV. (incorporated by reference to Exhibit 10.3 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.13(a) |  | Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.13(b) |  | First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.13(c) |  | Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.13(d) |  | Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.13(e) |  | Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(e) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.13(f) |  | Fifth Amendment, dated as of May 1, 2014, to Indenture of Lease by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant for Century 8, North Hollywood, CA. (incorporated by reference to Exhibit 10.14(f) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 27, 2015).
10.13(g) |  | Sixth Amendment, dated as of July 28, 2015, to Indenture of Lease by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.14(g) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).

56

Number |  | Exhibit Title
10.13(h) |  | Seventh Amendment, dated as of January 29, 2018, to Indenture of Lease by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant for Century 8, North Hollywood, CA. (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.14(a) |  | Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.21(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.14(b) |  | First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.21(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.14(c) |  | Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.21(c) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.14(d) |  | Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.21(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.14(e) |  | Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Cinema 16, Mountain View, CA. (incorporated by reference to Exhibit 10.10(d) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.14(f) |  | Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Cinema 16, Mountain View, CA. (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8—K, File No. 001-33401, filed January 29, 2018).
10.14(g) |  | Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.1 of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed June 3, 2020).
10.15(a) |  | Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA (incorporated by reference to Exhibit 10.25(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.15(b) |  | First Amendment, dated as of April 15, 2005, to Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA (incorporated by reference to Exhibit 10.25(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.15(c) |  | Second Amendment, dated as of September 29, 2005, to Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA (incorporated by reference to Exhibit 10.25(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.15(d) |  | Third Amendment, dated as of August 5, 2006, to Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA. (incorporated by reference to Exhibit 10.10(j) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.16(a) |  | Lease Agreement, dated as of October 1, 1996, by and between Syufy Enterprises, L.P.(succeeded by Stadium Promenade LLC), as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, CA (incorporated by reference to Exhibit 10.27(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.16(b) |  | First Amendment, dated as of April 15, 2005, to Lease Agreement, dated as of October 1, 1996, by and between Syufy Enterprises, L.P. (succeeded by Stadium Promenade LLC), as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, (incorporated by reference to Exhibit 10.27(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.16(c) |  | Second Amendment, dated as of September 29, 2005, to Lease Agreement, dated as of October 1, 1996, by and between Syufy Enterprises, L.P. (succeeded by Stadium Promenade LLC), as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, (incorporated by reference to Exhibit 10.27(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.16(d) |  | Third Amendment, dated as of August 5, 2006, to Lease Agreement, dated as of October 1, 1996, by and between Stadium Promenade LLC, as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, CA. (incorporated by reference to Exhibit 10.10(h) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).

57

Number |  | Exhibit Title
10.16(e) |  | Fourth Amendment, dated as of August 15, 2014, to Lease Agreement, dated as of October 1, 1996, by and between Stadium Promenade LLC, as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, CA (incorporated by reference to Exhibit 10.19(e) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.16(f) |  | Fifth Amendment, dated as of August 3, 2015, to Lease Agreement, dated as of October 1, 1996, by and between Stadium Promenade LLC, as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, CA (incorporated by reference to Exhibit 10.19(f) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.17(a) |  | Indenture of Lease, dated as of July 1, 1996, by and between Synm Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM (incorporated by reference to Exhibit 10.28(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.17(b) |  | First Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of July 1, 1996, by and between Synm Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM (incorporated by reference to Exhibit 10.28(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.17(c) |  | Second Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of July 1, 1996, by and between Synm Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM (incorporated by reference to Exhibit 10.28(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.17(d) |  | Third Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of July 1, 1996, by and between SYNM Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM. (incorporated by reference to Exhibit 10.10(g) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.17(e) |  | Fourth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of July 1, 1996, by and between SYNM Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM. (incorporated by reference to Exhibit 10.7 to Cinemark Holdings, Inc.’s Current Report on Form 8—K, File No. 001-33401, filed January 29, 2018).
10.18(a) |  | Indenture of Lease, dated as of September 3, 1996, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century 14, Roseville, CA (incorporated by reference to Exhibit 10.29(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.18(b) |  | First Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 3, 1996, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century 14, Roseville, CA (incorporated by reference to Exhibit 10.29(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.18(c) |  | Second Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 3, 1996, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century 14, Roseville, CA (incorporated by reference to Exhibit 10.29(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.18(d) |  | Third Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 3, 1996, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century 14, Roseville, CA. (incorporated by reference to Exhibit 10.10(e) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.18(e) |  | Fourth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of September 3, 1996, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century 14, Roseville, CA. (incorporated by reference to Exhibit 10.6 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.19(a) |  | Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 16, Ventura, CA (incorporated by reference to Exhibit 10.31(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.19(b) |  | First Amendment, dated as of October 1, 1996, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 16, Ventura, CA (incorporated by reference to Exhibit 10.31(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.19(c) |  | Second Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 16, Ventura, CA (incorporated by reference to Exhibit 10.31(c) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.19(d) |  | Third Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 16, Ventura, CA (incorporated by reference to Exhibit 10.31(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).

58

Number |  | Exhibit Title
10.19(e) |  | Fourth Amendment dated as of September 29, 2005 to Indenture of Lease, dated September 30, 1995 between Syufy Enterprises L.P., as landlord and Century Theatres, Inc., as tenant for Century Stadium 16, Ventura, CA (incorporated by reference to Exhibit 10.22(e) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 27, 2015).
10.19(f) |  | Fifth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Stadium 16, Ventura, CA (incorporated by reference to Exhibit 10.31(e) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.19(g) |  | Sixth Amendment dated November 29, 2012 to Indenture of Lease, dated as of September 30, 1995, between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Stadium 16, Ventura, CA (incorporated by reference to Exhibit 10.22(g) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 27, 2015).
10.20(a) |  | Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA (incorporated by reference to Exhibit 10.32(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.20(b) |  | First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA (incorporated by reference to Exhibit 10.32(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.20(c) |  | Second Amendment, dated as of October 1, 2001, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA (incorporated by reference to Exhibit 10.32(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.20(d) |  | Third Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA. (incorporated by reference to Exhibit 10.10(m) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.20(e) |  | Fourth Amendment, dated as of August 4, 2017, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA (incorporated by reference to Exhibit 10.23(e) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.20(f) |  | Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA. (incorporated by reference to Exhibit 10.10 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.21(a) |  | Indenture of Lease, dated as of September 30, 1995, by and between Syufy Properties, Inc. (succeeded by Syufy Enterprises, L.P.), as landlord and Century Theatres of Utah, Inc., as tenant, for Century 16, Salt Lake City, UT (incorporated by reference to Exhibit 10.33(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.21(b) |  | First Amendment, dated as of January 4, 1998, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Properties, Inc. (succeeded by Syufy Enterprises, L.P.), as landlord and Century Theatres of Utah, Inc., as tenant, for Century 16, Salt Lake City, UT (incorporated by reference to Exhibit 10.33(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.21(c) |  | Second Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Properties, Inc. (succeeded by Syufy Enterprises, L.P.), as landlord and Century Theatres of Utah, Inc., as tenant, for Century 16, Salt Lake City, UT (incorporated by reference to Exhibit 10.33(c) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.21(d) |  | Third Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Properties, Inc. (succeeded by Syufy Enterprises, L.P.), as landlord and Century Theatres of Utah, Inc., as tenant, for Century 16, Salt Lake City, UT (incorporated by reference to Exhibit 10.33(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.21(e) |  | Fourth Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Properties, Inc. (succeeded by Syufy Enterprises, L.P.), as landlord and Century Theatres of Utah, Inc., as tenant, for Century 16, Salt Lake City, UT (incorporated by reference to Exhibit 10.33(e) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.21(f) |  | Fifth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between SYUT Properties, Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres of Utah, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 16, Salt Lake City, UT. (incorporated by reference to Exhibit 10.10(l) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.22(a) |  | Indenture of Lease, dated as of April 17, 1998, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Larkspur, Larkspur, CA (incorporated by reference to Exhibit 10.34(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).

59

Number |  | Exhibit Title
10.22(b) |  | First Amendment, dated as of April 30, 2003, to Indenture of Lease, dated as of April 17, 1998, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Larkspur, Larkspur, CA (incorporated by reference to Exhibit 10.34(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.22(c) |  | Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of April 17, 1998, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Larkspur, Larkspur, CA (incorporated by reference to Exhibit 10.34(c) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.22(d) |  | Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of April 17, 1998, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Larkspur, Larkspur, CA (incorporated by reference to Exhibit 10.34(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.22(e) |  | Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of April 17, 1998, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Larkspur, Larkspur, CA. (incorporated by reference to Exhibit 10.10(k) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.22(f) |  | Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of April 17, 1998, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Larkspur, Larkspur, CA. (incorporated by reference to Exhibit 10.9 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.23(a) |  | Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV (incorporated by reference to Exhibit 10.35(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.23(b) |  | First Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV (incorporated by reference to Exhibit 10.35(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.23(c) |  | Second Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV (incorporated by reference to Exhibit 10.35(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.23(d) |  | Third Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV. (incorporated by reference to Exhibit 10.10(f) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.23(e) |  | Fourth Amendment, dated as of August 8, 2017, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV (incorporated by reference to Exhibit 10.26(e) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.23(f) |  | Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV. (incorporated by reference to Exhibit 10.8 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.24(a) |  | Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.24(b) |  | First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.24(c) |  | Second Amendment, dated as of October 1, 2001, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.24(d) |  | Third Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.24(e) |  | Fourth Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(e) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).

60

Number |  | Exhibit Title
10.24(f) |  | Fifth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.10(n) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.24(g) |  | Sixth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.11 to Cinemark Holdings, Inc.’s Current Report on Form 8—K, File No. 001-33401, filed January 29, 2018).
10.24(h) |  | Seventh Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.1 of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed June 3, 2020).
10.25(a) |  | Lease Agreement, dated as of May 26, 2015, by and between Sy Arden Way LLC, as landlord and Century Theatres, Inc., as tenant, for Howe ‘Bout Arden Center, Sacramento, CA (incorporated by reference to Exhibit 10.28(a) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.25(b) |  | Letter Agreement, dated as of February 8, 2016, to Lease Agreement, dated as of May 26, 2015, by and between Sy Arden Way LLC, as landlord and Century Theatres, Inc., as tenant, for Howe ‘Bout Arden Center, Sacramento, CA (incorporated by reference to Exhibit 10.28(b) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.26 |  | Cinemark Holdings, Inc. Performance Bonus Plan, as amended (incorporated by reference to Appendix B to Cinemark Holdings, Inc.’s Definitive Proxy Statement, filed April 11, 2013).
+10.27 |  | Third Amended and Restated Non-Employee Director Compensation Policy, dated as of February 15, 2017 (incorporated by reference to Exhibit 10.30 to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.28 |  | Aircraft Time Sharing Agreement, dated as of September 2, 2009, between Copper Beach Capital, LLC and Cinemark USA, Inc. (incorporated by reference to Exhibit 10.1 of Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed September 8, 2009).
10.29 |  | Limited Liability Company Agreement of FE Concepts, LLC dated as of April 20, 2018 (incorporated by reference to Exhibit 10.1 of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
10.30 |  | Management Services Agreement by and between FE Concepts, LLC and Cinema Operations, L.L.C. dated as of April 20, 2018 (incorporated by reference to Exhibit 10.2 of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
10.31 |  | Theatre Services Agreement by and between FE Concepts, LLC and CNMK Texas Properties, LLC dated as of April 20, 2018 (incorporated by reference to Exhibit 10.3 of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
10.32 |  | Form of Call Option Transaction Confirmation (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed August 24, 2020).
10.33 |  | Form of Warrants Confirmation (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed August 24, 2020).
*21 |  | Subsidiaries of Cinemark Holdings, Inc.
*23.1 |  | Consent of Deloitte & Touche LLP.
*31.1 |  | Certification of Mark Zoradi, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*31.2 |  | Certification of Sean Gamble, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*32.1 |  | Certification of Mark Zoradi, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
*32.2 |  | Certification of Sean Gamble, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
*101 |  | The following financial information from Cinemark Holdings, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 26, 2021, formatted in iXBRL (Inline eXtensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Equity, (v) Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements tagged as detailed text.
*104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

* | Filed herewith.

+ | Any management contract, compensatory plan or arrangement.

(P) | Paper filing.

61

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: February 26, 2021 |  | CINEMARK HOLDINGS, INC
|  | BY: |  | /s/ Mark Zoradi
|  |  |  | Mark Zoradi
|  |  |  | Chief Executive Officer

|  | BY: |  | /s/ Sean Gamble
|  |  |  | Sean Gamble
|  |  |  | Chief Financial Officer and
|  |  |  | Principal Accounting Officer

POWER OF ATTORNEY

Each person whose signature appears below hereby severally constitutes and appoints Mark Zoradi and Sean Gamble his true and lawful attorney-in-fact and agent, each with the power of substitution and resubstitution, for him in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K and to file the same, with accompanying exhibits and other related documents, with the Securities and Exchange Commission, and ratify and confirm all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue of said appointment.

Pursuant to the requirements of the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Name |  | Title |  | Date
/s/ Lee Roy Mitchell |  | Chairman of the Board of Directors and Director |  | February 26, 2021
Lee Roy Mitchell |  |  |  |
/s/ Mark Zoradi |  | Chief Executive Officer and Director |  | February 26, 2021
Mark Zoradi |  | (principal executive officer) |  |
/s/ Sean Gamble |  | Chief Financial Officer |  | February 26, 2021
Sean Gamble |  | (principal financial and accounting officer) |  |
/s/ Darcy Antonellis |  | Director |  | February 26, 2021
Darcy Antonellis |  |  |  |
/s/ Benjamin D. Chereskin |  | Director |  | February 26, 2021
Benjamin D. Chereskin |  |  |  |
/s/ Nancy Loewe |  | Director |  | February 26, 2021
Nancy Loewe |  |  |  |
/s/ Steven Rosenberg |  | Director |  | February 26, 2021
Steven Rosenberg |  |  |  |
/s/ Enrique F. Senior |  | Director |  | February 26, 2021
Enrique F. Senior |  |  |  |
/s/ Carlos M. Sepulveda |  | Director |  | February 26, 2021
Carlos M. Sepulveda |  |  |  |
/s/ Raymond W. Syufy |  | Director |  | February 26, 2021
Raymond W. Syufy |  |  |  |
/s/ Nina Vaca |  | Director |  | February 26, 2021
Nina Vaca |  |  |  |

62

SUPPLEMENTAL INFORMATION TO BE FURNISHED WITH REPORTS FILED PURSUANT TO

SECTION 15(d) OF THE ACT BY REGISTRANTS WHICH HAVE NOT REGISTERED

SECURITIES PURSUANT TO SECTION 12 OF THE ACT.

No annual report or proxy material has been sent to our stockholders. An annual report and proxy material may be sent to our stockholders subsequent to the filing of this Form 10-K. We shall furnish to the SEC copies of any annual report or proxy material that is sent to our stockholders.

63

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

|  | Page
CINEMARK HOLDINGS, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS: |  |
Report of Independent Registered Public Accounting Firm |  | F-2
Consolidated Balance Sheets, December 31, 2019 and 2020 |  | F-6
Consolidated Statements of Income (Loss) for the Years Ended December 31, 2018, 2019 and 2020 |  | F-7
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2018, 2019 and 2020 |  | F-8
Consolidated Statements of Equity for the Years Ended December 31, 2018, 2019 and 2020 |  | F-9
Consolidated Statements of Cash Flows for the Years Ended December 31, 2018, 2019 and 2020 |  | F-10
Notes to Consolidated Financial Statements |  | F-11

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of Cinemark Holdings, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Cinemark Holdings, Inc. and subsidiaries (the "Company") as of December 31, 2020 and 2019, the related consolidated statements of income, comprehensive income, equity, and cash flows, for each of the three years in the period ended December 31, 2020, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 26, 2021, expressed an unqualified opinion on the Company's internal control over financial reporting.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Impairment of Long-Lived Assets — Refer to Notes 1 and 11 to the financial statements

Critical Audit Matter Description

The impairment evaluation of long-lived assets is an assessment that begins with the Company’s monitoring of indicators of impairment on an individual theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not

F-2

be fully recoverable. Due to the temporary closure of the Company’s theatres effective March 18, 2020 as a result of the COVID-19 pandemic, the Company performed long-lived asset impairment evaluations during each quarter during the year ended December 31, 2020, including full quantitative impairment evaluations during each quarter except the quarter ended June 30, 2020, where the Company performed a qualitative impairment evaluation. When performing a quantitative impairment assessment, the Company estimates undiscounted cash flows at the theatre level from continuing use through the remainder of the theatre’s useful life. If the estimated undiscounted cash flows are not sufficient to recover the carrying value of the asset group, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. The Company applies significant judgment in estimating the fair value of theatres, based on projected operating performance, recent market transactions and current industry market cash flow multiples. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value. For its 2020 impairment assessments, significant management judgment was involved in estimating the impact the COVID-19 pandemic on future cash flows.

We identified the impairment of long-lived assets as a critical audit matter because of the significant judgment required by management to determine estimated undiscounted cash flows. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures to evaluate the reasonableness of management’s cash flow analysis. Although the carrying value of an individual theatre asset group typically isn’t material, change in the estimated useful life of a theatre, including the likelihood of exercising lease renewal options, and expected future theatre-level cash flows in light of the uncertainty presented from the COVID-19 pandemic could have a significant impact on the amount of any long-lived asset impairment charge.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to management’s undiscounted cash flow estimates, including the likelihood of exercising lease renewal options included the following, among others:

| • | We tested the effectiveness of the Company’s controls over its long-lived assets and long-lived asset impairment evaluation, including those over the estimation of future undiscounted cash flows.

| • | We evaluated management’s ability to forecast future theatre cash flows by:

| ▪ | Comparing management projected cash flow forecasts with:

| o | Historical cash flows and results

| o | Assessment of likelihood of exercising lease renewal options through inspection of underlying lease agreements and theatre projections used by management in evaluating the renewal option

| o | Internal communications to management and the Board of Directors

| o | Forecast information included in analyst reports, as well as, industry outlook information from the Company and peer external communications

| ▪ | Performing a sensitivity analysis on the estimated theatre level cash flows to reflect incremental effects of the COVID-19 pandemic and assess their impact on the impairment analysis.

| • | With the assistance of our fair value specialists, we evaluated the reasonableness of the market cash flow multiples by testing the source information and the mathematical accuracy of the calculations. We additionally developed a range of independent estimates and compared these to assumptions used by management.

| • | We tested the underlying source information and mathematical accuracy of management’s calculations.

Goodwill Impairment Evaluation - Refer to Notes 1, 10 and 11 to the financial statements

Critical Audit Matter Description

The Company evaluates goodwill for impairment annually or when changes in circumstances that may indicate the carrying value of goodwill may not be fully recoverable, and the evaluation is done at the reporting unit level. The Company performed a quantitative impairment analysis each quarter during the year ended December 31, 2020 except the quarter ended June 30, 2020, where the Company performed a qualitative impairment analysis. Under a quantitative analysis, the Company determines fair value or a reporting unit using the market approach, which the Company believes is the most common valuation approach used in the movie exhibition industry, and considers a

F-3

multiple of cash flows for each reporting unit as the basis for fair value. The Company also determines the fair value of its reporting units using the income approach to further validate the results of the market approach assessment. Significant judgment is involved in estimating future theatre-level cash flows and fair value of a reporting unit, in light of the uncertainty presented from the COVID-19 pandemic.

We identified the impairment of goodwill as a critical audit matter because of significant judgments required by management to estimate the fair value of its reporting units. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures to evaluate the reasonableness of management’s cash flow estimates, the selection of cash flow multiples used in the market approach and discount rates and used in the income approach.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to management’s estimates of future cash flows (“forecasts”), the selection of cash flow multiples and discount rates for the Company’s reporting units included the following, among others:

| • | We tested the effectiveness of the Company’s controls over its goodwill impairment evaluation, including those over the review of forecasts, cash flow multiples and discount rates used.

| • | We evaluated management’s ability to forecast future cash flows by:

| ▪ | Comparing management projected cash flow forecasts with:

| o | Historical cash flows and results

| o | Internal communications to management and the Board of Directors

| o | Forecast information included in analyst reports, as well as, industry outlook information from the Company and peer external communications

| ▪ | Performing a sensitivity analysis on the estimated theatre level cash flows to reflect incremental effects of the COVID-19 pandemic and assess their impact on the impairment analysis.

| • | With the assistance of our fair value specialists, we evaluated the reasonableness of the cash flow multiples and discount rates by testing the source information and the mathematical accuracy of the calculations. We additionally developed a range of independent estimates and compared these to those assumptions used by management.

| • | We tested the underlying source information and mathematical accuracy of management’s calculations.

Tax planning and restructuring considerations re. COVID-19 and tax relief legislation—Refer to Note 19 to the financial statements

Critical Audit Matter Description

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act was enacted in response to the global COVID-19 pandemic. The CARES Act contains several business tax provisions aimed at stimulating a failing economy. One of these provisions allows corporate taxpayers to take net operating losses earned in 2018, 2019 and 2020 and carry back those losses five years. As a result of the impact of the COVID-19 pandemic on the Company’s business, it generated significant net operating losses during the year ended December 31, 2020. The Company carried back these losses under the five-year net operating loss (“NOL”) carryback provision, which enabled the Company to benefit from these losses and re-measure certain deferred tax assets and liabilities at the former federal tax rate of 35%.

We identified certain tax positions recorded during the current year that generated significant tax losses in 2020 as a critical audit matter because of significant judgments required by management to estimate certain tax deductions and to interpret tax regulation as to the nature and timing of recognition of these deductions. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures included the following, among others:

F-4

| • | We tested the effectiveness of controls over income taxes, including those over the evaluation of tax positions taken as a result accounting for the impact of the COVID-19 pandemic and the CARES Act.

| • | We evaluated, with the assistance of our tax specialists, the appropriateness of certain underlying tax positions involving significant judgement. Specific considerations included:

| ▪ | Evaluation of certain tax losses with respect to investments in foreign subsidiaries

| ▪ | Assessing tax law and case law regarding the characterization and timing of the deductions

| ▪ | Applying provisions of the CARES Act including assessing its impact on net operating loss carrybacks and considering the realization of tax attributes dislodged or created due to the carrybacks

| ▪ | Evaluation of necessity of recording liabilities associated with federal and state uncertain tax positions

| • | We tested the reasonableness of management’s estimates by comparing the estimates to:

| ▪ | Internal forecasts and evaluating whether the information was consistent with evidence obtained in other areas of the audit

| ▪ | Internal communications to management and the Board of Directors

| ▪ | Forecast information included in analyst reports, as well as, industry outlook information from the Company and peer external communications

| ▪ | We tested the underlying source information and mathematical accuracy of the calculations.

/s/ Deloitte & Touche LLP

Dallas, Texas

February 26, 2021

We have served as the Company's auditor since 1988.

F-5

PART IV - FINANCIAL INFORMATION

Item 15. Financial Statement

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

|  | December 31, |  |  | December 31, |
|  | 2019 |  |  | 2020 |
Assets |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 488,313 |  |  | $ | 655,338 |
Inventories |  |  | 21,686 |  |  |  | 12,593 |
Accounts receivable |  |  | 83,722 |  |  |  | 25,265 |
Current income tax receivable |  |  | 4,082 |  |  |  | 165,151 |
Prepaid expenses and other |  |  | 37,187 |  |  |  | 34,400 |
Total current assets |  |  | 634,990 |  |  |  | 892,747 |
Theatre properties and equipment |  |  |  |  |  |  |  |
Land |  |  | 105,035 |  |  |  | 104,190 |
Buildings |  |  | 536,037 |  |  |  | 535,780 |
Property under finance lease |  |  | 152,519 |  |  |  | 147,156 |
Theatre furniture and equipment |  |  | 1,337,715 |  |  |  | 1,425,142 |
Leasehold interests and improvements |  |  | 1,216,931 |  |  |  | 1,190,835 |
Total |  |  | 3,348,237 |  |  |  | 3,403,103 |
Less: accumulated depreciation and amortization |  |  | 1,612,990 |  |  |  | 1,788,041 |
Theatre properties and equipment, net |  |  | 1,735,247 |  |  |  | 1,615,062 |
Operating lease right-of-use assets, net |  |  | 1,383,080 |  |  |  | 1,278,191 |
Other assets |  |  |  |  |  |  |  |
Goodwill |  |  | 1,283,371 |  |  |  | 1,253,840 |
Intangible assets, net |  |  | 321,769 |  |  |  | 314,195 |
Investment in NCM |  |  | 265,792 |  |  |  | 151,962 |
Investments in affiliates |  |  | 155,285 |  |  |  | 23,726 |
Long-term deferred tax asset |  |  | 9,369 |  |  |  | — |
Deferred charges and other assets, net |  |  | 39,114 |  |  |  | 33,199 |
Total other assets |  |  | 2,074,700 |  |  |  | 1,776,922 |
Total assets |  | $ | 5,828,017 |  |  | $ | 5,562,922 |
Liabilities and equity |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Current portion of long-term debt |  | $ | 6,595 |  |  | $ | 18,056 |
Current portion of operating lease obligations |  |  | 217,406 |  |  |  | 208,593 |
Current portion of finance lease obligations |  |  | 15,432 |  |  |  | 16,407 |
Current income tax payable |  |  | 5,195 |  |  |  | 5,632 |
Current liability for uncertain tax positions |  |  | 13,446 |  |  |  | — |
Accounts payable |  |  | 91,607 |  |  |  | 70,646 |
Accrued film rentals |  |  | 93,849 |  |  |  | 10,668 |
Accrued payroll |  |  | 55,227 |  |  |  | 23,388 |
Accrued property taxes |  |  | 34,337 |  |  |  | 35,586 |
Accrued other current liabilities (see Note 12) |  |  | 175,706 |  |  |  | 217,465 |
Total current liabilities |  |  | 708,800 |  |  |  | 606,441 |
Long-term liabilities |  |  |  |  |  |  |  |
Long-term debt, less current portion |  |  | 1,771,342 |  |  |  | 2,377,162 |
Operating lease obligations, less current portion |  |  | 1,223,462 |  |  |  | 1,138,142 |
Finance lease obligations, less current portion |  |  | 141,017 |  |  |  | 124,609 |
Long-term deferred tax liability |  |  | 141,836 |  |  |  | 79,525 |
Long-term liability for uncertain tax positions |  |  | 848 |  |  |  | 19,225 |
NCM screen advertising advances |  |  | 348,354 |  |  |  | 344,255 |
Other long-term liabilities |  |  | 44,036 |  |  |  | 74,594 |
Total long-term liabilities |  |  | 3,670,895 |  |  |  | 4,157,512 |
Commitments and contingencies (see Note 20) |  |  |  |  |  |  |  |
Equity |  |  |  |  |  |  |  |
Cinemark Holdings, Inc.'s stockholders' equity: |  |  |  |  |  |  |  |
Common stock, $0.001 par value: 300,000,000 shares authorized, 121,863,515 shares issued and 117,151,656 shares outstanding at December 31, 2019 and 123,627,080 shares issued and 118,576,099 shares outstanding at December 31, 2020 |  |  | 122 |  |  |  | 124 |
Additional paid-in-capital |  |  | 1,170,039 |  |  |  | 1,245,569 |
Treasury stock, 4,711,859 and 5,050,981 shares, at cost, at December 31, 2019 and December 31, 2020, respectively |  |  | (81,567 | ) |  |  | (87,004 | )
Retained earnings |  |  | 687,332 |  |  |  | 27,937 |
Accumulated other comprehensive loss |  |  | (340,112 | ) |  |  | (398,653 | )
Total Cinemark Holdings, Inc.'s stockholders' equity |  |  | 1,435,814 |  |  |  | 787,973 |
Noncontrolling interests |  |  | 12,508 |  |  |  | 10,996 |
Total equity |  |  | 1,448,322 |  |  |  | 798,969 |
Total liabilities and equity |  | $ | 5,828,017 |  |  | $ | 5,562,922 |

The accompanying notes are an integral part of the consolidated financial statements.

F-6

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

YEARS ENDED DECEMBER 31, 2018, 2019 AND 2020

(in thousands, except per share data)

|  | 2018 |  |  | 2019 |  |  | 2020 |
Revenues |  |  |  |  |  |  |  |  |  |  |  |
Admissions |  | $ | 1,834,173 |  |  | $ | 1,805,321 |  |  | $ | 356,508 |
Concession |  |  | 1,108,793 |  |  |  | 1,161,083 |  |  |  | 231,046 |
Other |  |  | 278,769 |  |  |  | 316,695 |  |  |  | 98,756 |
Total revenues |  |  | 3,221,735 |  |  |  | 3,283,099 |  |  |  | 686,310 |
Cost of operations |  |  |  |  |  |  |  |  |  |  |  |
Film rentals and advertising |  |  | 999,755 |  |  |  | 1,003,832 |  |  |  | 186,810 |
Concession supplies |  |  | 180,974 |  |  |  | 206,441 |  |  |  | 48,647 |
Salaries and wages |  |  | 383,860 |  |  |  | 410,086 |  |  |  | 145,031 |
Facility lease expense |  |  | 323,316 |  |  |  | 346,094 |  |  |  | 279,764 |
Utilities and other |  |  | 448,070 |  |  |  | 474,711 |  |  |  | 229,505 |
General and administrative expenses |  |  | 165,173 |  |  |  | 173,384 |  |  |  | 127,599 |
Depreciation and amortization |  |  | 261,162 |  |  |  | 261,155 |  |  |  | 259,776 |
Impairment of long-lived and other assets |  |  | 32,372 |  |  |  | 57,001 |  |  |  | 152,706 |
Restructuring costs |  |  | — |  |  |  | — |  |  |  | 20,369 |
(Gain) loss on disposal of assets and other |  |  | 38,702 |  |  |  | 12,008 |  |  |  | (8,923 | )
Total cost of operations |  |  | 2,833,384 |  |  |  | 2,944,712 |  |  |  | 1,441,284 |
Operating income (loss) |  |  | 388,351 |  |  |  | 338,387 |  |  |  | (754,974 | )
Other income (expense) |  |  |  |  |  |  |  |  |  |  |  |
Interest expense |  |  | (109,994 | ) |  |  | (99,941 | ) |  |  | (129,871 | )
Loss on debt amendments and refinancing |  |  | (1,484 | ) |  |  | — |  |  |  | — |
Interest income |  |  | 10,614 |  |  |  | 12,589 |  |  |  | 4,836 |
Foreign currency exchange loss |  |  | (11,660 | ) |  |  | (3,394 | ) |  |  | (4,865 | )
Distributions from NCM |  |  | 15,389 |  |  |  | 12,873 |  |  |  | 6,975 |
Non-cash distributions from other equity investee |  |  | — |  |  |  | — |  |  |  | 12,915 |
Interest expense - NCM |  |  | (19,724 | ) |  |  | (28,624 | ) |  |  | (23,595 | )
Equity in income (loss) of affiliates |  |  | 39,242 |  |  |  | 41,870 |  |  |  | (38,745 | )
Total other expense |  |  | (77,617 | ) |  |  | (64,627 | ) |  |  | (172,350 | )
Income (loss) before income taxes |  |  | 310,734 |  |  |  | 273,760 |  |  |  | (927,324 | )
Income taxes |  |  | 95,429 |  |  |  | 79,912 |  |  |  | (309,376 | )
Net income (loss) |  | $ | 215,305 |  |  | $ | 193,848 |  |  | $ | (617,948 | )
Less: Net income (loss) attributable to noncontrolling interests |  |  | 1,478 |  |  |  | 2,462 |  |  |  | (1,120 | )
Net income (loss) attributable to Cinemark Holdings, Inc. |  | $ | 213,827 |  |  | $ | 191,386 |  |  | $ | (616,828 | )
Weighted average shares outstanding |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 116,054 |  |  |  | 116,306 |  |  |  | 116,667 |
Diluted |  |  | 116,342 |  |  |  | 116,606 |  |  |  | 116,667 |
Earnings (loss) per share attributable to Cinemark Holdings, Inc.'s common stockholders |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 1.83 |  |  | $ | 1.63 |  |  | $ | (5.25 | )
Diluted |  | $ | 1.83 |  |  | $ | 1.63 |  |  | $ | (5.25 | )

The accompanying notes are an integral part of the consolidated financial statements.

F-7

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

YEARS ENDED DECEMBER 31, 2018, 2019 AND 2020

(In thousands)

|  | 2018 |  |  | 2019 |  |  | 2020 |
Net income (loss) |  | $ | 215,305 |  |  | $ | 193,848 |  |  | $ | (617,948 | )
Other comprehensive income (loss), net of tax |  |  |  |  |  |  |  |  |  |  |  |
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1,243, $2,692 and $3,532, net of settlements |  |  | (3,851 | ) |  |  | (8,210 | ) |  |  | (14,320 | )
Other comprehensive loss in equity method investments |  |  | (139 | ) |  |  | (142 | ) |  |  | — |
Foreign currency translation adjustments |  |  | (62,253 | ) |  |  | (12,753 | ) |  |  | (47,592 | )
Total other comprehensive loss, net of tax |  |  | (66,243 | ) |  |  | (21,105 | ) |  |  | (61,912 | )
Total comprehensive income (loss), net of tax |  |  | 149,062 |  |  |  | 172,743 |  |  |  | (679,860 | )
Comprehensive (income) loss attributable to noncontrolling interests |  |  | (1,478 | ) |  |  | (2,462 | ) |  |  | 1,120 |
Comprehensive income (loss) attributable to Cinemark Holdings, Inc. |  | $ | 147,584 |  |  | $ | 170,281 |  |  | $ | (678,740 | )

The accompanying notes are an integral part of the consolidated financial statements.

F-8

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY

YEARS ENDED DECEMBER 31, 2018, 2019 AND 2020

(in thousands, except per share amounts)

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Total |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Accumulated |  |  | Cinemark |  |  |  |  |  |  |  |  |
|  | Common Stock |  |  | Treasury Stock |  |  | Additional |  |  |  |  |  |  | Other |  |  | Holdings, Inc.'s |  |  |  |  |  |  |  |  |
|  | Shares |  |  |  |  |  |  | Shares |  |  |  |  |  |  | Paid-in- |  |  | Retained |  |  | Comprehensive |  |  | Stockholders' |  |  | Noncontrolling |  |  | Total |
|  | Issued |  |  | Amount |  |  | Acquired |  |  | Amount |  |  | Capital |  |  | Earnings |  |  | Loss |  |  | Equity |  |  | Interests |  |  | Equity |
Balance at January 1, 2018 |  |  | 121,001 |  |  | $ | 121 |  |  |  | (4,526 | ) |  | $ | (76,354 | ) |  | $ | 1,141,088 |  |  | $ | 582,222 |  |  | $ | (253,282 | ) |  | $ | 1,393,795 |  |  | $ | 11,893 |  |  | $ | 1,405,688 |
Cumulative effect of change in accounting principle, net of taxes of $2,267 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (7,021 | ) |  |  | — |  |  |  | (7,021 | ) |  |  | — |  |  |  | (7,021 | )
Issuance of restricted stock |  |  | 329 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Issuance of stock upon vesting of restricted stock units |  |  | 127 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year ended December 31, 2018 |  |  | — |  |  |  | — |  |  |  | (100 | ) |  |  | (2,905 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2,905 | ) |  |  | — |  |  |  | (2,905 | )
Share based awards compensation expense |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 14,336 |  |  |  | — |  |  |  | — |  |  |  | 14,336 |  |  |  | — |  |  |  | 14,336 |
Dividends paid to stockholders, $1.28 per share |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (149,492 | ) |  |  | — |  |  |  | (149,492 | ) |  |  | — |  |  |  | (149,492 | )
Dividends accrued on unvested restricted stock unit awards |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (624 | ) |  |  | — |  |  |  | (624 | ) |  |  | — |  |  |  | (624 | )
Dividends paid to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (992 | ) |  |  | (992 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 213,827 |  |  |  | — |  |  |  | 213,827 |  |  |  | 1,478 |  |  |  | 215,305 |
Reclassification of cumulative translation adjustments |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  |  |  |  |  | — |  |  |  | 518 |  |  |  | 518 |  |  |  | — |  |  |  | 518 |
Other comprehensive loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (66,243 | ) |  |  | (66,243 | ) |  |  | — |  |  |  | (66,243 | )
Balance at December 31, 2018 |  |  | 121,457 |  |  | $ | 121 |  |  |  | (4,626 | ) |  | $ | (79,259 | ) |  | $ | 1,155,424 |  |  | $ | 638,912 |  |  | $ | (319,007 | ) |  | $ | 1,396,191 |  |  | $ | 12,379 |  |  | $ | 1,408,570 |
Cumulative effect of change in accounting principle, net of taxes of $6,054 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 16,985 |  |  |  | — |  |  |  | 16,985 |  |  |  | — |  |  |  | 16,985 |
Issuance of restricted stock |  |  | 316 |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1 |  |  |  | — |  |  |  | 1 |
Issuance of stock upon vesting of restricted stock units |  |  | 91 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year ended December 31, 2019 |  |  | — |  |  |  | — |  |  |  | (86 | ) |  |  | (2,308 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2,308 | ) |  |  | — |  |  |  | (2,308 | )
Share based awards compensation expense |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 14,615 |  |  |  | — |  |  |  | — |  |  |  | 14,615 |  |  |  | — |  |  |  | 14,615 |
Dividends paid to stockholders, $1.36 per share |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (159,281 | ) |  |  | — |  |  |  | (159,281 | ) |  |  | — |  |  |  | (159,281 | )
Dividends accrued on unvested restricted stock unit awards |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (670 | ) |  |  | — |  |  |  | (670 | ) |  |  | — |  |  |  | (670 | )
Dividends paid to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2,333 | ) |  |  | (2,333 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 191,386 |  |  |  | — |  |  |  | 191,386 |  |  |  | 2,462 |  |  |  | 193,848 |
Other comprehensive loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (21,105 | ) |  |  | (21,105 | ) |  |  | — |  |  |  | (21,105 | )
Balance at December 31, 2019 |  |  | 121,864 |  |  | $ | 122 |  |  |  | (4,712 | ) |  | $ | (81,567 | ) |  | $ | 1,170,039 |  |  | $ | 687,332 |  |  | $ | (340,112 | ) |  | $ | 1,435,814 |  |  | $ | 12,508 |  |  | $ | 1,448,322 |
Issuance of restricted stock |  |  | 1,555 |  |  |  | 2 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | 2 |
Issuance of stock upon vesting of restricted stock units |  |  | 208 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year ended December 31, 2020 |  |  | — |  |  |  | — |  |  |  | (340 | ) |  |  | (5,437 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (5,437 | ) |  |  | — |  |  |  | (5,437 | )
Share based awards compensation expense ($521 recorded as restructuring costs) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 19,926 |  |  |  | — |  |  |  | — |  |  |  | 19,926 |  |  |  | — |  |  |  | 19,926 |
Dividends paid to stockholders, $0.36 per share |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (42,311 | ) |  |  | — |  |  |  | (42,311 | ) |  |  | — |  |  |  | (42,311 | )
Dividends accrued on unvested restricted stock unit awards |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (256 | ) |  |  | — |  |  |  | (256 | ) |  |  | — |  |  |  | (256 | )
Dividends paid to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (392 | ) |  |  | (392 | )
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (616,828 | ) |  |  | — |  |  |  | (616,828 | ) |  |  | (1,120 | ) |  |  | (617,948 | )
Issuance of convertible senior notes, net of allocated debt issue costs, including tax impact of $10,915 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 108,274 |  |  |  | — |  |  |  | — |  |  |  | 108,274 |  |  |  | — |  |  |  | 108,274 |
Call options purchased |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (142,094 | ) |  |  | — |  |  |  | — |  |  |  | (142,094 | ) |  |  | — |  |  |  | (142,094 | )
Proceeds from issuance of warrants |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 89,424 |  |  |  | — |  |  |  | — |  |  |  | 89,424 |  |  |  | — |  |  |  | 89,424 |
Amortization of accumulated losses for amended swap agreements |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  |  |  |  |  | — |  |  |  | 3,371 |  |  |  | 3,371 |  |  |  | — |  |  |  | 3,371 |
Other comprehensive loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (61,912 | ) |  |  | (61,912 | ) |  |  | — |  |  |  | (61,912 | )
Balance at December 31, 2020 |  |  | 123,627 |  |  | $ | 124 |  |  |  | (5,052 | ) |  | $ | (87,004 | ) |  | $ | 1,245,569 |  |  | $ | 27,937 |  |  | $ | (398,653 | ) |  | $ | 787,973 |  |  | $ | 10,996 |  |  | $ | 798,969 |

The accompanying notes are an integral part of the consolidated financial statements.

F-9

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

YEARS ENDED DECEMBER 31, 2018, 2019 AND 2020

(In thousands)

|  | 2018 |  |  | 2019 |  |  | 2020 |
Operating activities |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 215,305 |  |  | $ | 193,848 |  |  | $ | (617,948 | )
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Depreciation |  |  | 257,826 |  |  |  | 256,118 |  |  |  | 254,987 |
Amortization of intangible and other assets and favorable/unfavorable leases |  |  | 3,336 |  |  |  | 5,037 |  |  |  | 4,789 |
Amortization of long-term prepaid rents |  |  | 2,382 |  |  |  | — |  |  |  | — |
Amortization of debt issue costs |  |  | 5,561 |  |  |  | 5,311 |  |  |  | 7,332 |
Non-cash interest accretion on convertible notes |  |  | — |  |  |  | — |  |  |  | 5,714 |
Interest accrued on NCM screen advertising advances |  |  | — |  |  |  | — |  |  |  | 23,595 |
Amortization of NCM screen advertising advances and other deferred revenues |  |  | (21,706 | ) |  |  | (13,665 | ) |  |  | (31,679 | )
Amortization of accumulated losses for amended swap agreements |  |  | — |  |  |  | — |  |  |  | 3,371 |
Impairment of long-lived and other assets |  |  | 32,372 |  |  |  | 57,001 |  |  |  | 152,706 |
Share based awards compensation expense |  |  | 14,336 |  |  |  | 14,615 |  |  |  | 19,404 |
(Gain) loss on disposal of assets and other |  |  | 38,702 |  |  |  | 12,008 |  |  |  | (8,923 | )
Loss on debt amendments and refinancing |  |  | 1,484 |  |  |  | — |  |  |  | — |
Non-cash rent expense |  |  | — |  |  |  | (4,360 | ) |  |  | 2,357 |
Deferred lease expenses |  |  | (1,320 | ) |  |  | — |  |  |  | — |
Reclassification of cumulative translation adjustments |  |  | 518 |  |  |  | — |  |  |  | — |
Equity in (income) loss of affiliates |  |  | (39,242 | ) |  |  | (41,870 | ) |  |  | 38,745 |
Deferred income tax expenses |  |  | 23,187 |  |  |  | (1,843 | ) |  |  | (38,900 | )
Cash distributions recorded as reduction of equity investment |  |  | 30,143 |  |  |  | 53,366 |  |  |  | 25,430 |
Non-cash distributions from equity investees |  |  | — |  |  |  | — |  |  |  | (12,915 | )
Changes in other assets and liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Inventories |  |  | (1,813 | ) |  |  | (2,367 | ) |  |  | 9,093 |
Accounts receivable |  |  | (4,584 | ) |  |  | 11,326 |  |  |  | 58,457 |
Income tax receivable |  |  | 8,442 |  |  |  | (794 | ) |  |  | (161,069 | )
Prepaid expenses and other |  |  | 1,419 |  |  |  | (24,013 | ) |  |  | 2,787 |
Deferred charges and other assets, net |  |  | (6,303 | ) |  |  | (8,495 | ) |  |  | 9,904 |
Accounts payable and accrued expenses |  |  | (11,408 | ) |  |  | 36,106 |  |  |  | (97,273 | )
Income tax payable |  |  | 6,670 |  |  |  | (6,984 | ) |  |  | 2,289 |
Liabilities for uncertain tax positions |  |  | (10,066 | ) |  |  | 341 |  |  |  | 4,931 |
Other long-term liabilities |  |  | 11,674 |  |  |  | 21,309 |  |  |  | 12,718 |
Net cash provided by (used for) operating activities |  |  | 556,915 |  |  |  | 561,995 |  |  |  | (330,098 | )
Investing activities |  |  |  |  |  |  |  |  |  |  |  |
Additions to theatre properties and equipment and other |  |  | (346,073 | ) |  |  | (303,627 | ) |  |  | (83,930 | )
Proceeds from sale of assets and other |  |  | 3,920 |  |  |  | 3,155 |  |  |  | 614 |
Acquisitions of theatres in the U.S. and international markets, net of cash acquired |  |  | (11,289 | ) |  |  | (10,170 | ) |  |  | — |
Acquisition of NCM common units |  |  | (78,393 | ) |  |  | — |  |  |  | — |
Investment in joint ventures and other, net |  |  | (19,535 | ) |  |  | — |  |  |  | (50 | )
Net cash used for investing activities |  |  | (451,370 | ) |  |  | (310,642 | ) |  |  | (83,366 | )
Financing activities |  |  |  |  |  |  |  |  |  |  |  |
Dividends paid to stockholders |  |  | (149,492 | ) |  |  | (159,281 | ) |  |  | (42,311 | )
Payroll taxes paid as a result of restricted stock withholdings |  |  | (2,905 | ) |  |  | (2,308 | ) |  |  | (5,437 | )
Proceeds from convertible notes issued |  |  | — |  |  |  | — |  |  |  | 460,000 |
Proceeds from other borrowings |  |  | — |  |  |  | — |  |  |  | 272,322 |
Repayments of long-term debt |  |  | (7,984 | ) |  |  | (7,984 | ) |  |  | (6,691 | )
Payment of debt issue costs |  |  | (5,218 | ) |  |  | — |  |  |  | (24,981 | )
Purchase of convertible note hedges |  |  | — |  |  |  | — |  |  |  | (142,094 | )
Proceeds from warrants issued |  |  | — |  |  |  | — |  |  |  | 89,424 |
Fees paid related to debt amendments |  |  | (704 | ) |  |  | — |  |  |  | — |
Payments on finance leases |  |  | (25,353 | ) |  |  | (14,600 | ) |  |  | (15,432 | )
Other |  |  | (992 | ) |  |  | (2,333 | ) |  |  | (392 | )
Net cash provided by (used for) financing activities |  |  | (192,648 | ) |  |  | (186,506 | ) |  |  | 584,408 |
Effect of exchange rate changes on cash and cash equivalents |  |  | (9,222 | ) |  |  | (2,756 | ) |  |  | (3,919 | )
Increase (decrease) in cash and cash equivalents |  |  | (96,325 | ) |  |  | 62,091 |  |  |  | 167,025 |
Cash and cash equivalents: |  |  |  |  |  |  |  |  |  |  |  |
Beginning of period |  |  | 522,547 |  |  |  | 426,222 |  |  |  | 488,313 |
End of period |  | $ | 426,222 |  |  | $ | 488,313 |  |  | $ | 655,338 |

Supplemental information (see Note 18)

The accompanying notes are an integral part of the consolidated financial statements.

F-10

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

1. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business — Cinemark Holdings, Inc. and subsidiaries (the “Company”) operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curaçao and Paraguay.

Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark Holdings, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.

Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres, highly liquid investments with original maturities of three months or less when purchased and restricted cash. Cash investments are primarily in money market funds, certificates of deposit, commercial paper or other similar funds. Restricted cash as of December 31, 2020 was $13,847 and was related to cash deposits required to support bank letters of credit issued for bank loans of certain of the Company’s international subsidiaries. See Note 13 for further discussion.

Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to discounted tickets and gift cards sold to third party retail locations, receivables from landlords related to theatre construction projects, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.

Inventories — Concession and theatre supplies inventories are stated at the lower of cost (first-in, first-out method) or market.

Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

Category | Useful Life
Buildings on owned land | 40 years
Buildings on leased land | Lesser of lease term or useful life
Land and buildings under finance leases (1) | Lesser of lease term or useful life
Theatre furniture and equipment | 3 to 15 years
Leasehold improvements | Lesser of lease term or useful life

(1) | Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of finance lease assets as of December 31, 2019 and 2020 was $36,384 and $47,961, respectively.

The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis.

The Company may perform a qualitative impairment assessment or a quantitative impairment assessment, as described below:

F-11

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

| • | Quantitative approach The Company performs a quantitative evaluation at the theatre level using estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. Significant judgment, including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value. For its 2020 long-lived asset impairment assessments, significant management judgement was involved in estimating the impact of the temporary closure of its theatres and other impacts of the COVID-19 pandemic. Fair value is determined based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on projected operating performance, market transactions and industry trading multiples.

| • | Qualitative approach The Company’s qualitative assessment considers relevant market transactions, industry trading multiples and recent developments that would impact its estimates of future cash flows as compared to its most recent quantitative impairment assessment.

Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill which are described below:

| • | Quantitative approach Under a quantitative goodwill impairment analysis, the Company estimates the fair value of each reporting unit and compares it with its carrying value. Fair value is determined using the market approach, which is the most common valuation approach for the Company’s industry and considers a multiple of cash flows for each reporting unit as the basis for fair value. For the evaluations performed during the year ended December 31, 2020, the Company also performed its quantitative goodwill impairment analysis using the income approach to further validate the results of the assessment under the market approach. Significant judgment including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value of a reporting unit. For its 2020 goodwill impairment assessments, significant management judgement was involved in estimating the impact of the temporary closure of its theatres and other impacts of the COVID-19 pandemic. The Company’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, relevant market transactions and industry trading multiples.

| • | Qualitative approach The Company’s qualitative assessment of goodwill for each reporting unit considers economic and market conditions, industry trading multiples and the impact of recent developments and events on the estimated fair values as determined during its most recent quantitative assessment.

Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets as described below:

| • | Quantitative approach The Company compares the carrying values of its tradename assets to their estimated fair values. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of the tradenames to forecasted future revenues, with an adjustment for the present value of such royalties. Significant judgment, including management’s estimate of market royalty rates and long-term revenue forecasts, is involved in estimating the tradename fair values. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, were based on projected revenue performance and expected industry trends. For its 2020 tradename impairment assessments, the Company’s estimates also included considerations for the impact of the temporary closure of its theatres and impacts of the COVID-19 pandemic.

F-12

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

| • | Qualitative approach The Company’s qualitative assessment considers industry and market conditions and recent developments that may impact the revenues forecasts and other estimates as compared to its most recent quantitative assessment.

The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset:

Intangible Asset | Amortization Method
Goodwill | Indefinite-lived
Tradename | Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately six years.
Other intangible assets | Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to five years.

Lease Accounting — See Note 4 for discussion of the Company’s lease accounting policies.

Deferred Charges — Deferred charges and other assets consist of construction, lease and other deposits, equipment to be placed in service, and other assets of a long-term nature.

Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims. For the years ended December 31, 2018, 2019 and 2020, general liability claims were capped at $250, $500 and $500, respectively, per occurrence with an aggregate annual cap of approximately $4,750 for 2018. There were no annual caps applicable for 2019 and 2020. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. The Company has a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $250 per occurrence, with an annual cap of $5,000 for the years ended December 31, 2018, 2019 and 2020. The Company is also self-insured for domestic medical claims with a cap of $250 per occurrence for the years ended December 31, 2018, 2019 and 2020. As of December 31, 2019 and 2020, the Company’s self-insurance reserves were $11,577 and $9,034, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets.

Revenue and Expense Recognition — See Note 5 for discussion of revenue recognition and deferred revenues.

Film rental costs are subject to the film licensing arrangement and accrued based on the applicable box office receipts and either; 1) a sliding scale, which is generally established with the studio prior to the opening of the film, 2) firm terms or 3) estimates of the final settlement rate, which occurs at the conclusion of the film run. Under a sliding scale, the Company pays a percentage of box office revenues using a pre-determined scale that is based upon box office performance of the film for its full run. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts that can either be an aggregate rate for the full run or rates that decline over the term of the run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can generally be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental costs are adjusted at that time.

Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is based on the Company’s stock price on the grant date. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 17 for discussion of the Company’s share based awards and related compensation expense.

F-13

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. See further discussion at Note 19.

Segments — For the years ended December 31, 2018, 2019 and 2020, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 21.

Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 15 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2018, 2019 and 2020. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency.

The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018. See further discussion at Note 15.

Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 14 for a discussion of our fair value measurements for the years ended December 31, 2018, 2019 and 2020.

Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For certain acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair values of the assets acquired and liabilities

F-14

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third parties to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.

Interest Rate Swaps – The Company evaluates its interest rate swap agreements, which are designated as cash flow hedges, to determine whether they are highly effective on a quarterly basis in accordance with ASC Topic 815, Derivatives and Hedging. The fair values of the interest rate swaps are estimated based on future estimated net cash flows considering forecasted interest rates for the terms of the interest rate swap agreements as compared to the fixed interest rates paid under the agreements. If deemed to be highly effective, fair value estimates are recorded on the consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. If the swaps are determined to not be highly effective, the gains or losses are recorded in interest expense on the consolidated income statement. See further discussion at Note 13.

Restructuring Charges – During the year ended December 31, 2020, the Company recorded restructuring charges based on an approved and announced restructuring plan, specifically related to permanent headcount reductions, the permanent closure of underperforming theatres and the write-down of related theatre assets. The costs of the restructuring actions are accrued based on estimates at the time the plan is formalized, and adjustments are made to restructuring charges based on actual costs incurred. See further discussion at Note 3.

2. | NEW ACCOUNTING PRONOUNCEMENTS

ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, (“ASU 2019-12”). The purpose of ASU 2019-12 is to simplify the accounting for income taxes. The improvements in ASU 2019-12 include removing certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocation and calculating income taxes in interim periods. ASU 2019-12 also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, including interim periods within that year. The amendments in ASU 2019-12 should be applied prospectively. The Company is evaluating the impact of ASU 2019-12 and does not expect ASU-2019-12 to have a significant impact on its consolidated financial statements.

ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, (“ASU 2020-04”) and ASU 2021-01, Reference Rate Reform (Topic 848): Scope, (“ASU 2021-01”). The purpose of ASU 2020-04 is to provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. More specifically, the amendments in ASU 2020-04 provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in ASU 2021-01 clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The amendments in ASU 2020-04 and ASU 2021-01 are effective as of March 12, 2020 through December 31, 2022. The Company is evaluating ASU 2020-04 and ASU 2021-01 and their impact on its consolidated financial statements.

ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). In August 2020, the FASB issued ASU 2020-06, which simplifies the guidance on the issuer’s accounting for convertible debt instruments by removing the separation models for (1) convertible debt with a cash conversion feature and (2) convertible instruments with a beneficial conversion feature. As a result, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06. Also, ASU 2020-06 requires the

F-15

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

application of the if-converted method for calculating diluted earnings per share and treasury stock method will be no longer available. The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements.

3. | IMPACT OF THE COVID-19 PANDEMIC

The outbreak of the COVID-19 pandemic has had an unprecedented impact on the world and the movie exhibition industry. As a movie exhibitor that operates spaces where patrons gather in close proximity, the Company has been, and continues to be, significantly impacted. At the initial outbreak of the COVID-19 pandemic, to comply with government mandates, the Company temporarily closed all of its theatres in the U.S. and Latin America effective March 17, 2020 and March 18, 2020, respectively. In conjunction with the temporary closure of its theatres in March 2020, the Company implemented temporary personnel and salary reductions, limited non-essential operating and capital expenditures, and negotiated modified timing and/or abatement of contractual payments with landlords and other major suppliers until its theatres reopened. In addition, the Company suspended its quarterly dividend.

As of December 31, 2020, the Company had reopened 217 of its domestic theatres and 129 of its international theatres showing limited volume of new releases along with library content during reduced operating hours with limited capacities. While some staffing has been brought back to pre-COVID-19 pandemic levels given the theatre reopenings, the Company continues to maintain a temporary reduction in staffing while limiting capital expenditures to essential activities and projects. Government restrictions also continue to fluctuate with the state of the virus, impacting the Company’s reopening plans. The Company continues to work with landlords and other vendors on modified contractual payment terms while it continues to navigate through the impact of the COVID-19 pandemic and seek to recover a routine level of operations. .

Based on its current estimates of recovery, the Company believes it has and will generate sufficient cash to sustain operations. Nonetheless, the COVID-19 pandemic has had, and continues to have, adverse effects on the Company’s business, results of operations, cash flows and financial condition.

Some of the health and safety protocols that the Company has implemented in its theatres for the safety of its employees, guests and surrounding communities include the following:

| • | staggering showtimes and limiting capacities to maximize physical distancing;

| • | instituting a seat buffering technology to ensure social distancing within the auditorium;

| • | requiring face masks for all guests within the theater, which may only be removed for eating and drinking in the auditoriums;

| • | implementing stringent disinfecting and sanitizing protocols and providing ample supplies of hand sanitizer and seat wipes for patrons;

| • | delivering an abundant supply of fresh outdoor air, maintaining optimal air circulation and eliminating potential pollutants through filtration;

| • | encouraging contactless transactions; and

| • | requiring that employees receive special training, participate in wellness check-ins and use personal protective wear, including face masks and gloves.

With these comprehensive health and safety protocols in place, the Company believes it can more safely operate theaters while prioritizing the health of employees, guests and communities. The Company will continue to evolve these protocols based on changes to recommendations by local authorities throughout the region, as well as based on the Company’s experience as it reopens theatres domestically and throughout Latin America.

Restructuring Charges

In addition to the Company’s initial actions in response to the COVID-19 pandemic discussed above, during June 2020, Company management approved and announced a restructuring plan to realign its operations creating a more efficient cost structure (referred to herein as the “2020 Restructuring Plan”). The 2020 Restructuring Plan primarily includes a permanent headcount reduction at its domestic corporate office and the permanent closure of 15

F-16

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

domestic and 9 international theatres. The Company recorded $20,369 in restructuring costs on the consolidated statement of income for the year ended December 31, 2020. The following table summarizes the costs of the 2020 Restructuring Plan, payments and write-offs and the remaining liability at December 31, 2020:

|  | U.S. Operating Segment |  |  | International Operating Segment |  |  | Consolidated |
|  | Employee-related Costs |  | Facility Closure Costs |  | Total Charges |  |  | Employee-related Costs |  | Facility Closure Costs |  | Total Charges |  |  | Employee-related Costs |  | Facility Closure Costs |  | Total Charges |
Restructuring charges during the twelve months ended December 31, 2020 |  |  | 8,964 |  |  | 7,645 |  |  | 16,609 |  |  |  | 814 |  |  | 2,946 |  |  | 3,760 |  |  |  | 9,778 |  |  | 10,591 |  |  | 20,369 |
Amounts paid |  |  | (7,603 | ) |  | (1,649 | ) |  | (9,252 | ) |  |  | (814 | ) |  | (590 | ) |  | (1,404 | ) |  |  | (8,417 | ) |  | (2,239 | ) |  | (10,656 | )
Noncash write-offs |  |  | (521 | ) |  | (256 | ) |  | (777 | ) |  |  | — |  |  | (2,195 | ) |  | (2,195 | ) |  |  | (521 | ) |  | (2,451 | ) |  | (2,972 | )
Reserve balance at December 31, 2020 |  | $ | 840 |  | $ | 5,740 |  | $ | 6,580 |  |  | $ | — |  | $ | 161 |  | $ | 161 |  |  | $ | 840 |  | $ | 5,901 |  | $ | 6,741 |

The unpaid and accrued restructuring costs of $6,741 are reflected in accrued other current liabilities on the consolidated balance sheet as of December 31, 2020.

4. | LEASE ACCOUNTING

Real Estate Leases - The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with base terms generally ranging from 10 to 25 years. In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance and other costs applicable to the property. Variable lease payments include payments based on a percentage of retail sales or a percentage of retail sales over defined thresholds. Other variable lease payments include payments adjusted periodically for inflation, changes in attendance or changes in average ticket price. The Company can renew, at its option, many of its leases at defined or then market rental rates for various renewal periods. Some leases also provide for escalating rent payments throughout the lease term. The Company also leases certain office and warehouse facilities in the U.S. and in international locations, which generally only include fixed payments. The Company recognizes fixed lease expense for the operating leases on a straight-line basis over the lease term. The Company’s real estate lease agreements do not contain any residual value guarantees or restrictive covenants.

Equipment Leases - The Company leases certain equipment under operating leases, including trash compactors and various other equipment used in the day-to-day operation of its theatres. Certain of the leases require fixed lease payments to be made over the duration of the lease term, while others are variable in nature based on usage or sales. Certain of these leases are month-to-month, while others have noncancelable terms ranging from 5 to 6 years. The Company’s equipment lease agreements do not contain any residual value guarantees or restrictive covenants. The Company leased digital projectors through October 2020. See further discussion of the leased projectors at Note 9.

Lease Deferrals and Abatements - Upon the temporary closure of theatres in March 2020, the Company began negotiating the deferral of rent and other lease-related payments with its landlords while theatres remained closed. These discussions and negotiations have remained ongoing as the Company continues to be impacted by the COVID-19 pandemic. These negotiations resulted in amendments to the leases that involve varying concessions, including the abatement of rent payments during closure, deferral of all or a portion of rent payments to later periods and deferrals of rent payments combined with an early exercise of an existing renewal option or extension of the lease term. In certain locations, the Company is entitled to rent-free periods while theatres remain closed in accordance with local regulations. Total payments deferred as of December 31, 2020 were approximately $66,178, $48,366 of which is included in accrued other current liabilities and $17,812 of which is included in other long term liabilities on the consolidated balance sheet.

In April 2020, the FASB staff released guidance indicating that in response to the COVID-19 pandemic, an entity would not have to analyze each contract to determine whether enforceable rights and obligations for

F-17

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

concessions exist in the contract and could elect to apply or not apply the lease modification guidance in ASC Topic 842, Leases to those contracts. The election is available for concessions related to the effects of the COVID-19 pandemic that do not result in a substantial increase in the rights of the lessor or the obligations of the lessee. For example, this election is available for concessions that result in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract.

The Company elected to not remeasure the lease liabilities and right-of-use assets for those leases where the concessions and deferrals did not result in a significant change in total payments under the lease and where the remaining lease term did not change as a result of the negotiation. For those leases that were renewed or extended as a result of the negotiation to defer rent payments, the Company recalculated the related lease liability and right-of-use asset based on the new terms.

The following table represents the operating and finance right-of-use assets and lease liabilities as of the periods indicated.

|  |  | As of |  |  | As of |
Leases | Classification |  | December 31, 2019 |  |  | December 31, 2020 |
Assets (1) |  |  |  |  |  |  |  |  |
Operating lease assets | Operating lease assets |  | $ | 1,383,080 |  |  | $ | 1,278,191 |
Finance lease assets | Theatre properties and equipment, net of accumulated depreciation (2) |  |  | 116,135 |  |  |  | 99,195 |
Total lease assets |  |  | $ | 1,499,215 |  |  | $ | 1,377,386 |
Liabilities (1) |  |  |  |  |  |  |  |  |
Current |  |  |  |  |  |  |  |  |
Operating | Current portion of operating lease obligations |  | $ | 217,406 |  |  | $ | 208,593 |
Finance | Current portion of finance lease obligations |  |  | 15,432 |  |  |  | 16,407 |
Noncurrent |  |  |  |  |  |  |  |  |
Operating | Operating lease obligations, less current portion |  |  | 1,223,462 |  |  |  | 1,138,142 |
Finance | Finance lease obligations, less current portion |  |  | 141,017 |  |  |  | 124,609 |
Total lease liabilities |  |  | $ | 1,597,317 |  |  | $ | 1,487,751 |

(1) | The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal as reasonably certain until the necessary notification is provided to the landlord.

(2) | Finance lease assets are net of accumulated amortization of $36,384 and $47,961 as of December 31, 2019 and 2020, respectively.

As of December 31, 2020, the Company had signed lease agreements with total noncancelable lease payments of approximately $190,870 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of December 31, 2020. There were no significant noncancelable equipment lease agreements signed, but not yet commenced.

F-18

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

The following table represents the Company’s aggregate lease costs, by lease classification, for the periods indicated.

|  | Year Ended |  | Year Ended |
Lease Cost | Classification | December 31, 2019 |  | December 31, 2020 |
Operating lease costs |  |  |  |  |  |  |
Equipment (1) | Utilities and other | $ | 9,172 |  | $ | 3,324 |
Real Estate (2)(3) | Facility lease expense |  | 346,222 |  |  | 275,056 |
Total operating lease costs |  | $ | 355,394 |  | $ | 278,380 |
Finance lease costs |  |  |  |  |  |  |
Depreciation of leased assets | Depreciation and amortization | $ | 14,734 |  | $ | 14,662 |
Interest on lease liabilities | Interest expense |  | 7,786 |  |  | 7,014 |
Total finance lease costs |  | $ | 22,520 |  | $ | 21,676 |

(1) | Includes approximately $4,700 and $(465) of short-term lease payments for the years ended December 31, 2019 and 2020, respectively. The amount for the year ended December 31, 2020 was impacted by i) a decrease in short term lease payments while theatres were closed and ii) rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements

(2) | Includes approximately $68,799 and $7,058 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the year ended December 31, 2019 and 2020, respectively. The amount for the year ended December 31, 2020 was impacted by rent abatements on leases that were not recalculated in accordance with the FASB guidance discussed above, which resulted in variable rent credits in the amount of the rent abatements.

(3) | Approximately $1,614 and $1,445 of lease payments are included in general and administrative expenses primarily related to office leases for the year ended December 31, 2019 and 2020, respectively.

The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2020.

|  | Operating |  | Finance |  |  |  |
Years Ending |  | Leases |  | Leases |  | Total |
2021 (1) |  | $ | 268,390 |  | $ | 22,671 |  | $ | 291,061 |
2022 (1) |  |  | 250,956 |  |  | 21,935 |  |  | 272,891 |
2023 |  |  | 225,840 |  |  | 21,246 |  |  | 247,086 |
2024 |  |  | 194,197 |  |  | 20,165 |  |  | 214,362 |
2025 |  |  | 166,131 |  |  | 18,380 |  |  | 184,511 |
After 2025 |  |  | 508,104 |  |  | 70,533 |  |  | 578,637 |
Total lease payments |  | $ | 1,613,618 |  | $ | 174,930 |  | $ | 1,788,548 |
Less: Interest |  |  | 266,883 |  |  | 33,914 |  |  | 300,797 |
Present value of lease liabilities |  | $ | 1,346,735 |  | $ | 141,016 |  | $ | 1,487,751 |

F-19

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

| (1) | Amounts do not include rent payments deferred under amendments as discussed at Lease Deferrals and Abatements above. |

The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2020.

|  | As of |
Lease Term and Discount Rate |  | December 31, 2020 |
Weighted-average remaining lease term (years) (1) |  |  |  |
Operating leases - equipment |  |  | 2.5 |
Operating leases - real estate |  |  | 7.6 |
Finance leases - equipment |  |  | 4.4 |
Finance leases - real estate |  |  | 9.2 |
Weighted-average discount rate (2) |  |  |  |
Operating leases - equipment |  |  | 4.2 | %
Operating leases - real estate |  |  | 4.9 | %
Finance leases - equipment |  |  | 4.7 | %
Finance leases - real estate |  |  | 4.8 | %

| (1) | The lease assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord. |

| (2) | The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment. |

The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the periods presented.

|  | Year Ended |  |  | Year Ended |
Other Information |  | December 31, 2019 |  |  | December 31, 2020 |
Cash paid for amounts included in the measurement of lease liabilities |  |  |  |  |  |  |  |
Cash outflows for operating leases |  | $ | 281,895 |  |  | $ | 271,787 |
Cash outflows for finance leases - operating activities |  | $ | 7,576 |  |  | $ | 6,985 |
Cash outflows for finance leases - financing activities |  | $ | 14,600 |  |  | $ | 15,432 |
Non-cash amount of leased assets obtained in exchange for: |  |  |  |  |  |  |  |
Operating lease liabilities - real estate |  | $ | 113,318 |  |  | $ | 132,529 |
Operating lease liabilities - equipment |  | $ | 795 |  |  | $ | 188 |
Finance lease liabilities |  | $ | 21,535 |  |  | $ | — |

Lessor Arrangements

Under the Company’s Exhibitor Services Agreement (“ESA”) with National CineMedia, LLC (“NCM”), the nonconsecutive periods of use of the theatre screens by NCM qualify as a lease in accordance with ASC Topic 842. See further discussion in Note 8.

The Company rents its theatre auditoriums for corporate meetings, screenings, education and training sessions and other private events. These rentals, which are not significant to the Company, are generally one-time events and the related revenue is reflected as other revenue on the consolidated statement of income.

F-20

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

5. | REVENUE RECOGNITION

Revenue Recognition Policy

The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on when tickets are put on sale and seat availability. The Company recognizes such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when products are sold to the consumer or, if pre-ordered, after the associated pick-up date has passed. Other revenues primarily consist of screen advertising and screen rental revenues, promotional income, studio trailer placements and transactional fees. The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenues. Deferred revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for movie tickets or concession items. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the monthly subscription program fees as deferred revenues and records admissions revenues when the showtime for a movie ticket purchased with a credit has passed. The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, the Company recognizes the fee collected as other revenues on a straight-line basis over the term of the membership. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenues based on the number of reward points issued to customers and recognizes the deferred revenues when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company generally records breakage revenue on gift cards and discount ticket vouchers generally based on redemption activity and historical experience with unused balances. The Company records breakage revenue upon the expiration of loyalty points and subscription credits. Advances collected on concession and other contracts are deferred and recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company meets its performance obligations in accordance with the terms of the contracts.

Screen advertising and screen rental revenues for the U.S. operating segment primarily relate to the ESA with NCM and the Company’s agreement with its beverage concessionaire. Prior to September 17, 2019, such screen advertising was accounted for under ASC Topic 606, Revenue from Contracts with Customers, and effective upon the amendment of the ESA, NCM screen advertising was accounted for under ASC Topic 842. See table at Note 8 for screen advertising revenues recorded in other revenue under ASC Topic 606 prior to the amendment of the ESA and screen rental revenues recorded in other revenue under ASC Topic 842 subsequent to the amendment of the ESA.

Accounts receivable included approximately $31,620 and $6,232 of receivables related to contracts with customers as of December 31, 2019 and 2020, respectively. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the year ended December 31, 2020.

Disaggregation of Revenue

The following tables present revenues for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment.

|  | Twelve Months Ended |
|  | December 31, 2020 |
|  | U.S. |  |  | International |  |  |  |  |
|  | Operating |  |  | Operating |  |  |  |  |
Major Goods/Services |  | Segment (1) |  |  | Segment |  |  | Consolidated |
Admissions revenues |  | $ | 291,636 |  |  | $ | 64,872 |  |  | $ | 356,508 |
Concession revenues |  |  | 189,561 |  |  |  | 41,485 |  |  |  | 231,046 |
Screen advertising, screen rental and promotional revenues |  |  | 46,199 |  |  |  | 16,332 |  |  |  | 62,531 |
Other revenues |  |  | 29,513 |  |  |  | 6,712 |  |  |  | 36,225 |
Total revenues |  | $ | 556,909 |  |  | $ | 129,401 |  |  | $ | 686,310 |

F-21

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

|  | Twelve Months Ended |
|  | December 31, 2019 |
|  | U.S. |  |  | International |  |  |  |  |
|  | Operating |  |  | Operating |  |  |  |  |
Major Goods/Services |  | Segment (1) |  |  | Segment |  |  | Consolidated |
Admissions revenues |  | $ | 1,431,790 |  |  | $ | 373,531 |  |  | $ | 1,805,321 |
Concession revenues |  |  | 936,241 |  |  |  | 224,842 |  |  |  | 1,161,083 |
Screen advertising, screen rental and promotional revenues |  |  | 128,839 |  |  |  | 35,888 |  |  |  | 164,727 |
Other revenues |  |  | 84,033 |  |  |  | 67,935 |  |  |  | 151,968 |
Total revenues |  | $ | 2,580,903 |  |  | $ | 702,196 |  |  | $ | 3,283,099 |

|  | Twelve Months Ended |
|  | December 31, 2018 |
|  | U.S. |  |  | International |  |  |  |  |
|  | Operating |  |  | Operating |  |  |  |  |
Major Goods/Services |  | Segment (1) |  |  | Segment |  |  | Consolidated |
Admissions revenues |  | $ | 1,461,151 |  |  | $ | 373,022 |  |  | $ | 1,834,173 |
Concession revenues |  |  | 892,391 |  |  |  | 216,402 |  |  |  | 1,108,793 |
Screen advertising, screen rental and promotional revenues |  |  | 78,591 |  |  |  | 61,269 |  |  |  | 139,860 |
Other revenues |  |  | 106,824 |  |  |  | 32,085 |  |  |  | 138,909 |
Total revenues |  | $ | 2,538,957 |  |  | $ | 682,778 |  |  | $ | 3,221,735 |

| (1) | U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 21 for additional information on intercompany eliminations.

The following tables present revenues for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above).

|  | Twelve Months Ended |
|  | December 31, 2020 |
|  | U.S. |  |  | International |  |  |  |  |
|  | Operating |  |  | Operating |  |  |  |  |
|  | Segment (1) |  |  | Segment |  |  | Consolidated |
Goods and services transferred at a point in time |  | $ | 497,338 |  |  | $ | 109,997 |  |  | $ | 607,335 |
Goods and services transferred over time |  |  | 59,571 |  |  |  | 19,404 |  |  |  | 78,975 |
Total |  | $ | 556,909 |  |  | $ | 129,401 |  |  | $ | 686,310 |

|  | Twelve Months Ended |
|  | December 31, 2019 |
|  | U.S. |  |  | International |  |  |  |  |
|  | Operating |  |  | Operating |  |  |  |  |
|  | Segment (1) |  |  | Segment |  |  | Consolidated |
Goods and services transferred at a point in time |  | $ | 2,488,716 |  |  | $ | 621,785 |  |  | $ | 3,110,501 |
Goods and services transferred over time |  |  | 92,187 |  |  |  | 80,411 |  |  |  | 172,598 |
Total |  | $ | 2,580,903 |  |  | $ | 702,196 |  |  | $ | 3,283,099 |

|  | Twelve Months Ended |
|  | December 31, 2018 |
|  | U.S. |  |  | International |  |  |  |  |
|  | Operating |  |  | Operating |  |  |  |  |
|  | Segment (1) |  |  | Segment |  |  | Consolidated |
Goods and services transferred at a point in time |  | $ | 2,453,313 |  |  | $ | 608,347 |  |  | $ | 3,061,660 |
Goods and services transferred over time |  |  | 85,644 |  |  |  | 74,431 |  |  |  | 160,075 |
Total |  | $ | 2,538,957 |  |  | $ | 682,778 |  |  | $ | 3,221,735 |

F-22

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

| (1) | U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 21 for additional information on intercompany eliminations.

Screen Advertising Advances and Other Deferred Revenues

The following table presents changes in the Company’s deferred revenues for the year ended December 31, 2020.

Deferred Revenues |  | NCM Screen Advertising Advances (1) |  |  | Other Deferred Revenues (2) |  |  | Total |
Balance at January 1, 2020 |  | $ | 348,354 |  |  | $ | 138,426 |  |  | $ | 486,780 |
Amounts recognized as accounts receivable |  |  | — |  |  |  | 2,915 |  |  |  | 2,915 |
Cash received from customers in advance |  |  | — |  |  |  | 56,772 |  |  |  | 56,772 |
Common units received from NCM (see Note 8) |  |  | 3,620 |  |  |  | — |  |  |  | 3,620 |
Interest accrued related to significant financing component |  |  | 23,595 |  |  |  | — |  |  |  | 23,595 |
Revenue recognized during period |  |  | (31,314 | ) |  |  | (57,625 | ) |  |  | (88,939 | )
Foreign currency translation adjustments |  |  | — |  |  |  | (1,658 | ) |  |  | (1,658 | )
Balance at December 31, 2020 |  | $ | 344,255 |  |  | $ | 138,830 |  |  | $ | 483,085 |

| (1) | See Significant Financing Component discussion below. See Note 8 for the maturity of balances as of December 31, 2020.

| (2) | Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Amount is classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheet.

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of December 31, 2020 and when the Company expects to recognize this revenue.

|  | Twelve Months Ended December 31, |  |  |  |  |  |  |  |  |
Remaining Performance Obligations |  | 2021 |  |  | 2022 |  |  | 2023 |  | 2024 |  |  | 2025 |  |  | Thereafter |  |  | Total |
Deferred revenue - other |  | $ | 124,326 |  |  |  | 14,504 |  |  |  |  |  | — |  |  |  | — |  |  |  | — |  |  | $ | 138,830 |

6. | EARNINGS PER SHARE

The Company considers its unvested share based payment awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings per share pursuant to the two-class method. Basic earnings per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net income by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted earnings per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two class method and the treasury stock method.

F-23

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

The following table presents computations of basic and diluted earnings per share under the two class method:

|  | Year Ended |
|  | December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) attributable to Cinemark Holdings, Inc. |  | $ | 213,827 |  |  | $ | 191,386 |  |  | $ | (616,828 | )
(Earnings) loss allocated to participating share-based awards (1) |  |  | (1,168 | ) |  |  | (1,174 | ) |  |  | 4,279 |
Net income (loss) attributable to common stockholders |  | $ | 212,659 |  |  | $ | 190,212 |  |  | $ | (612,549 | )
Denominator (shares in thousands): |  |  |  |  |  |  |  |  |  |  |  |
Basic weighted average shares outstanding |  |  | 116,054 |  |  |  | 116,306 |  |  |  | 116,667 |
Common equivalent shares for restricted stock units (2) |  |  | 288 |  |  |  | 300 |  |  |  | — |
Diluted weighted average shares outstanding |  |  | 116,342 |  |  |  | 116,606 |  |  |  | 116,667 |
Basic earnings (loss) per share attributable to common stockholders |  | $ | 1.83 |  |  | $ | 1.63 |  |  | $ | (5.25 | )
Diluted earnings (loss) per share attributable to common stockholders |  | $ | 1.83 |  |  | $ | 1.63 |  |  | $ | (5.25 | )

| (1) | For the years ended December 31, 2018, 2019 and 2020, a weighted average of approximately 640 shares, 721 shares and 815 shares, of unvested restricted stock, respectively, are considered participating securities.

| (2) | For the year ended December 31, 2020, approximately 682 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.

The calculations of diluted earnings per share for the year ended December 31, 2020 does not include the impact of the conversation of the 4.50% Convertible Senior Notes, issued August 21, 2020, into 32,051,282 shares of common stock, as it would be anti-dilutive. Additionally, the average price of the Company’s common stock did not exceed $22.08 per share during the reporting period; therefore, additional shares that may be issued related to the recently issued warrants were not included in the calculation of diluted common equivalent shares. See further discussion of the 4.50% Convertible Senior Notes, the convertible note hedges and the warrants at Note 13.

7. | DIVIDENDS

Below is a summary of dividends declared for the fiscal periods indicated.

|  |  |  |  |  | Amount per Share of |  |  | Total |
Declaration Date |  | Record Date |  | Payable Date |  | Common Stock |  |  | Dividends (1) |
2/23/2018 |  | 3/8/2018 |  | 3/22/2018 |  | $ | 0.32 |  |  | $ | 37,471 |
5/25/2018 |  | 6/8/2018 |  | 6/22/2018 |  |  | 0.32 |  |  |  | 37,523 |
8/23/2018 |  | 9/4/2018 |  | 9/18/2018 |  |  | 0.32 |  |  |  | 37,530 |
11/15/2018 |  | 12/4/2018 |  | 12/18/2018 |  |  | 0.32 |  |  |  | 37,592 |
Total for year ended December 31, 2018 |  | $ | 1.28 |  |  | $ | 150,116 |
2/23/2019 |  | 3/8/2019 |  | 3/22/2019 |  | $ | 0.34 |  |  | $ | 39,905 |
5/24/2019 |  | 6/10/2019 |  | 6/24/2019 |  |  | 0.34 |  |  |  | 40,012 |
8/16/2019 |  | 9/4/2019 |  | 9/18/2019 |  |  | 0.34 |  |  |  | 40,020 |
11/22/2019 |  | 12/4/2019 |  | 12/18/2019 |  |  | 0.34 |  |  |  | 40,014 |
Total for year ended December 31, 2019 |  | $ | 1.36 |  |  | $ | 159,951 |
2/21/2020 |  | 3/6/2020 |  | 3/20/2020 |  | $ | 0.36 |  |  | $ | 42,567 |
Total for year ended December 31, 2020 |  | $ | 0.36 |  |  | $ | 42,567 |

F-24

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

| (1) | Of the dividends recorded during 2018, 2019 and 2020, $624, $670 and $256, respectively, were related to outstanding restricted stock units and will not be paid until such units vest. See Note 17.

The Company suspended its quarterly dividend in March 2020 as a result of the COVID-19 pandemic as discussed in Note 3.

8. | INVESTMENT IN NATIONAL CINEMEDIA LLC

Summary of Activity with NCM

Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 5 for discussion of revenue recognition.

|  | Investment in NCM |  |  | NCM Screen Advertising Advances |  |  | Distributions from NCM |  |  | Equity in (Earnings) Loss |  |  | Other Revenue |  |  | Interest Expense - NCM (3) |  |  | Cash Received |
Balance as of January 1, 2018 |  | $ | 200,550 |  |  | $ | (351,706 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Impact of adoption of ASC Topic 606 (2) |  |  | — |  |  |  | (9,288 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Receipt of common units due to annual common unit adjustment |  |  | 5,012 |  |  |  | (5,012 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Purchase of additional common units |  |  | 78,393 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Revenues earned under ESA (1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (31,867 | ) |  |  | 19,724 |  |  |  | 12,143 |
Receipt of excess cash distributions |  |  | (19,786 | ) |  |  | — |  |  |  | (13,231 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 33,017 |
Receipt under tax receivable agreement |  |  | (2,419 | ) |  |  | — |  |  |  | (2,158 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 4,577 |
Equity in earnings |  |  | 13,842 |  |  |  | — |  |  |  | — |  |  |  | (13,842 | ) |  |  | — |  |  |  | — |  |  |  | — |
Amortization of screen advertising advances |  |  | — |  |  |  | 15,764 |  |  |  | — |  |  |  | — |  |  |  | (15,764 | ) |  |  | — |  |  |  | — |
Balance as of and for the twelve months ended December 31, 2018 |  | $ | 275,592 |  |  | $ | (350,242 | ) |  | $ | (15,389 | ) |  | $ | (13,842 | ) |  | $ | (47,631 | ) |  | $ | 19,724.00 |  |  | $ | 49,737 |
Receipt of common units due to annual common unit adjustment |  |  | 1,552 |  |  |  | (1,552 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Revenues earned under ESA (1) (3) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (13,782 | ) |  |  | — |  |  |  | 13,782 |
Interest accrued related to significant financing component (2) |  |  | — |  |  |  | (28,624 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 28,624 |  |  |  | — |
Receipt of excess cash distributions |  |  | (23,452 | ) |  |  | — |  |  |  | (11,631 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 35,083 |
Receipt under tax receivable agreement |  |  | (2,492 | ) |  |  | — |  |  |  | (1,242 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,734 |
Equity in earnings |  |  | 14,592 |  |  |  | — |  |  |  | — |  |  |  | (14,592 | ) |  |  | — |  |  |  | — |  |  |  | — |
Amortization of screen advertising advances |  |  | — |  |  |  | 32,064 |  |  |  | — |  |  |  | — |  |  |  | (32,064 | ) |  |  | — |  |  |  | — |
Balance as of and for the twelve months ended December 31, 2019 |  | $ | 265,792 |  |  | $ | (348,354 | ) |  | $ | (12,873 | ) |  | $ | (14,592 | ) |  | $ | (45,846 | ) |  | $ | 28,624 |  |  | $ | 52,599 |
Receipt of common units due to annual common unit adjustment |  |  | 3,620 |  |  |  | (3,620 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Revenues earned under ESA (1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (4,689 | ) |  |  | — |  |  |  | 4,689 |
Interest accrued related to significant financing component (2) |  |  | — |  |  |  | (23,595 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 23,595 |  |  |  | — |
Receipt of excess cash distributions |  |  | (12,022 | ) |  |  | — |  |  |  | (5,914 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 17,936 |
Receipt under tax receivable agreement |  |  | (2,146 | ) |  |  | — |  |  |  | (1,061 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,207 |
Equity in loss |  |  | (10,627 | ) |  |  | — |  |  |  | — |  |  |  | 10,627 |  |  |  | — |  |  |  | — |  |  |  | — |
Impairment of investment in NCM (4) |  |  | (92,655 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Amortization of screen advertising advances |  |  | — |  |  |  | 31,314 |  |  |  | — |  |  |  | — |  |  |  | (31,314 | ) |  |  | — |  |  |  | — |
Balance as of and for the twelve months ended December 31, 2020 |  | $ | 151,962 |  |  | $ | (344,255 | ) |  | $ | (6,975 | ) |  | $ | 10,627 |  |  | $ | (36,003 | ) |  | $ | 23,595 |  |  | $ | 25,832 |

(1) | Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $11,965, $11,478 and $2,605 for the years ended December 31, 2018, 2019 and 2020, respectively.

(2) | As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and CUA agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption. In addition, the Company determined that a significant financing component existed for the ESA.

(3) | Approximately $4,828 represents screen rental revenues earned under the amendment to the ESA. See Note 5.

(4) | Recorded in impairment of long-lived and other assets on the consolidated income statement for the year ended December 31, 2020. See further discussion below.

F-25

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

In addition to the activity in the table above, the Company made payments to NCM of approximately $74, $61 and $9 during the years ended December 31, 2018, 2019 and 2020, respectively, related to certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets.

Investment in National CineMedia

NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company entered into an ESA with NCM, pursuant to which NCM primarily provides advertising to our theatres. On February 13, 2007, National Cinemedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. At the time of the NCMI IPO and as a result of amending the ESA, the Company received approximately $174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue or NCM screen advertising advances and was being amortized over the term of the Amended and Restated ESA, or through February 2041. Following the NCMI IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. The Company believes that the accounting model provided by ASC Topic 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution.

Common Unit Adjustments

In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As discussed in Note 6 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue or NCM screen advertising advances. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis

During March 2020, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 31, 2020, the Company received an additional 1,112,368 common units of NCM, each of which is convertible into one share of NCMI common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to deferred revenue of approximately $3,620. The fair value of the common units received was estimated based on the market price of NCMI common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. The deferred revenue is recognized on a straight-line basis over the remaining term of the ESA.

Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2018, 2019 and 2020:

Event |  | Date Common Units Received |  | Number of Common Units Received |  |  | Fair Value of Common Units Received |
2018 annual common unit adjustment |  | 3/29/2018 |  |  | 908,042 |  |  | $ | 5,012 |
2019 annual common unit adjustment |  | 3/31/2019 |  |  | 219,056 |  |  | $ | 1,552 |
2020 annual common unit adjustment |  | 3/31/2020 |  |  | 1,112,368 |  |  | $ | 3,620 |

F-26

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Acquisition of Common Units

On July 5, 2018, the Company acquired 10,738,740 common units of NCM from AMC for $78,393 in cash, or approximately $7.30 per common unit. As a result of the acquisition of these shares, the Company’s ownership of NCM increased from approximately 18% to 25%. The amount paid for the additional common units was recorded as an increase in the Company’s Tranche 2 investment in NCM.

Impairment of Investment in NCM

As of December 31, 2020, the Company owned a total of 40,850,068 common units of NCM, which represented an interest of approximately 25%. The estimated fair value of the Company’s investment in NCM was approximately $151,962 based on NCMI’s stock price as of December 31, 2020 of $3.72 per share (Level 1 input as defined in FASB ASC Topic 820). The Company and other industry participants, who are also members of the NCM network, have reopened some theatres and will continue to reopen theatres as local government restrictions allow. However, the market value of NCM, Inc.’s stock price has been below the Company’s book value of its investment in NCM as a result of the COVID-19 pandemic since March of 2020. Although the Company expects the industry to recover gradually over time, the investment in NCM was written down by $92,655, with a corresponding charge to impairment expense, in accordance with ASC 323-10-35. The write-down was due to the prolonged period of time for which the share price of NCMI was below the Company’s carrying value per common unit of its investment in NCM.

Exhibitor Services Agreement

As previously discussed, the Company’s domestic theatres are part of the in-theatre digital network operated by NCM, the terms of which are defined in the ESA. NCM provides advertising to its theatres through its branded “Noovie” pre-show entertainment program and also handles lobby promotions and displays for our theatres. The Company receives a monthly theatre access fee for participation in the NCM network and also earns screen advertising or screen rental revenue on a per patron basis. Prior to September 17, 2019, the ESA was accounted for under ASC Topic 606, Revenue from Contracts with Customers. Effective September 17, 2019, the Company signed an amendment to the ESA, under which the Company will provide incremental advertising time to NCM and has extended the term through February 2041. Since the agreement was amended, the Company was required to evaluate the revised contract under ASC Topic 842, Leases, and as a result, determined that the ESA met the definition of a lease. The Company leases nonconsecutive periods of use of its domestic theatre screens to NCM for purposes of showing third party advertising content. The lease, which is classified as an operating lease, generally requires variable lease payments based on the number of patrons attending the showtimes during which such advertising is shown. The lease agreement is considered short-term due to the fact that the nonconsecutive periods of use, or advertising time slots, are set on a weekly basis. The revenues earned under the ESA, both before and after the amendment, are reflected in other revenue on the consolidated income statement.

The recognition of revenue related to the deferred revenue or NCM screen advertising advances will continue to be recorded on a straight-line basis over the new term of the amended ESA through February 2041.

|  | Twelve Months Ended December 31, |  |  |  |  |  |  |  |  |
Remaining Maturity |  | 2021 |  |  | 2022 |  |  | 2023 |  |  | 2024 |  |  | 2025 |  |  | Thereafter |  |  | Total |
NCM screen advertising advances (1) |  | $ | 8,268 |  |  |  | 8,840 |  |  |  | 9,452 |  |  |  | 10,108 |  |  |  | 10,811 |  |  |  | 296,776 |  |  | $ | 344,255 |

| (1) | Amounts are net of the estimated interest to be accrued for the periods presented.

Significant Financing Component

In connection with the completion of the NCMI initial public offering, the Company amended and restated its ESA with NCM and received approximately $174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue and are being amortized over the term of the modified ESA, or through February 2041. In addition to the consideration received upon the ESA modification during 2007, the Company also receives consideration in the form of common units from NCM, at each annual common unit adjustment settlement, in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606.

F-27

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 4.4% to 8.3%. Effective September 17, 2019, upon the Company’s evaluation and determination that ASC Topic 842 applies to the amended ESA, the Company determined it acceptable to apply the significant financing component guidance from ASC Topic 606 by analogy as the economic substance of the agreement represents a financing arrangement.

Summary Financial Information for NCM

The tables below present summary financial information for NCM for the periods indicated:

|  | Year Ended |  |  | Year Ended |  |  | Year Ended |
|  | December 27, 2018 |  |  | December 26, 2019 |  |  | December 31, 2020 |
Revenues |  | $ | 441,400 |  |  | $ | 444,800 |  |  | $ | 89,887 |
Operating income (loss) |  | $ | 154,300 |  |  | $ | 155,700 |  |  | $ | (59,671 | )
Net income (loss) |  | $ | 98,400 |  |  | $ | 98,800 |  |  | $ | (115,753 | )

|  | As of |  |  | As of |
|  | December 26, 2019 |  |  | December 31, 2020 |
Current assets |  | $ | 185,400 |  |  | $ | 142,566 |
Noncurrent assets |  | $ | 706,600 |  |  | $ | 685,643 |
Current liabilities |  | $ | 125,500 |  |  | $ | 46,872 |
Noncurrent liabilities |  | $ | 947,800 |  |  | $ | 1,072,207 |
Members' deficit |  | $ | (181,300 | ) |  | $ | (290,870 | )

9. | OTHER INVESTMENTS

Below is a summary of activity for each of the Company’s other investments for the periods indicated:

|  | DCIP |  |  | AC JV, LLC |  |  | DCDC |  |  | FE Concepts |  |  | Other |  |  | Total |
Balance at January 1, 2018 |  | $ | 106,215 |  |  | $ | 5,916 |  |  | $ | 3,598 |  |  | $ | 104 |  |  | $ | 4,212 |  |  | $ | 120,045 |
Cash contributions |  |  | 2,076 |  |  |  | — |  |  |  | — |  |  |  | 20,000 |  |  |  | — |  |  |  | 22,076 |
Equity in income (loss) |  |  | 22,899 |  |  |  | 1,270 |  |  |  | 1,313 |  |  |  | (82 | ) |  |  | — |  |  |  | 25,400 |
Equity in comprehensive loss |  |  | (139 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (139 | )
Cash distributions received |  |  | (5,799 | ) |  |  | (1,920 | ) |  |  | (219 | ) |  |  | — |  |  |  | — |  |  |  | (7,938 | )
Other (1) |  |  | — |  |  |  | — |  |  |  | (2,437 | ) |  |  | (104 | ) |  |  | (137 | ) |  |  | (2,678 | )
Balance at December 31, 2018 |  | $ | 125,252 |  |  | $ | 5,266 |  |  | $ | 2,255 |  |  | $ | 19,918.00 |  |  | $ | 4,075 |  |  | $ | 156,766 |
Equity in income (loss) |  |  | 23,281 |  |  |  | 3,276 |  |  |  | 1,120 |  |  |  | (399 | ) |  |  | — |  |  |  | 27,278 |
Equity in comprehensive loss |  |  | (141 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (141 | )
Cash distributions received |  |  | (23,696 | ) |  |  | (3,520 | ) |  |  | (206 | ) |  |  | — |  |  |  | — |  |  |  | (27,422 | )
Other (1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1,196 | ) |  |  | (1,196 | )
Balance at December 31, 2019 |  | $ | 124,696 |  |  | $ | 5,022 |  |  | $ | 3,169 |  |  | $ | 19,519 |  |  | $ | 2,879 |  |  | $ | 155,285 |
Equity in loss |  |  | (24,559 | ) |  |  | (1,277 | ) |  |  | (1,036 | ) |  |  | (1,246 | ) |  |  | — |  |  |  | (28,118 | )
Cash contributions |  |  | 50 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 50 |
Cash distributions received |  |  | (10,383 | ) |  |  | — |  |  |  | (878 | ) |  |  | — |  |  |  | — |  |  |  | (11,261 | )
Non-cash distribution received (2) |  |  | (89,804 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (89,804 | )
Other (3) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2,426 | ) |  |  | (2,426 | )
Balance at December 31, 2020 |  | $ | — |  |  | $ | 3,745 |  |  | $ | 1,255 |  |  | $ | 18,273 |  |  | $ | 453 |  |  | $ | 23,726 |

| (1) | Other activity for DCDC for the year ended December 31, 2018 consisted of returns of capital originally contributed by the Company. Other activity for the year ended December 31, 2019 consists primarily of and mark-to-market adjustment on an investment in marketable securities.

| (2) | Consists of projectors distributed to the Company from DCIP as discussed below.

| (3) | Consists primarily of the impairment of a cost method investment (see Note 11 for discussion of impairments recorded) and mark-to-market adjustment on an investment in marketable securities.

Digital Cinema Implementation Partners LLC (“DCIP”)

On February 12, 2007, the Company, AMC and Regal (the “Exhibitors”) entered into a joint venture known as

F-28

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, DCIP and its subsidiaries completed an initial financing transaction to enable the purchase, deployment and leasing of digital projection systems to the Exhibitors under equipment lease and installation agreements. On March 31, 2011, DCIP obtained incremental financing necessary to complete the deployment of digital projection systems. DCIP also entered into long-term Digital Cinema Deployment Agreements (“DCDAs”) with six major motion picture studios pursuant to which Kasima LLC, one of DCIP’s subsidiaries, receives a virtual print fee ("VPF") each time the studio books a film or certain other content on the leased digital projection systems. Other content distributors entered into similar DCDAs that provide for the payment of VPFs for bookings of the distributor's content on a leased digital projection system. The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years, or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs. Cost recoupment occurs when revenues attributable to the digital projection systems exceed the financing, deployment, administration and other costs associated with the purchase of the digital projection systems. DCIP expects cost recoupment to occur during late 2021. Pursuant to the operating agreement between the Exhibitors and DCIP, DCIP began to distribute excess cash to the Exhibitors upon the payoff of its outstanding debt, which occurred during the year ended December 31, 2019.

As of December 31, 2020, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. Prior to the distribution received during November 2020, as discussed below, the Company accounted for its investment in DCIP and its subsidiaries under the equity method of accounting.

Below is summary financial information for DCIP as of and for the years ended December 31, 2018, 2019 and 2020:

|  | Year ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Revenues |  | $ | 172,534 |  |  | $ | 171,531 |  |  | $ | 30,561 |
Operating income (loss) |  | $ | 102,236 |  |  | $ | 99,812 |  |  | $ | (105,691 | )
Net income (loss) |  | $ | 94,757 |  |  | $ | 95,820 |  |  | $ | (114,243 | )

|  | As of |
|  | December 31, 2019 |  |  | December 31, 2020 |
Current assets |  | $ | 51,382 |  |  | $ | 36,372 |
Noncurrent assets |  | $ | 581,547 |  |  | $ | 205 |
Current liabilities |  | $ | 70,515 |  |  | $ | 39,844 |
Noncurrent liabilities |  | $ | 190 |  |  | $ | 687 |
Members' equity (deficit) |  | $ | 562,224 |  |  | $ | (3,954 | )

Through October 31, 2020, the Company leased digital projection systems under a master equipment lease agreement with Kasima LLC (“Kasima”), which is an indirect subsidiary of DCIP and a related party to the Company. The Company amended the master equipment lease agreement (“MELA”) with Kasmia effective November 1, 2020, which resulted in the termination of the MELA and a lease termination fee to be paid by the Company on a monthly basis until a) cost recoupment is met or b) the DCDA agreements between DCIP and the major studios have been terminated. Upon termination of the MELA, DCIP distributed the digital projection equipment to the Company.

The Company accounted for the lease termination and projector distribution as follows:

| • | The Company wrote off the operating lease right of use assets and lease liabilities of $7,468 and $14,102, respectively, and recorded a gain of $6,634 in gain (loss) on sale of assets and other.

| • | The Company recorded a lease termination liability of $4,169 and a corresponding loss in gain (loss) on sale of assets and other. The remaining termination liability of $3,474 as of December 31, 2020 is reflected in accrued other current liabilities on the consolidated balance sheet.

| • | The Company recorded the fair value of the projectors received from DCIP of $102,719 as equipment, with a corresponding reduction in its investment in DCIP of $89,804 and a $12,915 non-cash distribution.

F-29

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

In accordance with ASC 323-10-35, since the non-cash distribution exceeded the book value of its investment in DCIP, the Company suspended equity method accounting. The Company will resume equity method accounting when the value of its investment in DCIP exceeds the sum of the excess noncash distribution noted above and any future excess cash distributions.

In addition to the activity presented in the other investments table above, the Company had the following transactions with DCIP during the years ended December 31, 2018, 2019 and 2020:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Equipment lease payments (1) |  | $ | 4,862 |  |  | $ | 4,399 |  |  | $ | 1,729 |
Warranty reimbursements from DCIP |  | $ | (10,800 | ) |  | $ | (11,800 | ) |  | $ | (6,997 | )
Management services fees |  | $ | 730 |  |  | $ | 596 |  |  | $ | 208 |

| (1) | Excludes lease termination payments of $695 made during the year ended December 31, 2020. See discussion of MELA termination above. |

AC JV, LLC

During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Company paid event fees to AC of $12,481, $15,376 and $3,740 for the years ended December 31, 2018, 2019 and 2020, respectively, which are included in film rentals and advertising costs on the consolidated statements of income. The Company accounts for its investment in AC under the equity method of accounting.

Digital Cinema Distribution Coalition

The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $927, $896 and $428 to DCDC during the years ended December 31, 2018, 2019 and 2020, respectively, related to content delivery services, which is included in film rentals and advertising costs on the consolidated statements of income. The Company accounts for its investment in DCDC under the equity method of accounting.

FE Concepts, LLC

During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. In December of 2019, FE Concepts opened a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting. The Company has a theatre services agreement with FE Concepts under which it receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded $64 and $34 of related service fees during the years ended December 31, 2019 and 2020, respectively.

F-30

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Additional Considerations

Each of the investments above have been adversely impacted by the COVID-19 pandemic (see Note 3) due to the temporary closure of theatres across the U.S. The Company does not believe that any resulting decline in value of the underlying investments is other than temporary as the Company and other industry participants, who also have equity ownership interests in certain of the above investments, have reopened some theatres and will continue to reopen theatres as local government restrictions allow. The Company expects the industry to recover gradually over time. The Company performed a qualitative impairment analysis for its investments in AC and DCDC during the fourth quarter of 2020. Based on the analysis performed, no impairment was recorded for the year ended December 31, 2020.

10. | GOODWILL AND INTANGIBLE ASSETS, NET

The Company’s goodwill was as follows:

|  | U.S. Operating Segment |  |  | International Operating Segment |  |  | Total |
Balance at December 31, 2018 (1) |  | $ | 1,174,041 |  |  | $ | 102,283 |  |  | $ | 1,276,324 |
Acquisition of theatres (2) |  |  | 8,812 |  |  |  | 868 |  |  |  | 9,680 |
Foreign currency translation adjustments |  |  | — |  |  |  | (2,633 | ) |  |  | (2,633 | )
Balance at December 31, 2019 (1) |  | $ | 1,182,853 |  |  | $ | 100,518 |  |  | $ | 1,283,371 |
Impairment (3) |  |  | — |  |  |  | (16,128 | ) |  |  | (16,128 | )
Foreign currency translation adjustments |  |  | — |  |  |  | (13,403 | ) |  |  | (13,403 | )
Balance at December 31, 2020 (4) |  | $ | 1,182,853 |  |  | $ | 70,987 |  |  | $ | 1,253,840 |

(1) | Balances are presented net of historical accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

(2) | Amounts represent acquisition of two theatres in the U.S. and final purchase price adjustment for theatres acquired in Brazil during the year ended December 31, 2018.

(3) | See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020.

(4) | Balances are presented net of historical accumulated impairment losses of $214,031 for the U.S. operating segment and $43,750 for the international operating segment

As of December 31, intangible assets, net consisted of the following:

|  | Balance at January 1, 2019 |  |  | Additions (1) |  |  | Impact of ASC Topic 842 (3) |  |  | Amortization |  |  | Other |  |  | Balance at December 31, 2019 |
Intangible assets with finite lives: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross carrying amount |  | $ | 105,256 |  |  | $ | (143 | ) |  | $ | (18,024 | ) |  | $ | — |  |  | $ | (2,136 | ) |  | $ | 84,953 |
Accumulated amortization |  |  | (74,603 | ) |  |  | — |  |  |  | 13,597 |  |  |  | (4,994 | ) |  |  | 2,130 |  |  |  | (63,870 | )
Total net intangible assets with finite lives |  | $ | 30,653 |  |  | $ | (143 | ) |  | $ | (4,427 | ) |  | $ | (4,994 | ) |  | $ | (6 | ) |  | $ | 21,083 |
Intangible assets with indefinite lives: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tradename and other |  |  | 300,257 |  |  |  | 492 |  |  |  | — |  |  |  | — |  |  |  | (63 | ) |  |  | 300,686 |
Total intangible assets — net |  | $ | 330,910 |  |  | $ | 349 |  |  | $ | (4,427 | ) |  | $ | (4,994 | ) |  | $ | (69 | ) |  | $ | 321,769 |

F-31

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

|  | Balance at January 1, 2020 |  |  | Amortization |  |  | Other (2) |  |  | Balance at December 31, 2020 |
Intangible assets with finite lives: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross carrying amount |  | $ | 84,953 |  |  | $ | — |  |  | $ | (2,521 | ) |  | $ | 82,432 |
Accumulated amortization |  |  | (63,870 | ) |  |  | (4,746 | ) |  |  | 200 |  |  |  | (68,416 | )
Total net intangible assets with finite lives |  | $ | 21,083 |  |  | $ | (4,746 | ) |  | $ | (2,321 | ) |  | $ | 14,016 |
Intangible assets with indefinite lives: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tradename and other |  |  | 300,686 |  |  |  | — |  |  |  | (507 | ) |  |  | 300,179 |
Total intangible assets — net |  | $ | 321,769 |  |  | $ | (4,746 | ) |  | $ | (2,828 | ) |  | $ | 314,195 |

(1) | Amount represents intangible assets recorded as a result of two theatres acquired in the U.S. and final purchase price adjustment for theatres acquired in Brazil during the year ended December 31, 2018.

(2) | Includes the write-off of fully amortized intangible assets, foreign currency translation adjustments and impairment recorded related to a previously acquired theatre leasehold interest in Brazil. See Note 11 for discussion of impairment evaluations performed during the year ended December 31, 2020.

(3) | Amount represents intangible assets reclassified to operating lease right of use assets and finance lease assets upon the adoption of ASC 842 effective January 1, 2019.

Estimated aggregate future amortization expense for intangible assets is as follows:

For the year ended December 31, 2021 |  | $ | 2,686 |
For the year ended December 31, 2022 |  |  | 2,553 |
For the year ended December 31, 2023 |  |  | 2,460 |
For the year ended December 31, 2024 |  |  | 2,460 |
For the year ended December 31, 2025 |  |  | 2,342 |
Thereafter |  |  | 1,515 |
Total |  | $ | 14,016 |

11. | IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS

The Company reviews for impairment indicators related to its long-lived assets on a quarterly basis and goodwill on an annual basis or whenever events or changes in circumstances indicate the carrying amount of those assets may not be fully recoverable. Due to the temporary closure of the Company’s theatres effective March 18, 2020 as a result of the COVID-19 pandemic (see Note 3), the Company performed long-lived asset impairment evaluations during each quarter during the year ended December 31, 2020. The following table is a summary of the evaluations performed for each quarter by asset classification.

F-32

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

| Impairment |  | Asset |  | Valuation |  | Valuation
| Test |  | Category |  | Approach |  | Multiple
First Quarter | Quantitative |  | Goodwill |  | Market (1) |  | 8 times
|  |  | Tradename Intangible Assets |  | Income |  | N/A
|  |  | Other Long-lived Assets |  | Market |  | 6 times
Second Quarter | Qualitative |  | Goodwill |  | N/A |  | N/A
|  |  | Tradename Intangible Assets |  | N/A |  | N/A
|  |  | Other Long-lived Assets |  | N/A |  | N/A
Third Quarter | Quantitative |  | Goodwill |  | Market (1) |  | 2.9 to 7 times
|  |  | Tradename Intangible Assets |  | Income |  | N/A
|  |  | Other Long-lived Assets |  | Market |  | 3.2 to 6 times
Fourth Quarter | Quantitative |  | Goodwill |  | Market (1) |  | 3.1 to 7 times
|  |  | Tradename Intangible Assets |  | Income |  | N/A
|  |  | Other Long-lived Assets |  | Market |  | 3.1 to 6 times

| (1) | The Company also used the income approach to test goodwill for impairment for the respective period.

See Note 1 for a discussion of the Company’s impairment policy and a description of qualitative and quantitative impairment assessments.

The Company’s theatre asset, goodwill, intangible asset and investment impairment charges were as follows for the periods presented:

|  | Year Ended |
|  | December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
U.S. Segment |  |  |  |  |  |  |  |  |  |  |  |
Theatre properties |  | $ | 18,597 |  |  | $ | 36,005 |  |  | $ | 12,398 |
Theatre operating lease right-of-use assets |  |  | — |  |  |  | 10,457 |  |  |  | 13,216 |
Investment in NCM (1) |  |  | — |  |  |  | — |  |  |  | 92,655 |
Cost method investment |  |  | — |  |  |  | — |  |  |  | 2,500 |
U.S. total |  |  | 18,597 |  |  |  | 46,462 |  |  |  | 120,769 |
International segment |  |  |  |  |  |  |  |  |  |  |  |
Theatre properties |  |  | 13,775 |  |  |  | 8,821 |  |  |  | 9,951 |
Theatre operating lease right-of-use assets |  |  | — |  |  |  | 1,718 |  |  |  | 5,025 |
Goodwill |  |  | — |  |  |  | — |  |  |  | 16,128 |
Intangible assets |  |  | — |  |  |  | — |  |  |  | 833 |
International total |  |  | 13,775 |  |  |  | 10,539 |  |  |  | 31,937 |
Total impairment |  | $ | 32,372 |  |  | $ | 57,001 |  |  | $ | 152,706 |

| (1) | See Note 8 for discussion on NCM impairment.

For the years ended December 31, 2018 and 2019, the long-lived asset impairment charges recorded during each of the periods presented were for certain new concept theatres being developed and tested by the Company and other theatres that were individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. For the year ended December 31, 2020, long-lived asset and goodwill impairment charges were primarily due to the prolonged impact of the temporary closure of theatres as a result of the COVID-19 pandemic, as discussed at Note 3, and the expected recovery period.

F-33

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

12. | ACCRUED OTHER CURRENT LIABILITIES

Accrued other current liabilities consisted of the following as of the periods presented:

|  | December 31, |
|  | 2019 |  |  | 2020 |
Gift card liability (1) |  | $ | 48,481 |  |  | $ | 43,448 |
SuperSaver liability (1) |  |  | 40,778 |  |  |  | 38,882 |
Accrued lease payable (2) |  |  | — |  |  |  | 48,366 |
Other |  |  | 86,447 |  |  |  | 86,769 |
Total |  | $ | 175,706 |  |  | $ | 217,465 |

| (1) | See discussion of revenue recognition at Note 5. |

| (2) | See discussion of lease deferrals at Note 4. |

13. | LONG-TERM DEBT

As of December 31, long-term debt consisted of the following:

|  | December 31, |
|  | 2019 |  |  | 2020 |
Cinemark USA, Inc. term loan due 2025 |  | $ | 646,327 |  |  | $ | 639,731 |
Cinemark USA, Inc. 5.125% senior notes due 2022 |  |  | 400,000 |  |  |  | 400,000 |
Cinemark USA, Inc. 4.875% senior notes due 2023 |  |  | 755,000 |  |  |  | 755,000 |
Cinemark USA, Inc. 8.750% senior secured notes due 2025 |  |  | — |  |  |  | 250,000 |
Cinemark Holdings, Inc. 4.500% convertible senior notes due 2025 |  |  | — |  |  |  | 460,000 |
Other |  |  | — |  |  |  | 23,169 |
Total long-term debt |  |  | 1,801,327 |  |  |  | 2,527,900 |
Less current portion |  |  | 6,595 |  |  |  | 18,056 |
Less: Debt discounts and debt issuance costs, net of accumulated amortization |  |  | 23,390 |  |  |  | 132,682 |
Long-term debt, less current portion, net of debt discounts and unamortized debt issuance costs |  | $ | 1,771,342 |  |  | $ | 2,377,162 |

Senior Secured Credit Facility

Cinemark USA, Inc. has a senior secured credit facility that includes a $700,000 term loan and a $100,000 revolving credit line (the “Credit Agreement”).

Effective March 29, 2018, Cinemark USA, Inc. amended its Credit Agreement to extend the maturity of the term loan to March 2025, reduce the term loan interest rate by 0.25% and reduce real property mortgage requirements follows. As a result of the amendment, the Company recorded $1,484 as a loss on debt amended on the consolidated income statement and $4,962 as debt issue costs on the consolidated statement of cash flows for the year ended December 31, 2018. during 2017 and 2019:

Under the amended Credit Agreement, quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025.

Subsequent to the March 29, 2018 amendment noted in the table above, interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1)

F-34

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement.

At December 31, 2020, there was $639,731 outstanding under the term loan and no borrowings outstanding under the $100,000 revolving credit line. The average interest rate on outstanding term loan borrowings under the Credit Agreement at December 31, 2020 was approximately 3.4% per annum, after giving effect to the interest rate swaps discussed below.

Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to keep a consolidated net senior secured leverage ratio, as defined in the Credit Agreement, not to exceed 4.25 to 1. See discussion below regarding recent covenant waivers.

The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts (collectively the “Applicable Amount”). As of December 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $2,700,000 to its parent company and sole stockholder, Cinemark Holdings, Inc.

On April 17, 2020, in conjunction with the issuance of the 8.750% Secured Notes discussed below, the Company obtained a waiver of the leverage covenant, which applies when amounts are outstanding under the revolving line of credit, from the majority of revolving lenders under the Credit Agreement for the fiscal quarters ending September 30, 2020 and December 31, 2020. The waiver is subject to certain liquidity thresholds, restrictions on investments and the use of the Applicable Amount.

On August 21, 2020, in conjunction with the issuance of the 4.50% Convertible Senior Notes discussed below, the Company further amended the waiver of the leverage covenant to extend through the fiscal quarter ending September 30, 2021. The amendment also i) modifies the maintenance covenant calculation beginning with the calculation for the trailing twelve-month period ended December 31, 2021, ii) for purposes of testing the consolidated net senior secured leverage ratio for the fiscal quarters ending on December 31, 2021, March 31, 2022 and June 30, 2022, permits the Company to substitute Consolidated EBITDA for the first three fiscal quarters of 2019 in lieu of Consolidated EBITDA for the corresponding fiscal quarters of 2021, (iii) modifies the restrictions imposed by the covenant waiver, and (iv) makes such other changes to permit the issuance of the 4.50% Convertible Senior Notes discussed below

F-35

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

4.875% Senior Notes

On May 24, 2013, Cinemark USA, Inc. issued $530,000 aggregate principal amount of 4.875% senior notes

due 2023, at par value, (the “4.875% Senior Notes”). Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023.

On March 21, 2016, Cinemark USA, Inc. issued an additional $225,000 aggregate principal amount of the 4.875% Senior Notes, at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as Cinemark USA, Inc.’s existing 4.875% Senior Notes. The aggregate principal amount of $755,000 of 4.875% Senior Notes mature on June 1, 2023.

The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes.

The indenture governing the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $2,800,000 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture governing the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 4.875% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 4.875% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 4.875% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2.0 to 1.0 and the actual ratio as of December 31, 2020 was below zero.

Cinemark USA, Inc. may redeem the 4.875% Senior Notes in whole or in part at redemption prices specified in the indenture.

5.125% Senior Notes

On December 18, 2012, Cinemark USA, Inc. issued $400,000 aggregate principal amount of 5.125% senior notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022.

The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the

F-36

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes.

The indenture governing the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $2,800,000 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture governing the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 5.125% Senior Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.125% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.125% Senior Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2.0 to 1.0 and the actual ratio as of December 31, 2020 was approximately below zero.

Cinemark USA, Inc. may redeem the 5.125% Senior Notes in whole or in part at redemption prices specified in the indenture.

8.750% Secured Notes

On April 20, 2020, Cinemark USA, Inc. issued $250,000 aggregate principal amount of 8.750% senior secured notes due 2025 (the “8.750% Secured Notes”). The 8.750% Secured Notes will mature on May 1, 2025; provided, however, that if (i) on September 13, 2022, the aggregate outstanding principal amount of the 5.125% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50,000, the 8.750% Secured Notes will mature on September 14, 2022 and (ii) on February 27, 2023, the aggregate outstanding principal amount of the 4.875% Senior Notes that shall not have been purchased, repurchased, redeemed, defeased or otherwise acquired, retired, cancelled or discharged exceeds $50,000, the 8.750% Secured Notes will mature on February 28, 2023. Interest on the 8.750% Secured Notes will be payable on May 1 and November 1 of each year, beginning on November 1, 2020.

The 8.750% Secured Notes are fully and unconditionally guaranteed on a joint and several senior basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or in any other manner become liable with respect to any of Cinemark USA, Inc.’s or its guarantors’ other debt. If Cinemark USA, Inc. cannot make payments on the 8.750% Secured Notes when they are due, Cinemark USA, Inc.’s guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.750% Secured Notes.

The 8.750% Secured Notes and the guarantees are Cinemark USA, Inc.’s and its guarantors’ senior obligations and are:

| • | rank effectively senior in right of payment to Cinemark USA, Inc.’s and its guarantors’ existing and future debt that is not secured by the collateral as described within the indentures governing the 8.750% Secured Notes (“Collateral”), including all obligations under the Credit Agreement, and unsecured obligations, including the existing senior notes, in each case to the extent of the value of the collateral;

| • | rank effectively junior to Cinemark USA, Inc.’s and its guarantors’ existing and future debt secured by assets that are not part of the Collateral to the extent of the value of the collateral securing such debt, including all obligations under the Credit Agreement;

| • | otherwise rank equally in right of payment to Cinemark USA, Inc.’s and its guarantors’ existing and future senior debt, including debt under the Credit Agreement and the existing senior notes;

| • | rank senior in right of payment to Cinemark USA, Inc.’s and its guarantors’ future subordinated debt; and

F-37

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

| • | be structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s non-guarantor subsidiaries.

The indenture governing the 8.750% Secured Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2020, Cinemark USA, Inc. could have distributed up to approximately $3,100,000 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture governing the 8.750% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. Upon a change of control, as defined in the indenture governing the 8.750% Secured Notes, Cinemark USA, Inc. would be required to make an offer to repurchase the 8.750% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.750% Secured Notes allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2.0 to 1.0 and the actual ratio as of December 31, 2020 was below zero.

4.50% Convertible Senior Notes

On August 21, 2020, Cinemark Holdings, Inc. issued $460,000 aggregate principal amount of 4.500% convertible senior notes due 2025 (the “4.50% Convertible Senior Notes”). The 4.500% Convertible Senior Notes will mature on August 15, 2025, unless earlier repurchased or converted in accordance with the indenture. Interest on the 4.500% Convertible Senior Notes is payable on February 15 and August 15 of each year, beginning on February 15, 2021.

Holders of the 4.50% Convertible Senior Notes may convert their 4.50% Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2025 only under the following circumstances: (1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; (2) if the Company distributes to all or substantially all stockholders (i) rights options or warrants entitling them to purchase shares at a discount to the recent average trading price of the Company’s common stock (including due to a stockholder rights plan) or (ii) the Company’s assets or securities or rights, options or warrants to purchase the same with a per share value exceeding 10% of the trading price of the Company’s stock, (3) upon the occurrence of specified corporate events as described further in the indenture, or (4) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price (initially 14.35 per share), on each applicable trading day. Beginning May 15, 2025, holders may convert their 4.500% Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion of the 4.500% Convertible Senior Notes, the Company will pay or deliver cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election.

The initial conversion rate is 69.6767 shares of the Company’s common stock per $1,000 principal amount of the 4.50% Convertible Senior Notes. The conversion rate is subject to adjustment upon the occurrence of certain events. If a make-whole fundamental change as defined in the indenture governing the 4.50% Convertible Senior Notes occurs prior to the maturity date, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its 4.50% Convertible Senior Notes in connection with such make-whole fundamental change.

The 4.500% Convertible Senior Notes are effectively subordinated to any of the Company’s, or its subsidiaries’, existing and future secured debt to the extent of the value of the assets securing such indebtedness, including obligations under the Credit Agreement. The 4.500% Convertible Senior Notes are structurally subordinated to all existing and future debt and other liabilities of our subsidiaries, including trade payables and

F-38

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

including Cinemark USA’s 5.125% Senior Notes, 4.875% Senior Notes and the 8.750% Secured Notes, or, collectively, Cinemark USA’s senior notes (but excluding all obligations under the Credit Agreement which are guaranteed by the Company). The 4.500% Convertible Senior Notes rank equally in right of payment with all of the Company’s existing and future unsubordinated debt, including all obligations under the Credit Agreement, which such Credit Agreement is guaranteed by the Company, and senior in right of payment to any future debt that is expressly subordinated in right of payment to the 4.500% Convertible Senior Notes. The 4.500% Convertible Notes are not guaranteed by any of Cinemark Holdings, Inc.’s subsidiaries.

In accordance with accounting guidance on debt and equity financing, the Company bifurcated the gross proceeds from the issuance of 4.500% Convertible Senior Notes and recorded a portion as long-term debt and a portion in equity. The long-term debt value was based on the fair value of the debt, determined as the present value of principal and interest payments assuming a market interest rate for similar debt that excluded a conversion feature. The difference between the face value of the 4.500% Convertible Senior Notes and the fair value is referred to as the debt discount, and represents the amount allocated to equity. The debt discount is being amortized to interest expense at an effective interest rate of 10.00% over the contractual terms of the notes.

Concurrently with the issuance of the 4.500% Convertible Senior Notes, the Company entered into privately negotiated convertible note hedge transactions (the “Hedge Transactions”) with one or more of the initial purchasers of the 4.500% Convertible Senior Notes or their respective affiliates (the “Option Counterparties”). The Hedge Transactions cover the number of shares of the Company’s common stock that will initially underlie the aggregate amount of the 4.50% Convertible Senior Notes, subject to anti-dilution adjustments substantially similar to those applicable to the 4.50% Convertible Senior Notes. The Hedge Transactions are generally expected to reduce potential dilution to the Company’s common stock upon any conversion of the 4.500% Convertible Senior Notes and/or offset any cash payments the Company may be required to make in excess of the principal amount of converted 4.50% Convertible Senior Notes, as the case may be. Concurrently with entering into the Hedge Transactions, the Company also entered into separate privately negotiated warrant transactions with Option Counterparties whereby it sold to Option Counterparties warrants to purchase (subject to the net share settlement provisions set forth therein) up to the same number of shares of the Company’s common stock, subject to customary anti-dilution adjustments (the “Warrant Transactions”). The warrants could separately have a dilutive effect to the extent that the market value per share of the Company’s common stock exceeds the strike price of the warrants on the applicable expiration dates unless, subject to the terms of the warrants, the Company elects to cash settle the warrants. The exercise price of the warrants is initially $22.08 and is subject to certain adjustments under the terms of the warrants. The Company received $89,424 in cash proceeds from the Warrant Transactions, which were used along with proceeds from the 4.50% Convertible Senior Notes, to pay approximately $142,094 to enter into the Hedge Transactions. The tax impact of the conversion option and the Hedge Transactions and the Warrant Transactions amounted to $10,915 and was recorded in additional paid-in-capital.

Together, the Hedge Transactions and the Warrants are intended to reduce the potential dilution from the conversion of the 4.500% Convertible Senior Notes. The Hedge Transactions and Warrants are recorded in equity and are not accounted for as derivatives, in accordance with applicable accounting guidance.

Additional Borrowings of International Subsidiaries

During the year ended December 31, 2020, certain of the Company’s international subsidiaries borrowed an aggregate of USD $22,322 under various local loans. Below is a summary of these loans:

|  | Loan Amounts |  |  |  |  |  |  |  |  |
Loan Description(s) |  | (in USD) |  |  | Interest Rates |  |  | Applicable Covenants |  | Maturity
Colombia (3 loans) |  | $ | 4,437 |  |  | 3.25% to 5.85% plus variable |  |  | Negative and ratio covenants |  | May 2023 September 2025
Peru loan |  | $ | 2,913 |  |  | 1.5% |  |  | Negative covenants |  | September 2023
Brazil (3 loans) |  | $ | 8,986 |  |  | 1.59% to 8.08% |  |  | Negative covenants |  | November 2021 October 2023
Chile loan |  | $ | 5,986 |  |  | 0.29% |  |  | Negative covenants |  | November 2023

F-39

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Fair Value of Long Term Debt

The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt was $1,801,327 and $2,527,900 as of December 31, 2019 and 2020. The fair value of the Company’s long term debt was $$1,826,503 and $2,652,635 as of December 31, 2019 and 2020, respectively.

Covenant Compliance and Debt Maturity

As of December 31, 2020, the Company believes it was in full financial compliance with all agreements, including related covenants, governing its outstanding debt.

The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2020 matures as follows:

2021 |  | $ | 18,056 |
2022 |  |  | 413,068 |
2023 |  |  | 766,347 |
2024 |  |  | 6,886 |
2025 |  |  | 1,323,543 |
Thereafter |  |  | — |
Total |  | $ | 2,527,900 |

Interest Rate Swap Agreements

Effective March 31, 2020, the Company amended and extended its three then existing interest rate swap agreements and entered into a fourth interest rate swap agreement, all of which are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualify for cash flow hedge accounting. Upon amending the interest rate swap agreements effective March 31,2020, the Company determined that the interest payments hedged with the agreements are still probable to occur, therefore the loss that accumulated on the swaps prior to the amendments of $29,359 is being amortized to interest expense through December 31, 2022, the original maturity dates of the swaps. Approximately $3,371 was recorded in amortization of accumulated losses for amended swaps in the condensed consolidated income statement for the year ended December 31, 2020.

The fair values of the interest rate swaps are recorded on the Company’s consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 2 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35.

Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2020:

|  |  |  |  |  |  |  |  |  |  |  |  |  | Estimated |
|  |  |  |  |  |  |  |  |  |  |  |  |  | Fair Value at |
Notional |  |  |  |  |  |  |  |  |  |  |  |  | December 31, |
Amount |  |  | Effective Date |  | Pay Rate |  |  | Receive Rate |  | Expiration Date |  | 2020 (1) |
$ | 137,500 |  |  | December 31, 2018 |  | 2.12% |  |  | 1-Month LIBOR |  | December 31, 2024 |  | $ | 9,905 |
$ | 175,000 |  |  | December 31, 2018 |  | 2.12% |  |  | 1-Month LIBOR |  | December 31, 2024 |  |  | 12,721 |
$ | 137,500 |  |  | December 31, 2018 |  | 2.19% |  |  | 1-Month LIBOR |  | December 31, 2024 |  |  | 10,416 |
$ | 150,000 |  |  | March 31, 2020 |  | 0.57% |  |  | 1-Month LIBOR |  | March 31, 2022 |  |  | 805 |
|  |  |  |  |  |  |  |  |  |  |  | Total |  | $ | 33,847 |

F-40

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

(1) | Approximately $9,516 is included in accrued other current liabilities and $24,331 is included in other long-term liabilities on the consolidated balance sheet as of December 31, 2020.

| 14. | FAIR VALUE MEASUREMENTS

The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2020:

|  | As of |  | Carrying |  |  | Fair Value |
Description |  | December 31, |  | Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Interest rate swap liabilities |  | 2019 |  | $ | 15,995 |  |  | $ | — |  |  | $ | 15,995 |  |  | $ | — |
Interest rate swap liabilities |  | 2020 |  | $ | 33,847 |  |  | $ | — |  |  | $ | 33,847 |  |  | $ | — |

The Company also uses the market and income approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 1 and Note 11). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 13). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2018, 2019 and 2020.

15. | FOREIGN CURRENCY TRANSLATION

The accumulated other comprehensive loss account in stockholders’ equity of $340,112 and $398,653 at December 31, 2019 and 2020, respectively, includes the cumulative foreign currency losses of $328,053 and $375,539, respectively, from translating the financial statements of the Company’s international subsidiaries and the change in fair values of the Company’s interest rate swap agreements designated as hedges.

As of December 31, 2020, all foreign countries where the Company has operations, other than Argentina, are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018.

F-41

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries, whose functional currency is other than the US dollar, for the periods presented.

|  |  |  |  |  |  |  |  |  |  |  | Other Comprehensive |
|  |  |  |  |  |  |  |  |  |  |  | Income (Loss) |
|  | Exchange Rate as of December 31, |  |  | For the Year Ended December 31, |
Country |  | 2018 |  | 2019 |  | 2020 |  |  | 2018 |  |  | 2019 (1) |  |  | 2020 (1) |
Brazil |  |  | 3.88 |  |  | 4.02 |  |  | 5.20 |  |  | $ | (34,086 | ) |  | $ | (8,140 | ) |  | $ | (42,698 | )
Argentina (1) |  |  | 37.68 |  |  | 59.89 |  |  | 84.12 |  |  |  | (14,357 | ) |  |  | — |  |  |  | — |
Colombia |  |  | 3,249.75 |  |  | 3,277.14 |  |  | 3,432.50 |  |  |  | (1,795 | ) |  |  | (362 | ) |  |  | (2,183 | )
Chile |  |  | 694.74 |  |  | 736.86 |  |  | 714.14 |  |  |  | (8,924 | ) |  |  | (5,158 | ) |  |  | 1,228 |
Peru |  |  | 3.39 |  |  | 3.37 |  |  | 3.65 |  |  |  | (2,136 | ) |  |  | 257 |  |  |  | (3,403 | )
All other |  |  |  |  |  |  |  |  |  |  |  |  | (955 | ) |  |  | 650 |  |  |  | (536 | )
|  |  |  |  |  |  |  |  |  |  |  | $ | (62,253 | ) |  | $ | (12,753 | ) |  | $ | (47,592 | )

(1) | For Argentina, represents the cumulative comprehensive loss recorded through June 30, 2018. The impact of translating Argentina financial results to U.S. dollars, subsequent to June 30, 2018, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statements of income. A loss of $3,707 and gain of $1,243 were recorded for the years ended December 31, 2019 and 2020, respectively. |

During the year ended December 31, 2018, the Company reclassified $518 of cumulative foreign currency translation adjustments, related to the settlement of an intercompany note between a domestic and an international subsidiary, from accumulated other comprehensive loss to foreign currency exchange gain (loss) on the consolidated statement of income.

16. | NONCONTROLLING INTERESTS IN SUBSIDIARIES

Noncontrolling interests in subsidiaries of the Company were as follows at December 31:

|  | December 31, |
|  | 2019 |  |  | 2020 |
Cinemark Partners II — 24.6% interest (in one theatre) |  | $ | 7,953 |  |  | $ | 7,706 |
Laredo Theatres – 25% interest (in two theatres) |  |  | 2,139 |  |  |  | 1,681 |
Greeley Ltd. — 49% interest (in one theatre) |  |  | 1,908 |  |  |  | 1,101 |
Other |  |  | 508 |  |  |  | 508 |
Total |  | $ | 12,508 |  |  | $ | 10,996 |

There were no changes in the Company’s ownership interest in its subsidiaries during the years ended December 31, 2018, 2019 and 2020.

17. | CAPITAL STOCK

Common Stock — Common stockholders are entitled to vote on all matters submitted to a vote of the Company’s stockholders. Subject to the rights of holders of any then outstanding shares of the Company’s preferred stock, the Company’s common stockholders are entitled to dividends declared by the board of directors. The shares of the Company’s common stock are not subject to any redemption provisions. The Company has no issued and outstanding shares of preferred stock.

The Company’s ability to pay dividends is effectively limited by its status as a holding company and the terms of its subsidiary’s indentures and senior secured credit facility, which also significantly restricts the ability of certain of the Company’s subsidiaries to pay dividends directly or indirectly to the Company. See Note 13 for discussion of restrictions contained within the debt agreements of the Company’s subsidiaries.

F-42

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Treasury Stock — Treasury stock represents shares of common stock repurchased by the Company and not yet retired. The Company has applied the cost method in recording its treasury shares.

Below is a summary of the Company’s treasury stock activity for the years ended December 31, 2018, 2019 and 2020.

| Number of Treasury Shares |  |  | Cost |
Balance at January 1, 2018 |  | 4,525,870 |  |  | $ | 76,354 |
Restricted stock withholdings (1) |  | 75,801 |  |  |  | 2,905 |
Restricted stock forfeitures (2) |  | 24,520 |  |  |  | — |
Balance at December 31, 2018 |  | 4,626,191 |  |  | $ | 79,259 |
Restricted stock withholdings (1) |  | 59,060 |  |  |  | 2,308 |
Restricted stock forfeitures (2) |  | 26,608 |  |  |  | — |
Balance at December 31, 2019 |  | 4,711,859 |  |  | $ | 81,567 |
Restricted stock withholdings (1) |  | 264,522 |  |  |  | 5,437 |
Restricted stock forfeitures (2) |  | 74,600 |  |  |  | — |
Balance at December 31, 2020 |  | 5,050,981 |  |  | $ | 87,004 |

(1) | The Company withheld restricted shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units. The Company determined the number of shares to be withheld based upon market values that ranged from $8.03 to $44.44 per share.

(2) | The Company repurchased forfeited restricted shares at a cost of $0.001 per share in accordance with the 2017 Omnibus Plan.

As of December 31, 2020, the Company had no plans to retire any shares of its treasury stock.

Restricted Stock — Below is a summary of restricted stock activity for the years ended December 31, 2018, 2019 and 2020:

|  | Year Ended |  |  | Year Ended |  |  | Year Ended |
|  | December 31, 2018 |  |  | December 31, 2019 |  |  | December 31, 2020 |
|  | Shares of Restricted Stock |  |  | Weighted Average Grant Date Fair Value |  |  | Shares of Restricted Stock |  |  | Weighted Average Grant Date Fair Value |  |  | Shares of Restricted Stock |  |  | Weighted Average Grant Date Fair Value |
Outstanding at January 1 |  |  | 650,581 |  |  | $ | 35.81 |  |  |  | 704,353 |  |  | $ | 38.68 |  |  |  | 783,823 |  |  | $ | 37.53 |
Granted |  |  | 328,734 |  |  | $ | 38.72 |  |  |  | 315,899 |  |  | $ | 37.34 |  |  |  | 1,555,361 |  |  | $ | 17.68 |
Vested |  |  | (250,442 | ) |  | $ | 31.27 |  |  |  | (209,821 | ) |  | $ | 41.10 |  |  |  | (832,609 | ) |  | $ | 29.30 |
Forfeited |  |  | (24,520 | ) |  | $ | 38.62 |  |  |  | (26,608 | ) |  | $ | 37.69 |  |  |  | (74,600 | ) |  | $ | 30.72 |
Outstanding at December 31 |  |  | 704,353 |  |  | $ | 38.68 |  |  |  | 783,823 |  |  | $ | 37.53 |  |  |  | 1,431,975 |  |  | $ | 21.11 |

During the year ended December 31, 2020, the Company granted 1,555,361 shares of restricted stock to directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of the Company’s common stock on the dates of grant, which ranged from $8.39 to $32.12 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. Restricted stock granted to directors vests over a one-year period. Restricted stock grants of 300,891 shares to employees vested immediately on the date of grant, while the remaining grants to employees vest over periods ranging from one year to four years based on continued service. The recipients of restricted stock are entitled to receive dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period.

Impact of 2020 Restructuring Plan - As part of the Company’s employee-related restructuring actions discussed in Note 3, the vesting period for certain share based awards was accelerated on a pro-rata basis based upon the grant dates and each employee’s separation date. The Company considers the accelerated vest of these awards to be a modification under ASC Topic 718 Stock Compensation. Based on the terms of the severance agreements, the

F-43

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Company estimated the number of awards expected to vest at each employee’s expected separation date and revalued such awards based on the modification date, or the date on which employees were notified of the 2020 Restructuring Plan. The modification date fair value per share was $15.95. The Company recorded incremental compensation expense of approximately $521 related to these modifications, which is reflected in restructuring costs on the Company’s condensed consolidated income statement.

During December 2020, in recognition of its employees’ dedication and hard work during the year ended December 31, 2020 amid the prolonged impacts of the COVID-19 pandemic, the Company accelerated the vest of certain restricted stock and restricted stock unit awards that would have otherwise vested during 2021. A total of 191,983 shares of restricted stock and 87,911 restricted stock units vested on December 15, 2020.

Below is a summary of restricted stock award activity recorded for the periods indicated.

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Compensation expense recognized during the period |  | $ | 9,655 |  |  | $ | 10,185 |  |  | $ | 15,473 |
Fair value of restricted shares that vested during the period |  | $ | 9,501 |  |  | $ | 8,024 |  |  | $ | 16,870 |
Income tax deduction upon vesting of restricted stock awards |  | $ | 1,744 |  |  | $ | 1,516 |  |  | $ | 5,620 |

As of December 31, 2020, the remaining unrecognized compensation expense related to these restricted stock awards was approximately $20,183. The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

Restricted Stock Units — During the years ended December 31, 2018, 2019 and 2020, the Company granted restricted stock units representing 228,194, 306,651 and 436,681 hypothetical shares of common stock, respectively, to employees. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement). The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. As an example, if the Company achieves an IRR equal to 9.0% for the 2017 grant, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR. All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of common stock if the participant continues to provide services through the fourth anniversary of the grant date.

At the time of each of the restricted stock unit grants, the Company assumes the IRR level to be reached for the defined measurement period will be the target IRR level in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the target IRR level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period. The Company assumed forfeiture rates ranging from 0% to 5% for the restricted stock unit awards granted during 2018, 2019 and 2020. Restricted stock unit award participants are eligible to receive dividend equivalent payments if and at the time the restricted stock unit awards vest.

F-44

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2018, 2019 and 2020 at each of the three levels of financial performance (excluding forfeitures):

|  | Granted During the Year Ended December 31, |
|  | 2018 |  |  |  |  |  |  | 2019 |  |  | 2020 |
|  | Number of |  |  | Value at |  |  | Number of |  |  | Value at |  |  | Number of |  |  | Value at |
|  | Units |  |  | Grant(1) |  |  | Units |  |  | Grant(1) |  |  | Units |  |  | Grant(1) |
at threshold IRR |  |  | 76,065 |  |  | $ | 2,967 |  |  |  | 136,285 |  |  | $ | 5,011 |  |  |  | 190,707 |  |  | $ | 6,125 |
at target IRR |  |  | 152,129 |  |  | $ | 5,938 |  |  |  | 204,427 |  |  | $ | 7,517 |  |  |  | 286,060 |  |  | $ | 9,188 |
at maximum IRR |  |  | 228,194 |  |  | $ | 8,906 |  |  |  | 306,651 |  |  | $ | 11,276 |  |  |  | 436,681 |  |  | $ | 14,026 |

(1) | The grant date fair value for units issued during the year ended December 31, 2018 ranged from $37.55 to $39.03. The grant date fair value for the units issued during the year ended December 31, 2019 was $36.77 per share .The grand date fair value for the units issued during the year ended December 31, 2020 was $32.12 .

The current financial performance factors and respective vesting rates for each of the 2018, 2019 and 2020 grants are as follows:

|  | Year Ended December 31, |  |  | Percentage of Shares Vesting |
|  | 2018 |  |  | 2019 |  |  | 2020 |  |  |  |  |
Threshold IRR |  | 6.0% |  |  | 6.0% |  |  | 6.0% |  |  | 33.3% |
Target IRR |  | 8.0% |  |  | 8.0% |  |  | 8.0% |  |  | 66.6% |
Maximum IRR |  | 14.0% |  |  | 14.0% |  |  | 14.0% |  |  | 100.0% |

Below is a summary of activity for restricted stock unit awards for the periods indicated:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Number of restricted stock unit awards that vested during the period |  |  | 127,084 |  |  |  | 90,895 |  |  |  | 208,204 |
Fair value of restricted stock unit awards that vested during the period |  | $ | 4,846 |  |  | $ | 3,658 |  |  | $ | 5,050 |
Accumulated dividends paid upon vesting of restricted stock unit awards |  | $ | 526 |  |  | $ | 386 |  |  | $ | 942 |
Compensation expense recognized during the period |  | $ | 4,681 |  |  | $ | 4,430 |  |  | $ | 3,931 |
Income tax benefit recognized upon vesting of restricted stock unit awards |  | $ | 708 |  |  | $ | 397 |  |  | $ | 788 |

During the year ended December 31, 2019, the Company modified the performance target levels for the restricted stock unit awards granted during February 2017 and February 2018 for all participants other than certain executive officers. The modification adjusted the threshold, target and maximum IRR levels from 7.0%, 9.5% and 13.0%, respectively, to 6.0%, 8.0% and 14.0%, respectively. The Company accounted for the change in performance measures as modifications of each award, and recorded a reduction to compensation expense of $132 at the time of the modification. Simultaneous with the modification of the restricted stock unit awards granted during February 2017, the Company determined that the final IRR reached for the respective measurement period was 9.3%, which resulted in a reduction in compensation expense of approximately $563.

As of December 31, 2020, the Company had restricted stock units outstanding that represented a total 890,680 hypothetical shares of common stock.

As of December 31, 2020, the remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $11,849, which reflects an IRR level of 9.3% that was achieved for the 2017 grant and an IRR level of 8.0% that is estimated for the 2018, 2019 and 2020 grants. The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

F-45

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

18. | SUPPLEMENTAL CASH FLOW INFORMATION

The following is provided as supplemental information to the consolidated statements of cash flows:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Cash paid for interest |  | $ | 98,411 |  |  | $ | 93,907 |  |  | $ | 102,859 |
Cash paid (refunds received) for income taxes, net |  | $ | 64,199 |  |  | $ | 88,670 |  |  | $ | (116,916 | )
Cash balance classified as restricted (1) |  | $ | — |  |  | $ | — |  |  | $ | 13,847 |
Noncash investing and financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (2) |  | $ | (5,728 | ) |  | $ | 22,013 |  |  | $ | (13,259 | )
Theatre properties acquired under finance leases |  | $ | 18,851 |  |  | $ | 21,535 |  |  | $ | — |
Theatre properties acquired as distribution from equity investee (see Note 9) |  | $ | — |  |  | $ | — |  |  | $ | 102,719 |
Investment in NCM – receipt of common units (see Note 8) |  | $ | 5,012 |  |  | $ | 1,552 |  |  | $ | 3,620 |
Interest expense - NCM (see Notes 5 and 8) |  | $ | (19,724 | ) |  | $ | (28,624 | ) |  | $ | (23,595 | )
Dividends accrued on unvested restricted stock unit awards |  | $ | (624 | ) |  | $ | (670 | ) |  | $ | (256 | )

| (1) | Funds are held as collateral for letters of credit associated with certain of the Company’s international subsidiary loans. See further discussion at Note 13.

| (2) | Additions to theatre properties and equipment included in accounts payable as of December 31, 2019 and 2020 were $37,004 and $14,991, respectively.

19. | INCOME TAXES

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was enacted in response to the global COVID-19 pandemic. The CARES Act contains several business tax provisions aimed at stimulating a failing economy. One of these provisions allows corporate taxpayers to take net operating losses earned in 2018, 2019 and 2020 and carry back those losses five years. As a result of the impact of the COVID-19 pandemic on the Company’s business, it generated significant net operating losses during the year ended December 31, 2020. The Company carried back these losses under the five-year net operating loss (“NOL”) carryback provision, which enabled the Company to benefit from these losses and re-measure certain deferred tax assets and liabilities at the former federal tax rate of 35%. During the year ended December 31, 2020, the Company recorded tax benefits of $187,515 related to the NOL carryback provision.

The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Income (loss) before income taxes: |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 289,727 |  |  | $ | 235,571 |  |  | $ | (784,167 | )
Foreign |  |  | 21,007 |  |  |  | 38,189 |  |  |  | (143,157 | )
Total |  | $ | 310,734 |  |  | $ | 273,760 |  |  | $ | (927,324 | )

F-46

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Current and deferred income taxes were as follows:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Current: |  |  |  |  |  |  |  |  |  |  |  |
Federal |  | $ | 46,826 |  |  | $ | 45,247 |  |  | $ | (271,162 | )
Foreign |  |  | 11,822 |  |  |  | 24,022 |  |  |  | 397 |
State |  |  | 13,594 |  |  |  | 12,486 |  |  |  | 289 |
Total current expense |  | $ | 72,242 |  |  | $ | 81,755 |  |  | $ | (270,476 | )
Deferred: |  |  |  |  |  |  |  |  |  |  |  |
Federal |  | $ | 27,055 |  |  | $ | (298 | ) |  | $ | (50,445 | )
Foreign |  |  | (6,166 | ) |  |  | 5 |  |  |  | 13,266 |
State |  |  | 2,298 |  |  |  | (1,550 | ) |  |  | (1,721 | )
Total deferred taxes |  | $ | 23,187 |  |  | $ | (1,843 | ) |  | $ | (38,900 | )
Income taxes |  | $ | 95,429 |  |  | $ | 79,912 |  |  | $ | (309,376 | )

A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Computed statutory tax expense |  | $ | 65,254 |  |  | $ | 57,490 |  |  | $ | (194,739 | )
State and local income taxes, net of federal income tax impact |  |  | 12,611 |  |  |  | 8,479 |  |  |  | (1,153 | )
Changes in valuation allowance |  | 131 |  |  |  | 2,532 |  |  |  | 46,731 |
Foreign tax rate differential |  |  | 2,235 |  |  |  | 4,646 |  |  |  | (6,633 | )
Foreign dividends |  | — |  |  | — |  |  | — |
Foreign tax credits |  |  | 3,927 |  |  |  | 4,143 |  |  | — |
Impacts related to 2017 Tax Act (1) |  |  | 19,180 |  |  | — |  |  | — |
Impacts related to COVID-19 pandemic (2) |  | — |  |  | — |  |  |  | (187,515 | )
Changes in uncertain tax positions |  |  | (6,139 | ) |  |  | 197 |  |  |  | 24,879 |
Other, net |  |  | (1,770 | ) |  |  | 2,425 |  |  |  | 9,054 |
Income taxes |  | $ | 95,429 |  |  | $ | 79,912 |  |  | $ | (309,376 | )

(1) | The amount for the year ended December 31, 2018 includes a one-time charge to true-up deferred taxes of $1,913 and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $17,267.

(2) | The amount for the year ended December 31, 2020 includes benefits of a rate differential on earnings of $122,975, tax losses with respect to investments in foreign subsidiaries and a write down of certain intercompany receivables associated with the Company’s foreign subsidiaries of $135,599, offset by a tax charge for the remeasurement of deferred taxes and tax attributes of $49,866 and dislodged foreign tax credits not benefited of $21,193.

As of December 31, 2020, the Company had approximately $160,487 of accumulated undistributed earnings and profits, approximately $113,364 of which was subject to the one-time transition tax pursuant to the 2017 Tax Act. Additional tax due on the repatriation of previously-taxed earnings would generally be foreign withholding and U.S. state income taxes. The Company does not intend to repatriate these offshore earnings and profits, and therefore has not recorded any deferred taxes on such earnings. The Company considers any excess of the amount for financial reporting over the tax basis of its investment in its foreign subsidiaries to be indefinitely reinvested. At this time, the determination of deferred tax liabilities on this amount is not practicable.

F-47

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

Deferred Income Taxes

The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of the periods presented consisted of the following:

|  | December 31, |
|  | 2019 |  |  | 2020 |
Deferred liabilities: |  |  |  |  |  |  |  |
Theatre properties and equipment |  | $ | 138,382 |  |  | $ | 142,253 |
Operating lease right-of-use assets |  |  | 322,750 |  |  |  | 297,452 |
Intangible asset — other |  |  | 39,282 |  |  |  | 41,297 |
Intangible asset — tradenames |  |  | 72,821 |  |  |  | 72,268 |
Investment in partnerships |  |  | 62,914 |  |  |  | 20,402 |
Total deferred liabilities |  |  | 636,149 |  |  |  | 573,672 |
Deferred assets: |  |  |  |  |  |  |  |
Deferred revenue - NCM |  |  | 85,362 |  |  |  | 83,998 |
Deferred revenue - Other |  |  | 9,953 |  |  |  | 6,208 |
Prepaid rent |  |  | 5,672 |  |  |  | 5,255 |
Gift Cards |  |  | 7,402 |  |  |  | 9,265 |
Operating lease obligations |  |  | 336,034 |  |  |  | 313,552 |
Finance lease obligations |  |  | 34,956 |  |  |  | 31,284 |
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital |  |  | 5,131 |  |  |  | 19,475 |
Other tax loss carryforwards |  |  | 17,053 |  |  |  | 89,320 |
Other tax credit and attribute carryforwards |  |  | 46,577 |  |  |  | 121,698 |
Other expenses, not currently deductible for tax purposes |  |  | 15,901 |  |  |  | 17,698 |
Total deferred assets |  |  | 564,041 |  |  |  | 697,753 |
Net deferred income tax (asset) liability before valuation allowance |  |  | 72,108 |  |  |  | (124,081 | )
Valuation allowance against deferred assets – non-current |  |  | 60,359 |  |  |  | 203,606 |
Net deferred income tax liability |  | $ | 132,467 |  |  | $ | 79,525 |
Net deferred tax (asset) liability — Foreign |  | $ | (4,539 | ) |  | $ | 7,280 |
Net deferred tax liability — U.S. |  |  | 137,006 |  |  |  | 72,245 |
Total |  | $ | 132,467 |  |  | $ | 79,525 |

As noted above, as a result of the CARES Act, the Company generated U.S. taxable income in prior years and expects to have a U.S. tax net operating loss for the year ended December 31, 2020 that will be carried back to prior years when the tax rate was 35%. Most of the state and all foreign jurisdictions in which the Company operates, however, only allow for net operating losses to be carried forward with varying expiration dates. A majority of our foreign tax credit carryforwards expire in 2024 and 2027, with the remainder expiring in 2029. Foreign net operating losses have varying carryforward periods with some being indefinite. Similarly, state net operating losses have varying carryforward periods with some being indefinite.

The Company assesses the likelihood that it will be able to recover its deferred tax assets against future sources of taxable income, and reduce the carrying amounts of deferred tax assets by recording a valuation allowance, if, based on all available evidence, the Company believes it is more likely than not that all or a portion of such assets will not be realized. During the year ended December 31, 2020 the Company generated significant pre-tax losses and more specifically, during the fourth quarter of 2020 the Company reached a three-year cumulative pre-tax loss position that is heavily weighted as objectively verifiable negative evidence. For purposes of assessing

F-48

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

the recoverability of its deferred tax assets, the Company determined that it could not include future projected earnings in the analysis due to its recent history of significant pre-tax losses.

The Company has established a valuation allowance against certain deferred tax assets for which the ultimate realization of future benefits is uncertain. Expiring carryforwards and the required valuation allowances are adjusted annually. After application of the valuation allowances described above, the Company anticipates that no limitations will apply with respect to utilization of any of the other deferred tax assets described above.

The Company’s valuation allowance changed from $60,359 at December 31, 2019 to $203,606 at December 31, 2020 (see Note 23). The increase relates to federal deferred tax assets with respect to foreign tax credits, all net foreign deferred tax assets, all state net operating loss carryforwards and minor state tax attributes. The valuation allowance associated with operating loss carryforwards and foreign deferred tax assets is primarily a result of not having sufficient income from deferred tax liability reversals in future periods to support the realization of the deferred tax assets. When the Company begins to generate taxable income at a normal level, the Company expects to reverse the valuation allowances with an offsetting increase to reported earnings.

Uncertain Tax Positions

The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the periods presented:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Balance at January 1, |  | $ | 18,266 |  |  | $ | 10,561 |  |  | $ | 10,235 |
Gross increases - tax positions in prior periods |  |  | — |  |  | 1 |  |  |  | 32,417 |
Gross decreases - tax positions in prior periods |  |  | (143 | ) |  |  | — |  |  |  | (88 | )
Gross increases - current period tax positions |  |  | 424 |  |  |  | 202 |  |  |  | 4,010 |
Settlements |  |  | (7,191 | ) |  |  | (522 | ) |  |  | — |
Foreign currency translation adjustments |  |  | (795 | ) |  |  | (7 | ) |  |  | (46 | )
Balance at December 31, |  | $ | 10,561 |  |  | $ | 10,235 |  |  | $ | 46,528 |

The Company had $14,294 and $51,643 of unrecognized tax benefits, including interest and penalties, as of December 31, 2019 and 2020, respectively. Of these amounts, $14,294 and $51,643 represent the amount of unrecognized tax benefits that, if recognized, would impact the effective income tax rate for the years ended December 31, 2019 and 2020, respectively. The Company had $4,058 and $5,114 accrued for interest and penalties as of December 31, 2019 and 2020, respectively.

The Company prepares and files income tax returns based upon its interpretation of tax laws and regulations and record estimates based upon these judgments and interpretations. In the normal course of business, the Company’s income tax returns are subject to examination by various taxing authorities. Such examinations may result in future tax and interest assessments by these taxing authorities. Inherent uncertainties exist in estimates of tax contingencies due to changes in tax law resulting from legislation, regulation, and/or as concluded through the various jurisdictions' tax court systems. Significant judgment is exercised in applying complex tax laws and regulations across multiple global jurisdictions where we conduct our operations. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based upon the technical merits of the position.

The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2017. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2016. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2006.

The Company is currently scheduled for an audit in California for tax years 2017 and 2018 and is under audit in the non-U.S. tax jurisdiction of Brazil.

F-49

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

20. | COMMITMENTS AND CONTINGENCIES

Employment Agreements — As of December 31, 2020, the Company had employment agreements with Lee Roy Mitchell, Mark Zoradi, Sean Gamble, Valmir Fernandes and Michael Cavalier. The employment agreements for Messrs. Mitchell, Gamble, Fernandes and Cavalier are subject to automatic extensions for a one year period, unless the employment agreements are terminated. The employment agreement for Mr. Zoradi will expire on December 31, 2021 unless extended by the Company and Mr. Zoradi. The base salaries stipulated in the employment agreements are subject to review at least annually during the term of the agreements for increase (but not decrease) by the Company’s Compensation Committee. Management personnel subject to these employment agreements are eligible to receive annual cash incentive bonuses upon the Company meeting certain performance targets established by the Compensation Committee.

Retirement Savings Plan — The Company has a 401(k) retirement savings plan (“401(k) Plan”) for the benefit of all eligible employees and makes matching contributions as determined annually in accordance with the 401(k) Plan. Employer matching contribution payments of $6,052 and $1,562 were made during 2019 and 2020, respectively. A liability of approximately $2,123 was recorded at December 31, 2020 for employer contribution payments to be made in 2021 for the remaining amounts owed for plan year 2020.

Legal Proceedings

From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, patent claims, landlord-tenant disputes, contractual disputes with landlords over certain termination rights or the right to discontinue rent payments due to the COVID-19 pandemic and other contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

Cinemark Holdings, Inc., et al vs Factory Mutual Insurance Company. The Company filed suit on November 18, 2020, in the District Court, 471st Judicial District, Collin County, Texas. On December 22, 2020, the case was moved to the US District Court for the Eastern District of Texas, Sherman Division. The Company submitted a claim under its property insurance policy issued by Factory Mutual Insurance Company (the “FM Policy”) for losses sustained as a result of the COVID-19 pandemic and the forced closure of the Company’s theatres pursuant to orders issued by various government agencies. Factory Mutual Insurance Company (“FM”) denied the Company’s claim. The Company is seeking damages resulting from FM’s breach of contract, FM’s bad faith conduct and a declaration of the parties’ rights under the FM Policy. While the Company cannot predict the outcome of this litigation, management believes this lawsuit will not have a material adverse effect on the company’s financial position or results of operations.

Intertrust Technologies Corporation (“Intertrust”) v. Cinemark Holdings, Inc., Regal, AMC, et al. This case was filed against the Company on August 7, 2019 in the Eastern District of Texas – Marshall Division alleging patent infringement. The Company firmly maintains that the contentions of the Plaintiff are without merit and will vigorously defend itself against the lawsuit. Although the Company does not believe that it has infringed on any of Intertrust’s patents, it cannot predict the outcome of this litigation.

Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles. Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortiously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional,

F-50

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards. Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees. During 2018, the Company recorded a litigation reserve based on the jury award, court costs and attorney’s fees. The trial court denied a motion for a judgment notwithstanding the verdict and a motion for a new trial. The Company appealed the judgment. On October 2, 2020 the Court of Appeals of the State of California reversed the judgement in favor of the Plaintiff and rendered judgement in favor of the Company. Plaintiff has agreed to not appeal this ruling to the California Supreme Court; therefore, the ruling in favor of the Company is final and non-appealable. The Company reversed the litigation reserve in the third quarter of 2020.

21. | SEGMENTS

The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report asset information by segment because that information is not used to evaluate Company performance or allocate resources between segments.

Below is a breakdown of select financial information by reportable operating segment:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Revenues |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 2,551,719 |  |  | $ | 2,594,246 |  |  | $ | 559,184 |
International |  |  | 682,778 |  |  |  | 702,196 |  |  |  | 129,401 |
Eliminations |  |  | (12,762 | ) |  |  | (13,343 | ) |  |  | (2,275 | )
Total revenues |  | $ | 3,221,735 |  |  | $ | 3,283,099 |  |  | $ | 686,310 |
Adjusted EBITDA (1) |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 648,576 |  |  | $ | 615,161 |  |  | $ | (226,981 | )
International |  |  | 132,941 |  |  |  | 129,884 |  |  |  | (49,899 | )
Total Adjusted EBITDA |  | $ | 781,517 |  |  | $ | 745,045 |  |  | $ | (276,880 | )
Capital expenditures |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 270,870 |  |  | $ | 230,561 |  |  | $ | 64,026 |
International |  |  | 75,203 |  |  |  | 73,066 |  |  |  | 19,904 |
Total capital expenditures |  | $ | 346,073 |  |  | $ | 303,627 |  |  | $ | 83,930 |

| (1) | Distributions from equity investees are reported entirely within the U.S. operating segment.

F-51

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

The following table sets forth a reconciliation of net income to Adjusted EBITDA:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Net income (loss) |  | $ | 215,305 |  |  | $ | 193,848 |  |  | $ | (617,948 | )
Add (deduct): |  |  |  |  |  |  |  |  |  |  |  |
Income taxes |  |  | 95,429 |  |  |  | 79,912 |  |  |  | (309,376 | )
Interest expense (1) |  |  | 109,994 |  |  |  | 99,941 |  |  |  | 129,871 |
Loss on debt amendments and refinancing |  |  | 1,484 |  |  |  | — |  |  |  | — |
Other income (2) |  |  | (18,472 | ) |  |  | (22,441 | ) |  |  | 62,369 |
Distributions from DCIP (3) |  |  | 5,799 |  |  |  | 23,696 |  |  |  | 10,383 |
Other cash distributions from equity investees (4) |  |  | 24,344 |  |  |  | 29,670 |  |  |  | 15,047 |
Non-cash distributions from other equity investee (5) |  |  | — |  |  |  | — |  |  |  | (12,915 | )
Depreciation and amortization |  |  | 261,162 |  |  |  | 261,155 |  |  |  | 259,776 |
Impairment of long-lived assets and investments |  |  | 32,372 |  |  |  | 57,001 |  |  |  | 152,706 |
(Gain) loss on disposal of assets and other |  |  | 38,702 |  |  |  | 12,008 |  |  |  | (8,923 | )
Restructuring charges |  |  | — |  |  |  | — |  |  |  | 20,369 |
Non-cash rent expense |  |  | — |  |  |  | (4,360 | ) |  |  | 2,357 |
Deferred lease expenses |  |  | (1,320 | ) |  |  | — |  |  |  | — |
Amortization of long-term prepaid rents |  |  | 2,382 |  |  |  | — |  |  |  | — |
Share based awards compensation expense |  |  | 14,336 |  |  |  | 14,615 |  |  |  | 19,404 |
Adjusted EBITDA |  | $ | 781,517 |  |  | $ | 745,045 |  |  | $ | (276,880 | )

| (1) | Includes amortization of debt issue costs.

| (2) | Includes interest income, foreign currency exchange gain (loss), interest expense – NCM and equity in income of affiliates and excludes distributions from NCM.

| (3) | See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 9. These distributions are reported entirely within the U.S. operating segment.

| (4) | Reflects cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 8 and 9). These distributions are reported entirely within the U.S. operating segment.

| (5) | Reflects non-cash distribution of projectors from DCIP (see Note 9). These distributions are reported entirely within the U.S. operating segment.

Financial Information About Geographic Area

Below is a breakdown of select financial information by geographic area:

|  | Year Ended December 31, |
|  | 2018 |  |  | 2019 |  |  | 2020 |
Revenues |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 2,551,719 |  |  | $ | 2,594,246 |  |  | $ | 559,184 |
Brazil |  |  | 283,009 |  |  |  | 302,074 |  |  |  | 59,321 |
Other international countries |  |  | 399,769 |  |  |  | 400,122 |  |  |  | 70,080 |
Eliminations |  |  | (12,762 | ) |  |  | (13,343 | ) |  |  | (2,275 | )
Total |  | $ | 3,221,735 |  |  | $ | 3,283,099 |  |  | $ | 686,310 |

|  | December 31, 2019 |  |  | December 31, 2020 |
Theatre Properties and Equipment-net |  |  |  |  |  |  |  |
U.S. |  | $ | 1,479,603 |  |  | $ | 1,392,780 |
Brazil |  |  | 140,570 |  |  |  | 72,080 |
Other international countries |  |  | 212,960 |  |  |  | 150,202 |
Total |  | $ | 1,735,247 |  |  | $ | 1,615,062 |

F-52

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

22. | RELATED PARTY TRANSACTIONS

The Company manages theatres for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is the Company’s Chairman of the Board and directly and indirectly owns approximately 8% of the Company’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $654, $694 and $146 of management fee revenues during the years ended December 31, 2018, 2019 and 2020, respectively. All such amounts are included in the Company’s consolidated financial statements with the intercompany amounts eliminated in consolidation.

The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the years ended December 31, 2018, 2019 and 2020, the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was approximately $68, $114 and $12, respectively.

The Company currently leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of the Company’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the years ended December 31, 2018, 2019 and 2020, the Company paid total rent of approximately $23,447, $25,678 and $23,810, respectively, to Syufy. During 2019, the Company began providing digital equipment support to drive-in theatres owned by Syufy. The Company recorded approximately $30 and $0 of management fees related to these services during the years ended December 31, 2019 and 2020, respectively.

The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 9 for further discussion. The Company has a theatre services agreement with FE Concepts under which the Company receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded $64 and $34 of service fees during the years ended December 31, 2019 and 2020, respectively. Additionally, the Company held a holiday party at the facility owned by FE Concepts for which the Company paid FE Concepts $78 in event fees during the year ended December 31, 2019.

23. | VALUATION AND QUALIFYING ACCOUNTS

The Company’s valuation allowance for deferred tax assets for the periods presented were as follows:

|  | Valuation Allowance for Deferred Taxes |
Balance at January 1, 2018 |  | $ | 35,246 |
Additions |  |  | 22,005 |
Deductions |  |  | (2,526 | )
Balance at December 31, 2018 |  | $ | 54,725 |
Additions |  |  | 7,611 |
Deductions |  |  | (1,977 | )
Balance at December 31, 2019 |  | $ | 60,359 |
Additions |  |  | 144,239 |
Deductions |  |  | (992 | )
Balance at December 31, 2020 |  | $ | 203,606 |

F-53

CINEMARK HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In thousands, except share and per share data

24. | QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

|  | 2019 |
|  | First Quarter |  |  | Second Quarter |  |  | Third Quarter |  |  | Fourth Quarter |  |  | Full Year |
Revenues |  | $ | 714,723 |  |  | $ | 957,756 |  |  | $ | 821,817 |  |  | $ | 788,803 |  |  | $ | 3,283,099 |
Operating income |  | $ | 57,368 |  |  | $ | 156,052 |  |  | $ | 58,531 |  |  | $ | 66,436 |  |  | $ | 338,387 |
Net income |  | $ | 33,193 |  |  | $ | 101,861 |  |  | $ | 31,955 |  |  | $ | 26,839 |  |  | $ | 193,848 |
Net income attributable to Cinemark Holdings, Inc. |  | $ | 32,728 |  |  | $ | 100,971 |  |  | $ | 31,353 |  |  | $ | 26,334 |  |  | $ | 191,386 |
Net income per share attributable to Cinemark Holdings, Inc.’s common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.28 |  |  | $ | 0.86 |  |  | $ | 0.27 |  |  | $ | 0.22 |  |  | $ | 1.63 |
Diluted |  | $ | 0.28 |  |  | $ | 0.86 |  |  | $ | 0.27 |  |  | $ | 0.22 |  |  | $ | 1.63 |

|  | 2020(1) |
|  | First Quarter |  |  | Second Quarter |  |  | Third Quarter |  |  | Fourth Quarter |  |  | Full Year |
Revenues |  | $ | 543,616 |  |  | $ | 8,974 |  |  | $ | 35,478 |  |  | $ | 98,242 |  |  | $ | 686,310 |
Operating income (loss) |  | $ | (42,919 | ) |  | $ | (214,275 | ) |  | $ | (210,784 | ) |  | $ | (286,996 | ) |  | $ | (754,974 | )
Net income (loss) |  | $ | (59,422 | ) |  | $ | (170,816 | ) |  | $ | (148,036 | ) |  | $ | (239,674 | ) |  | $ | (617,948 | )
Net income (loss) attributable to Cinemark Holdings, Inc. |  | $ | (59,591 | ) |  | $ | (170,389 | ) |  | $ | (147,592 | ) |  | $ | (239,256 | ) |  | $ | (616,828 | )
Net income (loss) per share attributable to Cinemark Holdings, Inc.’s common stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (0.51 | ) |  | $ | (1.45 | ) |  | $ | (1.25 | ) |  | $ | (2.03 | ) |  | $ | (5.25 | )
Diluted |  | $ | (0.51 | ) |  | $ | (1.45 | ) |  | $ | (1.25 | ) |  | $ | (2.03 | ) |  | $ | (5.25 | )

| (1) | Quarterly results during the year ended December 31, 2020 were impacted by the COVID-19 pandemic (see Note 3) as well as impairment recorded (see Notes 1 and 11).

*****

F-54

SCHEDULE 1 - CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CINEMARK HOLDINGS, INC.

PARENT COMPANY BALANCE SHEETS

(In thousands, except share data)

|  | December 31, |  |  | December 31, |
|  | 2019 |  |  | 2020 |
Assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 97 |  |  | $ | 394,800 |
Prepaid assets and other |  |  | — |  |  |  | 8 |
Investment in subsidiaries |  |  | 1,461,701 |  |  |  | 773,999 |
Total assets |  | $ | 1,461,798 |  |  | $ | 1,168,807 |
Liabilities and equity |  |  |  |  |  |  |  |
Liabilities |  |  |  |  |  |  |  |
Accrued other current liabilities, including accounts payable to subsidiaries |  | $ | 24,948 |  |  | $ | 38,338 |
Long-term debt |  |  | — |  |  |  | 352,206 |
Other long-term liabilities |  |  | 1,036 |  |  |  | (9,710 | )
Total liabilities |  |  | 25,984 |  |  |  | 380,834 |
Commitments and contingencies (see Note 6) |  |  |  |  |  |  |  |
Equity |  |  |  |  |  |  |  |
Common stock, $0.001 par value: 300,000,000 shares authorized, 121,863,515 shares issued and 117,151,656 shares outstanding at December 31, 2019 and 123,627,080 shares issued and 118,576,099 shares outstanding at December 31, 2020 |  |  | 122 |  |  |  | 124 |
Additional paid-in-capital |  |  | 1,170,039 |  |  |  | 1,245,569 |
Treasury stock, 4,711,859 and 5,050,981 shares, at cost, at December 31, 2019 and December 31, 2020, respectively |  |  | (81,567 | ) |  |  | (87,004 | )
Retained earnings |  |  | 687,332 |  |  |  | 27,937 |
Accumulated other comprehensive loss |  |  | (340,112 | ) |  |  | (398,653 | )
Total equity |  |  | 1,435,814 |  |  |  | 787,973 |
Total liabilities and equity |  | $ | 1,461,798 |  |  | $ | 1,168,807 |

The accompanying notes are an integral part of the condensed financial information of the registrant.

S-1

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF INCOME (LOSS)

YEARS ENDED DECEMBER 31, 2018, 2019 and 2020

(in thousands)

|  | 2018 |  |  | 2019 |  |  | 2020 |
Revenues |  | $ | — |  |  | $ | — |  |  | $ | — |
Cost of operations |  |  | 2,535 |  |  |  | 2,556 |  |  |  | 2,236 |
Operating loss |  |  | (2,535 | ) |  |  | (2,556 | ) |  |  | (2,236 | )
Interest expense |  |  | — |  |  |  | — |  |  |  | (14,220 | )
Other income |  |  | 22 |  |  |  | 20 |  |  |  | 56 |
Loss before income taxes and equity in income of subsidiaries |  |  | (2,513 | ) |  |  | (2,536 | ) |  |  | (16,400 | )
Income taxes |  |  | 605 |  |  |  | 609 |  |  |  | 5,740 |
Equity in income (loss) of subsidiaries, net of taxes |  |  | 215,735 |  |  |  | 193,313 |  |  |  | (606,168 | )
Net income (loss) |  | $ | 213,827 |  |  | $ | 191,386 |  |  | $ | (616,828 | )

The accompanying notes are an integral part of the condensed financial information of the registrant.

S-2

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF COMPREHENSIVE INCOME

YEARS ENDED DECEMBER 31, 2018, 2019 and 2020

(In thousands)

|  | 2018 |  |  | 2019 |  |  | 2020 |
Net income (loss) |  | $ | 213,827 |  |  | $ | 191,386 |  |  | $ | (616,828 | )
Other comprehensive income (loss), net of tax |  |  |  |  |  |  |  |  |  |  |  |
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1,243, $2,692 and $3,532, net of settlements |  |  | (3,851 | ) |  |  | (8,210 | ) |  |  | (10,949 | )
Other comprehensive income (loss) in equity method investments |  |  | (139 | ) |  |  | (142 | ) |  |  | — |
Foreign currency translation adjustments |  |  | (62,253 | ) |  |  | (12,753 | ) |  |  | (47,592 | )
Total other comprehensive loss, net of tax |  |  | (66,243 | ) |  |  | (21,105 | ) |  |  | (58,541 | )
Comprehensive income (loss) attributable to Cinemark Holdings, Inc. |  | $ | 147,584 |  |  | $ | 170,281 |  |  | $ | (675,369 | )

The accompanying notes are an integral part of the condensed financial information of the registrant.

S-3

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF CASH FLOWS

YEARS ENDED DECEMBER 31, 2018, 2019 and 2020

(in thousands)

|  | 2018 |  |  | 2019 |  |  | 2020 |
Operating Activities |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 213,827 |  |  | $ | 191,386 |  |  | $ | (616,828 | )
Adjustments to reconcile net income (loss) to cash provided by operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Share based awards compensation expense |  |  | 920 |  |  |  | 920 |  |  |  | 919 |
Equity in (income) loss of subsidiaries |  |  | (215,735 | ) |  |  | (193,313 | ) |  |  | 606,168 |
Changes in other assets and liabilities |  |  | 4,509 |  |  |  | 4,237 |  |  |  | 19,984 |
Net cash provided by operating activities |  |  | 3,521 |  |  |  | 3,230 |  |  |  | 10,243 |
Investing Activities |  |  |  |  |  |  |  |  |  |  |  |
Dividends received from subsidiaries |  |  | 148,750 |  |  |  | 158,450 |  |  |  | 42,000 |
Net cash provided by investing activities |  |  | 148,750 |  |  |  | 158,450 |  |  |  | 42,000 |
Financing Activities |  |  |  |  |  |  |  |  |  |  |  |
Dividends paid to stockholders |  |  | (149,492 | ) |  |  | (159,281 | ) |  |  | (42,311 | )
Proceeds from convertible notes issued |  |  | — |  |  |  | — |  |  |  | 460,000 |
Payment of debt issue costs |  |  | — |  |  |  | — |  |  |  | (17,122 | )
Purchase of convertible note hedges |  |  | — |  |  |  | — |  |  |  | (142,094 | )
Proceeds from warrants issued |  |  | — |  |  |  | — |  |  |  | 89,424 |
Payroll taxes paid as a result of noncash stock option exercises |  |  | (2,905 | ) |  |  | (2,308 | ) |  |  | (5,437 | )
Net cash provided by (used for) financing activities |  |  | (152,397 | ) |  |  | (161,589 | ) |  |  | 342,460 |
Increase (decrease) in cash and cash equivalents |  |  | (126 | ) |  |  | 91 |  |  |  | 394,703 |
Cash and cash equivalents: |  |  |  |  |  |  |  |  |  |  |  |
Beginning of period |  |  | 132 |  |  |  | 6 |  |  |  | 97 |
End of period |  | $ | 6 |  |  | $ | 97 |  |  | $ | 394,800 |

The accompanying notes are an integral part of the condensed financial information of the registrant.

S-4

CINEMARK HOLDINGS, INC.

NOTES TO PARENT COMPANY FINANCIAL STATEMENTS

In thousands, except share and per share data

1. | BASIS OF PRESENTATION

Cinemark Holdings, Inc. conducts substantially all of its operations through its subsidiaries. These statements should be read in conjunction with the Company’s consolidated financial statements and notes included elsewhere in this annual report on Form 10-K. There are significant restrictions over Cinemark Holdings, Inc.’s ability to obtain funds from its subsidiaries through dividends, loans or advances as contained in Cinemark USA, Inc.’s senior secured credit facility and the indentures to each of the 4.875% Senior Notes, the 5.125% Senior Notes and the 8.750% Secured Notes (collectively referred to herein as the “Notes”). These condensed parent company financial statements have been prepared in accordance with Rule 12-04, Schedule I of Regulation S-X, as the restricted net assets of Cinemark Holdings, Inc.’s subsidiaries under each of the debt agreements previously noted exceeds 25 percent of the consolidated net assets of Cinemark Holdings, Inc. As of December 31, 2020, the restricted net assets totaled approximately $665,618 and $608,788 under the senior secured credit facility and the Notes, respectively. See Note 13 to the Company’s consolidated financial statements included elsewhere in this annual report on Form 10-K.

2. | DIVIDEND PAYMENTS

Below is a summary of dividends declared for the fiscal periods indicated.

|  |  |  |  |  | Amount per Share of |  |  | Total |
Declaration Date |  | Record Date |  | Payable Date |  | Common Stock |  |  | Dividends (1) |
2/23/2018 |  | 3/8/2018 |  | 3/22/2018 |  | $ | 0.32 |  |  | $ | 37,471 |
5/25/2018 |  | 6/8/2018 |  | 6/22/2018 |  |  | 0.32 |  |  |  | 37,523 |
8/23/2018 |  | 9/4/2018 |  | 9/18/2018 |  |  | 0.32 |  |  |  | 37,530 |
11/15/2018 |  | 12/4/2018 |  | 12/18/2018 |  |  | 0.32 |  |  |  | 37,592 |
Total for year ended December 31, 2018 |  | $ | 1.28 |  |  | $ | 150,116 |
2/23/2019 |  | 3/8/2019 |  | 3/22/2019 |  | $ | 0.34 |  |  | $ | 39,905 |
5/24/2019 |  | 6/10/2019 |  | 6/24/2019 |  |  | 0.34 |  |  |  | 40,012 |
8/16/2019 |  | 9/4/2019 |  | 9/18/2019 |  |  | 0.34 |  |  |  | 40,020 |
11/22/2019 |  | 12/4/2019 |  | 12/18/2019 |  |  | 0.34 |  |  |  | 40,014 |
Total for year ended December 31, 2019 |  | $ | 1.36 |  |  | $ | 159,951 |
2/21/2020 |  | 3/6/2020 |  | 3/20/2020 |  | $ | 0.36 |  |  | $ | 42,567 |
Total for year ended December 31, 2020 |  | $ | 0.36 |  |  | $ | 42,567 |

(1) | Of the dividends recorded during 2018, 2019 and 2020, $624, $670 and $256, respectively, were related to outstanding restricted stock units and will not be paid until such units vest.

3. | DIVIDENDS RECEIVED FROM SUBSIDIARIES

During the years December 31, 2018, 2019 and 2020, Cinemark Holdings, Inc. received cash dividends of $148,750, $158,450 and $42,000, respectively, from its subsidiary, Cinemark USA, Inc.

4. | LONG-TERM DEBT

On August 21, 2020, Cinemark Holdings, Inc. issued $460,000 aggregate principal amount of 4.50% Convertible Senior Notes, which will mature on August 15, 2025. Additionally, certain of Cinemark Holdings, Inc.’s subsidiaries have direct outstanding debt obligations. For a discussion of the debt obligations of Cinemark Holdings, Inc.’ and its subsidiaries, see Note 13 to the Company’s consolidated financial statements included elsewhere in this annual report on Form 10-K.

S-5

CINEMARK HOLDINGS, INC.

NOTES TO PARENT COMPANY FINANCIAL STATEMENTS

In thousands, except share and per share data

5. | CAPITAL STOCK

Cinemark Holdings, Inc.’s capital stock along with its long-term incentive plan and related activity are discussed in Note 17 of the Company’s consolidated financial statements included elsewhere in this annual report on Form 10-K.

6. | COMMITMENTS AND CONTINGENCIES

Cinemark Holdings, Inc. has no direct commitments and contingencies, but its subsidiaries do. See Note 20 of the Company’s consolidated financial statements included elsewhere in this annual report on Form 10-K

*****

S-6